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Summary 
 
 
Polyketides (PKs) represent one of the largest groups of natural products found in fungi, 
bacteria and plants. Since many useful polyketides either originate from sources that are 
difficult or even impossible to cultivate or are produced in inadequate amounts in the 
natural hosts, it is of interest to express polyketide synthases (PKSs) in Saccharomyces 
cerevisiae. The advantages of this cell factory are that the techniques necessary for 
cultivation and genetic manipulation are well established and it is generally regarded as 
safe. 6-Methylsalicylic acid synthase (6-MSAS) was chosen as a model PKS which is 
naturally produced by e.g. Penicillium patulum. Functional expression of the 6-MSAS 
gene in S. cerevisiae requires the co-expression of a heterologous phosphopantetheinyl 
transferase (PPTase) to convert the apo-PKS into its active holo form. 
 
In order to optimize the production of polyketides, several approaches were explored, e.g. 
using different PPTases from B. subtilis and A. nidulans, respectively, for the activation of 
heterologously expressed PKS in yeast. Metabolic engineering was also applied 
throughout this study e.g. by enhancing the supply of precursors for polyketide 
biosynthesis. Furthermore, the 6-MSAS gene was also integrated in the yeast chromosome 
to maintain a stable 6-MSA production, and different amounts of glucose were applied in 
the batch cultivations to investigate the optimum initial glucose concentration for the 
production of 6-MSA. The whole genome transcription was further analyzed together with 
the analysis of metabolic fluxes in order to reveal the differences between the reference 
strain and the strain expressing 6-MSAS. Finally, to identify further targets for metabolic 
engineering, an in-silico study using a genome scale metabolic model was applied for 
analysis of the effect on production of gene-deletions. 
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Dansk sammenfatning 
 
 
Polyketider repræsenterer en stor gruppe af naturstoffer der producers af skimmelsvampe, 
bakterier og planter. En række af disses stoffer finder anvendelse som lægemidler, f.eks. 
antibiotika, kolesterolsænkende stoffer eller som kemoterapi i forbindelse med 
kræftbehandling. Mange interessante polyketider produceres dog naturligt i meget små 
mængder, og det er derfor interessant at udvikle nye generiske cellefabrikker til at 
producere disse stoffer i store mængder. Bagegær Saccharomyces cerevisiae er interessant 
at anvende som en sådan generisk cellefabrik idet der veludviklede teknikker til storskala 
fermentering af denne organisme, der er udviklet en række molekylærbiologiske værktøjer 
og den er såkaldt Generally Regarded as Safe (GRAS) godkendt. I dette studium er 6-
Methylsalicylic acid (6-MSA) valgt som et model polyketid for at vurdere muligheden for 
at producere polyketider i gær. 6-MSA produceres normalt i skimmelsvampe, f.eks. 
Penicillium patulum, men for at kunne producere 6-MSA i gær kræver foruden 
ekspression af den polyketid synthetase der producerer 6-MSA også ekspression af en 
heterolog phosphopantetheinyl transferase (PPTase) der kan omdanne polyketid 
synthetasen fra dens inaktive apo-form til dens aktive holo-form. 
 
For at optimere produktionen af 6-MSA i gær blev forskellige strategier evalueret. To 
forskellige PPTaser, fra henholdsvis B. subtilis og A. nidulans, blev evalueret, og det blev 
fundet af PPTasen fra A. nidulans gav højst produktivitet. Der blev endvidere foretaget 
metabolic engineering for at forøge dannelsen af precursoren malonoyl-CoA der anvendes 
til produktion af 6-MSA. Genet der koder for 6-MSA polyketid synthetasen blev også 
integreret i gærens kromosom for at etablere en stabil stamme. Til sidst i studiet blev 
nogle af de udviklede stammer analyseret i nærmere detaljer ved anvendelse af 
transkriptionsanalyse og metabolsk flux analyse. 
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Chapter 1  
Introduction 
 
 
1.1     Secondary metabolites 
Microorganisms especially fungi and bacteria provide us with an enormous variety of 
secondary metabolites, several of which have profound biological activities that can be 
exploited. Secondary metabolites are often associated with differentiation and sporulation, 
and are therefore produced as soon as the growth rate of the producing micoorganism 
declines and during the stationary phase. This phase of growth has been termed the 
idiophase in contrast to the trophophase characterized by activity of the primary 
metabolism that is involved in synthesis of cellular macromolecules during exponential 
growth of microbes (Carlile et al., 2001). Hence, batch and fedbatch rather than 
continuous cultivation is usually favoured for secondary metabolite production. 
 
Secondary metabolites tend to have an enormous variety of structures and biosynthetic 
origins, and they are often complex with unusual or unique components. There are several 
examples where the discovered secondary metabolites have been found to have structural 
features previously unknown in chemistry (Berdy, 1974). The tremendous variability in 
structures of secondary metabolites makes these compounds to belong to many different 
classes of organic compounds: aminocyclitols, amino sugars, quinones, coumarins, 
epoxides, glutarimides, glycosides, indole derivatives, lactones, macrolides, naphthalenes, 
nucleosides, peptides, phenazines, polyacetylenes, polyenes, pyrroles, quinolines, and 
terpenoids. In addition secondary metabolites possess unusual chemical linkages, such as 
β-lactam rings, cyclic peptides made of normal and modified amino acids, unsaturated 
bonds of polyacetylenes and polyenes, and large ring of macrolides. As a result of the 
broad substrate specificity of some biosynthetic enzymes, secondary metabolites are
 1
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produced typically as members of a particular chemical family (Martin and Gutierrez, 
1992). In spite of the diversity in chemical structures, secondary metabolites have the 
property in common that they are all synthesized from low molecular weight compounds 
which also are intermediates in synthesis of cell constituents during exponential growth 
(Rose, 1976) 
 
Although secondary metabolites do not have any obvious function in cell growth, it has 
been suggested that certain secondary metabolites may have a metabolic role, such as 
mediating passage of certain molecules across the plasma membrane (valinomycin, 
alamethicin), and playing a role in competition or combating other microbes in natural 
micro-environments (Rose, 1976), allowing the producer to invade territory occupied by 
the victim, and to utilize nutrients released upon its death (penicillin, cephalosporin, 
fusidic acid, griseofulvin, strobilurin, and sordarin) (Carlile et al., 2001). Additionally, in 
nature a secondary metabolites producer interacts with hundreds of other microorganisms 
and secondary metabolites are probably important signals in the communication between 
different members of the microbial communities (Davies, 2006). No molecular ecological 
studies are available to support or disclaim the notion of dispensability of secondary 
metabolites in nature. However, the variety of roles found for secondary metabolites 
suggests that removal of secondary metabolites from the producer organisms results in the 
long-term disappearance of those microorganisms from their usual habitats (Demain et al., 
1989) 
 
Secondary metabolites are greatly involved in the taxonomic studies and phylogenomic 
analysis, since the strains can be classified based on secondary metabolites profiles 
(Samson and Frisvad, 2004). However, the production of a particular secondary 
metabolite is restricted to certain taxonomic group of microorganisms which may not be 
closely related, and it varies considerably between different isolates of the same species. 
For example, cyclosporin A is produced by several strains of three species of 
Tolypocladium, but also by strains of species of Beauveria, Fusarium, Neocosmospora 
and Stachybotrys (Carlile et al., 2001).  
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The genes encoding the enzymes the in the biosynthesis pathways of secondary metabolite 
normally occur in clusters on a single chromosome. Examples includes ergot alkaloids in 
Claviceps purpurea, with 15 enzymic steps from tryptophan to ergotamine; aflatoxins in 
Aspergillus parasiticus; and penicillins in Penicillium chrysogenum (Bu’Lock and Barr, 
1979; Sakuno et al., 2005). The significance of secondary metabolism gene clusters is that 
they may play a role in coordinated regulation of the expression of these genes, via 
appropriate transcription factors. In fungi, the genes in the same cluster are not under the 
same promoter but still likely to be co-regulated. In some cases a single polypeptide gene 
product may have multiple catalytic sites involved in the biosynthesis of a particular 
secondary metabolite (Carlile et al., 2001). The importance of secondary metabolites is 
easily defined by the numerous pharmaceutical agents that can be used for the treatment of 
infections, tumours and for promoting the health such as cholesterol lowering agents. 
Other important uses have also been found, for example versimide from Aspergillus 
versicolor which can be used as an insecticide (Cole and Rolinson, 1972), and 
monascorubrin from Monascus sp. that can be as a food colorant (Juzlova et al., 1996). 
 
Secondary metabolites from micoorganisms in nature with different environments and 
climates have been screened continuously, e.g. the testing of culture broths from a large 
number of microbial isolates in specific biological or biochemical assays, ranging from the 
use of whole organisms to the use of single pure enzymes, for new bioactive compounds 
which may be developed to commercial products or are interesting to study for other 
purposes. Lots of new bioactive secondary metabolites were discovered from 
microorganisms living both pathogenically on animals and freely in the soils (Wawrik et 
al., 2007), glaciers (Zhao et al., 2007) and even in the deep ocean (Mayer et al., 2007). 
Many insect pathogenic fungi in the species of Cordyceps (Figure 1.1) and Verticillium, 
found in wild abundance tropical wet Thailand, represent a rich sources of structurally 
novel biologically active secondary metabolites that display the antimalarial and 
antituberculosis activities (Nilanonta et al., 2003; Isaka et al., 2005). More recently, a new 
bioactive compound exhibiting an antimicrobial property produced by Roseobactor sp. 
from the deep sea water was found during the Danish Galathea III expedition in 2006 
(Figure 1.2). 
 3
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Figure 1.1. The fungus Cordyceps nippo-
nica grown on ant lions, collected from 
Khao Yai National Park, central Thailand, 
produces cordypyridones A and B which 
exhibit the antimalarial activity (Isaka et 
al., 2005). 
 
Figure 1.2. Roseobactor sp., isolated from 
sea water produced the antibiotic 
polyketide indicated by the clear zone 
around the colonies. (Photograph: Rane 
Baadsgaard Lange, the Danish Expedition 
Foundation). 
Microbial secondary metabolites represent an almost never ending source of bioactive 
compounds, with many compounds not yet being discovered. However, even though 
screening of microorganisms for the production of secondary metabolites has been very 
profitable, and has resulted in identification of many important pharmaceuticals, it is 
costly and time demanding. Thus, it takes typically between 8 and 15 years to develop a 
new drug or antibiotic. Only 1 in 15,000-50,000 from the original screening will make it 
to the marketplace. It costs more than 50 million dollars to bring a novel compound to 
market, involving initial research and development, testing for efficacy and safety, and 
clinical trials, but the rewards can be high. The secondary metabolite market is in excess 
of 40 billion dollars a year, as illustrated in Table 1.1.  
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Table 1.1. Estimated annual market of secondary metabolites (Demain, 2000) 
                         Metabolite                          World market ($ millions) 
Antibiotics 
 Cephalosporins 
 Penicillins G & V 
 Erythromycins 
 Tetracyclines 
 Vancomycin & Teichoplanin 
 Rocephin (semisynthetic cephalosporin) 
28,000 
11,000 
4,400 
3,500 
1,400 
1,000 
1,000 
Hypocholesterolemic agents 
 Statins 
 
8,400 
Immunosuppressants 
 Cyclosporin A 
 
1,500 
Antihelmintics 
 Avermectins  
 
1,000 
Antitumor agents 
 Taxol 
 
1,000 
Bioinsecticides 
 Bt toxin 
 
125 
Plant growth enhancers 
 Gibberellins  
 
120 
 
1.2     Polyketides 
Polyketides represent a major group of secondary metabolites with great structural variety 
(Figure 1.3), which derive from the condensation of acetate units resulting in the 
biosynthesis of a carbon chain, with alternate carbon atoms coming from the methyl and 
carboxyl groups of the acyl building block. The acetate origin of these compounds leads to 
a formation of even-numbered carbon chains (Mann, 1987; Hanson 2003). Several 
polyketide metabolites are of economic importance as antibiotics, anticancer drugs, 
immunosuppressants and cholesterol lowering agents such as erythromycin (macrolide 
antibiotic), vancomycin (aromatic antibiotic), rapamycin (polyene immunosuppressant), 
lovastatin (aromatic anticholesterol). Many polyketide metabolites such as aflatoxin, 
patulin, and ochratoxin A are known as mycotoxins causing diseases and contaminating 
stored food and animal feeds. Especially, the aflatoxins from A. flavus are among the most 
dangerous fungal toxins and cause liver cancer. (Miranda et al., 2007). 
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Figure 1.3. The structures of some selected polyketides. 
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The most significant group of prokaryotes which produce polyketides is the actinomycetes, 
whereas eukaryotic polyketide producers are primarily represented by not only the fungi, 
but also the plants producing chalcone metabolites which are believed to be involved in 
the defence against the invading fungal and bacterial plant pathogens (Martin, 1993). 
Polyketide biosynthesis is similar to the assembly of fatty acids which are considered as 
primary metabolites, since they are essential for the growth primarily as constituents of the 
cellular plasma membrane (Harwood, 1988; Ohlrogge et al, 1993; Smith, 1994). However, 
polyketides are classified as secondary metabolites, since these compounds, although they 
have cellular functions, are not essential to the survival of the organism. There are a great 
variety of polyketide secondary metabolites since they are synthesized by the diverse of 
prokaryotes and higher eukaryotes.  
 
Even though the structural diversity of polyketides is tremendous, but they share a 
common origin, the decarboxylative condensation of malonate with an acylthioester to 
form a β-keto-thioester. This reaction is repeated depending on the programming of the 
enzymatic apparatus involved, leading to the condensation of acetate groups into a carbon 
chain containing ketogroups. The carbon backbones of all polyketide metabolites are 
assembled in this way, and it is the subsequent processing of the ketone group which is the 
key to the enormous structural diversity among the polyketides. If the ketone groups are 
reduced to methylene groups, this route leads to the formation of fatty acids. On the other 
hands, if there is no reduction of the keto groups the result will be the formation of 
aromatic compounds. However, many polyketides are results of processing of the carbon 
chain in between these two extremes, with some keto groups remaining unreduced, e.g. 
reduction only to a ketone or an alcohol group (Staunton and Weissman, 2001). One group 
of the polyketides are the aromatic ones and they may be further grouped by the number 
of their constituent acetate units ranging from triketide to more complex polyketides. 
Some typical aromatic microbial polyketides are the tetraketide 6-methylsalicylic acid (6-
MSA) from Penicillium patulum, the immunosuppressive tetraketide mycophenolic acid 
from P. brevicompactum, the pentaketide mullein from Aspergillus melleus, the antifungal 
heptaketide griseofulvin from P. griseofulvum, and the nonaketides lovastatin from A. 
terreus, and aflatoxin from A. flavus (Turner, 1971).  
 7
Chapter 1                                                                                                                           Introduction 
1.3     Biosynthesis of polyketides  
The enzymes responsible for polyketide production are called polyketide synthases 
(PKSs). Regardless of the differences in their end products, most PKSs share a minimum 
of four different domains, namely KS (ketosynthase), AT (acyltransferase), KR 
(ketoreductase), and ACP (acyl carrier protein). However, the domains DH (dehydratase), 
TE (thioesterase) and CYC (cyclase) are also found in PKSs. PKSs have been classified 
into three categories based on their enzyme architecture and gene organization, and how 
closely they mimic the architecture of type I (multifunctional polypeptide found in 
vertebrate) or type II (monofunctional and separated polypeptide with multienzyme 
complex found in bacteria and plant) fatty acid synthases. The three types of PKS are; 
type I) bacterial modular PKS e.g. erythromycin PKS, rapamycin PKS, and iterative 
fungal PKS e.g. 6-MSAS, lovastatin PKS, type II) bacterial aromatic PKS e.g. tetracycline 
PKS, actinorhodin PKS, and type III) plant PKS (Shen, 2003). The enzyme architectures 
of the first two types of PKSs are shown in Figure 1.4.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. The domain architechture of polyketide synthases; A) type I bacterial modular 
PKS – erythromycin PKS; B) type I fungal PKS – 6-MSAS; C) type II bacterial aromatic 
PKS – actinorhodin PKS. (Figure modified from Staunton and Weissman, 2001) 
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Recently it was suggested to move away from the above mentioned classification of PKSs 
since there are some PKSs in the transitional stages of the different types (Müller, 2004). 
Regardless of type of PKS, there are highly conserved domains shared among all PKS 
genes, mostly notably within the KS domain (Bingle et al., 1999), and these domains may 
be useful for targeting PKSs in diverse organisms, as well as the studying the evolutionary 
and phylogenetic relationship between different PKSs.  
 
The biosynthesis of polyketides is similar to that of fatty acids. The only difference is the 
degree of the subsequent reduction of the resulting keto groups as mentioned above. One 
of the keys to the control of polyketide or fatty acid biosynthesis is the ACP which 
introduces the intermediate acyl thioesters around the catalytic sites of the polyketide 
synthase, the acyl thioester being covalently attached to a 4´-phosphopantetheine moiety 
of the ACP which is post-translationally attached to a serine residue in the ACP 
(Hutchison et al. 1992). The biosynthesis of a polyketide is illustrated in Figure 1.5.  
 
CoA-S R1
O
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. The biosynthesis of a polyketide. (Figure modified from Katz and Donadio, 
1993)  
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The polyketide biosynthesis starts by the generation of malonyl-CoA from acetyl-CoA by 
acetyl-CoA carboxylase. Malonyl-CoA as an extender unit is then transacylated with the 
4´-phosphopantetheine moiety of the ACP by acyl transferase (AT), resulting in the 
formation of malonyl-S-ACP. A molecule of acetyl-CoA as a starter unit is covalently 
attached to a cysteine residue at the active site of the condensing enzyme, ketosynthase 
(KS), followed by a decarboxylative condensation between the malonyl and the acetyl 
groups, catalyzed by the KS itself. The ketone of the resulting the ACP bound β-ketoacyl 
chain is then reduced, with one molecule of NADPH, by a keto reductase (KR) to a 
hydroxyl group (OH). The hydroxyl group could be subsequently dehydrated by 
dehydratase and further reduced by an enoyl reductase (ER) with the usage of one 
molecule of NADPH to yield the saturated butyryl intermediate. Finally the reduced 
butyryl moiety is transacylated to the cysteine residue on the KS domain and a new cycle 
can initiate – a malonyl group is attached to ACP and another cycle of condensation takes 
place, adding two carbon atoms to the growing acyl chain in each cycle. This process is 
repeated until the desired chain length is achieved. After that the chain will be released 
from the ACP by and acyl transferase or thioesterase. Whereas only malonyl-CoA is used 
as extender unit in aromatic polyketide, type I polyketides can use a variety of coenzyme 
A esters e.g. propionyl-CoA and methylmalonyl-CoA as building blocks. The use of 
different starter and extender units is allowing further diversity among polyketide 
structures in addition to the varying degree of reduction of the keto groups. After the 
synthesis of the polyketide chain, individual polyketides undergo subsequent 
modifications such as cyclizations, methylation, dimerizations or other highly specific 
modifications often called tailoring processes in order to reach the final products 
(Hopwood and Sherman, 1990).  
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1.4     6-Methylsalicylic acid, a model polyketide 
Even though fungal polyketides represent a large group of secondary metabolites, only a 
few fungal polyketide-derived secondary metabolites have been studied in detail. These 
include mycotoxins from some species of Aspergillus, e.g. aflatoxin, patulin from 
Penicillium species (Steyn, 1981), some antimicrobial agents such as griseofulvin 
produced by Penicillium griseofulvum, polyketide-derived melanins from phytopathogenic 
fungi (Bell and Wheeler, 1986) and 6-methylsalicylic acid (6-MSA), a model polyketide, 
from P. patulum.  
 
A significant advance in understanding fungal polyketide biosynthesis has been made 
through the study of 6-MSA biosynthesis by P. patulum (Shoolingin-Jordan and 
Campuzano, 1999). 6-MSA is one of the simplest polyketides since it is derived from one 
acetate starter molecule and three malonate extender units. (Martin and Gutierrez, 1992). 
The PKS responsible for biosynthesis of 6-MSA, so called 6-MSAS, contains the 
following domains; KS, AT, DH, KR and ACP (Figure 1.4). The biosynthesis of 6-MSA 
from P. patulum is shown in Figure 1.6, and it indicates that the domains in 6-MSAS are 
used repeatedly to catalyze three rounds of chain extension. The first condensation is 
followed directly by reaction with a second equivalent of malonate extender unit, while 
the second condensation is followed by reduction and dehydration of the newly-formed 
keto group. After the third cycle, the chain goes through cyclization, dehydration and 
enolisation to release the aromatic 6-MSA. The absence of a thioesterase (TE) domain in 
6-MSAS could suggest the operation of a mechanism other than hydrolysis, involving a 
ketene intermediate, which could be achieved by the involvement of the adjacent hydroxyl 
group and hydration of the resulting ketene to the acid, although this has not been 
experimentally verified (Shoolingin-Jordan and Campuzano, 1999). 6-MSA, however, is 
later converted to patulin by the same fungus, P. patulum, resulting in low amounts of 6-
MSA detected in the media, typically 0.2 mg/L in minimal media cultivations of P. 
patulum (Wattanachaisaereekul et al., unpublished data). 
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Figure 1.6. The biosynthetic pathway of the fungal polyketide 6-methylsalicylic acid (6-
MSA) (Staunton and Weissman, 2001) 
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The 6-MSAS gene from P. patulum has been isolated and sequenced. It was identified as a 
5,322 bp long open reading frame coding for a protein of 1,774 amino acids and 190,731 
Da molecular mass (Beck et al., 1990). Additionally, one of the genes (fas2) encoding the 
fatty acid synthase in P. patulum is also know (Wiesner et al., 1988). Therefore, it is of 
interest to compare at the amino acid level between the fatty acid synthase (FAS) and the 
polyketide synthase (PKS) of the same fungus. Fatty acid synthase and other polyketide 
synthases occur either as large, multifunctional enzymes (type I PKS) or as aggregrated 
systems of individual component enzyme (type II PKS). In Saccharomyces cerevisiae and 
P. patulum the FAS is a multifunctional protein encoded by two unlinked gene FAS1 and 
FAS2 that encode β-subunit and α-subunit, respectively, which aggregate to form the α/β 
fatty acid synthase. (Lynen, 1980). The FAS2 proteins of S. cerevisiae and P. patulum are 
similar visualized by the domain organization in Figure 1.7 which shows that the acyl 
carrier protein (ACP), ketoreductase (KR) and ketosynthase (KS) functional regions are 
located on the large FAS2 polypeptide (1,887 amino acids). At the nucleotide level, the 
FAS2 gene of P. patulum reveals high similarity to the S. cerevisiae FAS2 genes (about 
50-70% nucleotide similarity over the various domains) (Wiesner et al., 1988). However, 
the P. patulum FAS2 gene is interrupted by two short introns which are absent in the S. 
cerevisiae gene. 
 
Inspection of the domain structure reveals that the organization of 6-MSAS gene from P. 
patulum is identical to that of A. terreus IBT12713 amplified by RT-PCR, which 
contained 5,409 bp coding for a protein of 1,803 amino acids (Chapter 7). Furthermore, 
comparison of the 6-MSAS amino acid sequence with type I FAS from S. cerevisiae, 
animals and its FAS2 shows that overall structure of 6-MSAS from P. patulum resembles 
more closely to that of animal FAS multifunctional proteins than the fungal α/β subunit 
type I FAS, indicating that the P. patulum 6-MSAS is more related and share a common 
evolutionary origin to a heterologous than to its own homologous FAS (Figure 1.7). 
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Figure 1.7. Organization of the domains in the 6-MSAS of P. patulum and A. terrues 
compared to the arrangement in the FAS of P. patulum, S. cerevisiae, chicken, and mouse 
from the conserved domain database (CDD). The number shown on the figure represents 
the length of the genes in kb.  
 
From P. patulum 6-MSAS, a cysteine residue (Cysteine at position 204) was identified as 
the ketosynthase (KS) active site (Hopwood and Sherman, 1990) based on the similarity 
with the ketosynthase domains of various PKS, FAS, peptides and NRPS from different 
organisms. (Figure 1.8-A). The domain acyltransferase (AT) of the 6-MSAS (Serine at 
position 653) has been deduced by its similarity with the highly characteristic motif of the 
animal FAS acetyl-malonyl transferase domains. It seems as if the chain initiation and 
elongation of fungal polyketide is similar to that of the animal FAS system. However, the 
central region of the 6-MSAS has some similarity with the central region of the animal 
FAS and yeast FAS1, which encodes for the dehydratase domain.   
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In 6-MSAS of P. patulum, a ketoreductase (KR) domain exists near the C-terminus of the 
6-MSAS (amino acid position 1419-1424) where a nucleotide biding site motif (Gly-Leu-
Gyl-Val-Leu-Gly) fits the Gly-X-Gly-X-X-Gly consensus for the ketoreductase domains 
in the animal FAS. Finally, a predicted acyl carrier protein (ACP) region occurs at the C-
terminus of the 6-MSAS. It includes a phosphopantetheine binding Serine at position 1732, 
which is similar to the phosphopantetheine biding sequence in several FASs, PKSs, and 
also in the oligopeptide synthetases from various animals and microorganisms (Figure 1.8-
B).  
 
A: KS domain 
 
PKS  * 
6-MSAS- P.patulum      195 GPSTAVDAACASSLVAIHHG 
6-MSAS- A.terrues  207 GPSTAVDAACASSLVAIHHG 
PKS- B.subtilis       671 GPSIAVSSACSSSLNAIHLA 
PKS- Corynebacterium diphtheriae 160 GPAFTVQTACSTSLVAIHLG 
PKS- Symbiont bacterium of Rove beetle 185 GPSLCVDTMCSGSLTALHLA 
PKS- Streptomyces avermitilis 201 GPSFAVDAACSSSLIALETA 
Melanin PKS- Colletorichum lagenarium 544 GPSLNVDTACSSSAAALNVA 
Red pigment bikaverin- Gibberella fujikuroi 191 GPSMTFDTACSASAVAIHTA 
CagA, Enediyne antitumor- S.globisporus 202 GGGYTVDGACSSSLLSITTA 
RedX- S.coelicolor A3(2) 717 AVPVAVEAACASSLAAVDVA 
Afb1, Aflatoxin B1- A.parasiticus 534 GPSYTNDTACSSSLAAIHLA 
MmpV, Mupirocin- Pseudomonas fluorescens 206 GPSLALDTMCSSAATALHLA 
YA, cornidial yellow pigment- A.nidulans 539 GPSVSVDTACSSSLAAIHLA 
FAS 
FAS- Gallus gallus (chicken) 152 GPSLTIDTACSSSLMALENA 
FAS- Homo sapiens (human)  152 GPSIALDTACSSSLMALQNA 
FAS- Schizochytrium sp. (marine micro-alga) 206 GMNCVVDAACASSLIAVKVA 
FASI- Cryptosporidium parvum (protozoan parasite)  3201 GPSMTVDTACASSLTAACIA 
FASNI- Caenorhabditis elegans (soil nematode)  161 GPSFSVDTACSSSLLALQLA 
PEPTIDE 
E.coli 158 GPCVTVQASCATSLVAVHLA 
Drosophila melanogaster (Fruit fly) 170 GPSFIVDTACSSSLVALNHA 
NRPS 
Albicidin pathotoxin synthetase- X.albilineans  897 GPSEVINSACSSSLVALHRA 
Pseudomonas syringae 1812 GPALSVQAACGSSLIAVHLA 
Yersinia pestis 832 GPALTIDTACSSSLVALDSA 
 
 
B: ACP domain 
 
PKS * 
6-MSAS- P.patulum 1726 ADLGVDSVMTVTLRRQLQL 
6-MSAS- A.terreus 1756 SDLGVDSVMTVSLRGQLQK 
Curamycin PKS- S.cyaneus  38 ADFGLDSLGLLGIVGELEN 
OTC (Oxytetracyclin) PKS- S.rimosus  35 DALGYDSLALLNTVGRIER  
Monensin PKS- S.cinnamonensis  36 ALLGYESLALLETGGCIER 
PpsA (Phenolpthiocerol) PKS- M. tuberculosis  37 ADLGVSSRDAVVLSGELSE 
Tetracenomycin PKS- S.glaucescens  35 QDLGYDSIALLEISAKLEQ 
WA conidial green pigment- A. nidulans 1676 ADYGVDSLLSLTVTGKYRE 
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FAS 
FAS- Bos taurus (cattle)  38 KDLGLDSLDQVEIIMAMED 
FAS- Cyanophora paradoxa (photoautotrophic protist)  43 EDLKIDSLDLVEIIKQIEE  
FAS- Gallus gallus (chicken) 2152 ADLGLDSLMGVEVRQTLER 
FAS- Mycobacterium tuberculosis  35 DDVGLDSVAFAVGMVAIEE 
FAS- Odontella sinensis (marine diatom)  32 KDLGADSLDVVELIMAFEE 
FAS- Saccharomyces cerevisiae  76 KDLGLDSLDTVELLVAIEE 
FAS- Saccharopolyspora erythraea  33 EDLGMDSLDLVELVSALED 
FASI- Arabidopsis thaliana  73 NDLGLDSLDTVEIVMAIEE 
FASI- 
PEPTIDE 
Hordeum vulgare (barley)  97 SELGADSLDTVEIVMGLEE 
Alpha-aminoadipate reductase- S.cerevisiae 874 FDLGGHSILATKMIFTLKK 
Alpha-aminoadipate reductase- Schizo.pombe 910 FDIGGHSILATRLIFELRK 
Erythronolide synthase- S.erythraea 2848 TELGFDSLTAVGLRNQLQQ 
Gramicidin S synthaseI- Brevibacillus brevis 566 YALGGDSIKAIQVAARLHS 
Isochorismatase- E.coli 239 IDYGLDSVRMMALAARWRK 
β-LACTAMS 
ACVS- Acromonium chrysogenum 821 FRLGGHSIACIQLIARVRQ 
ACVS- Amycolatopsis lactamdurans 814 FRLGGQSISCILLIARVRQ 
ACVS- A. nidulans 876 FRLGGHSITCIQLIARIRQ 
 
 
Figure 1.8. The conserved amino acid of 6-MSASs and several PKSs, FASs, and NRPSs 
in; A) KS domain, B) ACP domain. The conserved cystein (C) for starter unit binding site 
in KS domain, and conserved serine (S) for phosphopantetheine binding site in ACP 
domain are marked by *. The sequences in this figure were obtained from the search of 6-
MSAS gene in the conserved domain database (CDD). 
 
1.5     Heterologous expression of polyketide synthases 
The recombinant DNA technology that was introduced in the 1970s has made spectacular 
advances in the biotechnological and pharmaceutical industries. Many recombinant 
products are already on the market and many more are about to be commercialized. The 
knowledge of genetic and metabolic engineering technologies enables immense 
possibilities for manufacture of exotic and valuable substances that were virtually 
unobtainable before. These include the substances produced by non-native producers so-
called heterologous products. Heterologous production is often associated with secondary 
metabolites such as various polyketides that are difficult to produce using the natural 
producers, and they are usually carried out in microorganisms or heterologous hosts 
mostly bacteria and yeast in order to achieve high yields by taking advantage of the rapid 
growth rates of these host cells.  
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The production of polyketides in heterologous hosts offers many advantages over the use 
of natural producers. As mentioned before, several useful polyketides are derived from the 
microorganisms with poor growth characteristics or even unculturable such as lichens 
mycobionts, which often grow a few millimeters per year in nature (Carlile et al., 2001) 
and approximately 800 secondary metabolites, of which more than half are polyketides, 
have been characterized from lichens (Huneck and Yoshimura, 1996). In order to identify 
and obtain these numerous hypothetical products and to use the enormous genetic 
potential in an efficient way, heterologous expression of these genes enconding PKS are 
required. In addition some of the natural producers yield poor titer of useful polyketides 
even in the optimized conditions. Therefore, the transfer of PKS gene from the 
unculturable sources or the sources with poor yields into a well-characterized and robust 
host is beneficial not only for enhancing the rate of product formation but also to make 
these compounds available for the pharmaceutical industry. Moreover, the use of more 
amenable hosts can even enhance the possibility to engineer novel polyketide analogs by 
combinatorial biosynthesis (Floss, 2006).  
 
The examples of heterologous production of polyketides provided in Table 1.2 show that 
most of them are bacterial polyketide metabolites which are successfully produced in 
Streptomyces sp. and E. coli. For heterologous expression of bacterial PKSs gene, 
Streptomyces seems to be a better heterologous host than E.coli. Even though genetically 
modified PKS in E. coli can be more easily constructed and introduced, the uncommon 
precursor metabolites or unusual starter and extender units necessary for biosynthesis of 
the desired polyketide are often absent in E. coli.  
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Table 1.2. Examples of heterologous production of polyketides in different hosts. 
 
        Polyketide Function Natural producer Heterologous host Reference 
Fungal type I PK 
   6-MSA 
        " 
        " 
        " 
        " 
   Pentaketide T4HN 
   Naphthopyrone 
   Lovastatin 
 
antibiotic 
        " 
        " 
        " 
        " 
pigment 
pigment 
anticholesterolemic 
 
A. terreus 
        " 
P. patulum 
          " 
          " 
C. lagenarium 
A. fumigatus 
A. terreus 
 
A. nidulans 
        " 
S. cerevisiae, E.coli 
S. cerevisiae 
Nicotiana spp. (Tobacco) 
A. oryzae 
A. oryzae 
E. coli 
 
Fujii et al. (1996) 
Regueira et al. (2007) 
Kealey et al. (1998) 
Wattanachaisaereekul et al. (2007)* 
Yalpani et al. (2001) 
Fujii et al. (1999) 
Watanabe et al. (2000) 
Ma et al. (2006) 
Bacterial type I PK 
   6-deoxyerythronolide B 
                 " 
                 " 
   Rapamycin 
   Picromycin/Methymycin 
   Epothilone  
            " 
   Megalomicin 
   Avermectin 
   Aureothin 
   Spinosyn 
   Monensin 
   Soraphen A 
   Tylosin  
 
antibiotic 
       " 
       " 
Immunosuppressant 
antibiotic 
antitumor 
        " 
antiparasitic 
anthelmintic 
antitumor, antifungal 
antibiotic 
antibiotic 
antifungal 
antibiotic 
 
Sacc. erythraea 
             " 
             " 
S. hygroscopicus 
S. venezuelae 
Sor. Cellulosum 
             " 
M. megalomicea 
S. avermitilis 
S. thioluteus 
Sacc. spinosa 
S. cinnamonensis 
Sor. cellulosum 
S. fradiae 
 
E. coli 
      " 
S. lividans 
S. lividans, E. coli 
S. lividans 
S. coelicolor 
E. coli 
Sacc. erythraea 
S. lividans 
S. lividans 
Sacc. erythraea 
S. coelicolor 
S. lividans 
S. venezuelae 
 
Roberts et al. (1993) 
Menzella et al. (2006) 
Xue et al. (1999) 
König et al. (1997) 
Tang et al. (1999) 
Tang et al. (2000) 
Mutka et al. (2006) 
Volchegursky et al. (2000) 
Wohlert et al. (2001) 
He and Hertweck (2003), (2004) 
Martin et al. (2003) 
Oliynyk et al. (2003) 
Zirkle et al. (2004) 
Jung et al. (2006) 
Bacterial type II PK 
   Enterocin 
           " 
   Naphthocyclinone 
   Oleandomycin 
   Elloramycin 
   Maytansinoid 
   Actinorhodin 
   Fredericamycin 
   Chartreusin  
   Steffimycin 
   Oxytetracycline 
 
bacteriostatic 
           " 
antibiotic 
antibiotic 
antibiotic, antitumor 
antitumor 
antibiotic 
antitumor 
antitumor 
antitumor 
antibiotic 
 
S. maritimus 
           " 
S. arenae 
S. antibioticus 
S. olivaceus 
Actino. pretiosum 
S. coelicolor 
S. griseus 
S. chartreusis 
S.  steffisburgensis 
S. rimosus 
 
S. lividans 
         " 
S. coelicolor 
S. lividans 
S. lividans, E. coli 
S. coelicolor 
S. lividans 
S. albus 
S. albus 
S. albus 
S. coelicolor 
 
Ziermann and Betlach (1999) 
Hertweck et al. (2004) 
Brünker et al. (1999), (2001) 
Shah et al. (2000) 
Rafanan et al. (2001) 
Yu et al. (2002) 
Kalaitzis and Moore (2004) 
Wendt-Pienkowski et al. (2005) 
Xu et al. (2005) 
Gullón et al. (2006) 
Zhang et al. (2006) 
Plant type III PK 
   Stibene 
   Naringenin 
   Anthocyanin 
 
antifungal 
antioxidant 
pigment 
 
P. strobus (pine) 
R. idaeus (raspberry) 
Matthiola incana 
 
E. coli 
E. coli 
E. coli 
 
Raiber et al. (1995) 
Zheng et al. (2001) 
Hemleben et al. (2004) 
* See Chapter 2  
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Approximately 60% of the known bioactive polyketides are bacterial polyketides mainly 
from actinomycetes, and the rest are fungal polyketides. Due to the rudimentary 
knowledge about fungal polyketides, they have not been studied and heterologously 
produced in other hosts at the same level as bacterial polyketides, even though several 
polyketides from fungi exhibit interesting biological properties that cannot be found in 
bacteria. So far only a few fungal polyketides have been heterologously produced such as 
6-MSA. Since this is a relatively small polyketide as well as it exhibits antibiotic property 
and is involved in the biosynthesis of the toxin patulin, 6-MSA was the first fungal 
polyketide to be cloned, purified and successfully produced in different kinds of hosts 
namely E. coli, S. cerevisiae, S. coelicolor, A. nidulans, and tobacco (Table 1.2). Much 
knowledge was gained from the biosynthesis and the heterologous production of 6-MSA, 
making 6-MSA a good choice as a model fungal polyketide.  
 
Through the heterologous production of 6-MSA in each surrogate host, it was obvious that 
E. coli and Streptomyces are far from the ideal hosts for the production of fungal 
polyketides. It has been reported that eukaryotic genes or proteins expressed in 
prokaryotes are often incorrectly or incompletely processed after translation and wrongly 
folded, which results in formation of the wrong product (Primrose, 1986; Zabriskie and 
Arcuri, 1986). In E. coli the largest native protein or the RNA polymerase β-subunit is 
only 155 kDa in size (Julien et al., 2000) and it is therefore difficult to express large 
proteins like PKS in soluble and active form in E. coli. Furthermore, E. coli produces 
endotoxins and extensive purification is required to obtain products free of pyrogens 
(Kingsman et al., 1985). In addition, the use of bacteria as heterologous host for the 
production of fungal polyketide could be problematic due to the high GC-content in their 
chromosome especially in Streptomyces (Borodina et al., 2005), resulting in undesirable 
codon bias leading to low level translation. 
 
For the heterologous production of fungal polyketides, a filamentous fungal expression 
system such as A. nidulans is better than bacterial systems. Since its metabolic function is 
well-characterized and there are good genetic tools for A. nidulans, this organism offers an 
alternative system for the expression of fungal polyketide synthases. Its native PPTase 
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(NpgA) is very efficient to phosphopantetheinylate PKSs at the ACP domain into the 
active form, and hence no PPTase from another microorgainsm is required. Furthermore, 
it is generally not necessary to remove the introns from PKS genes. However, the use of 
filamentous fungi as the heterologuous host for the production of fungal polyketide has so 
far been limited. This is due to the complicated biomolecular tools and techniques 
comparatively to that of other hosts. Furthermore, the wall growth and other undesirable 
morphologies that usually occur during cultivation of filamentous fungi in liquid media 
are problematic especially for large scale processes (Hamer, 2004). 
 
Apart from the bacterial and filamentous fungi expression system, the budding yeast S. 
cerevisiae represents a useful alternative and is the most well characterized eukaryotic 
organism for expression of heterologous genes. A drawback on the use of S. cerevisiae as 
a heterologous host is that there is codon usage bias with expression of fungal genes. 
Furthermore, the PPTase (Ppt2 and Lys5) in S. cerevisiae which are involved only in fatty 
acid and lysine biosynthesis and not in the biosynthesis of polyketides (Stuible et al., 
1998; Ehmann et al., 1999), cannot activate heterologously expressed PKSs. In other 
words, a PPTase has to be co-expressed in order to convert heterologous PKSs to their 
active form (Figure 1.9). In addition, the introns in fungal PKS encoding genes have to be 
removed as yeast can generally not remove fungal introns in its mRNA splicing system.  
 
S. cerevisiae is a unicellular organism which is well suited for industrial fermentation and 
large scale processes. Unlike E. coli and Streptomyces, S. cerevisiae lacks detectable 
endotoxins and it is generally regarded as safe because of a long history of use in food and 
pharmaceutical industries. Genetic manipulation of S. cerevisiae has been made easier 
with greatly improved understanding of yeast biology and genetics. Recombinant genes 
can be expressed in this yeast correctly folded and modified at the posttranslational level 
to yield a biologically active product. Furthermore, the process technology for yeast 
cultures is well developed. Finally, expression in yeast may allow natural extracellular 
release of protein because of a secretion system that is similar to that of higher eukaryotes 
including native fungal polyketide producers. Biologically active secreted products are 
 20
Chapter 1                                                                                                                           Introduction 
substantially easier to recover than what is usually produced by recombinant bacteria 
(Chisti and Moo-Young, 1994).  
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Figure 1.9. The change of 6-MSAS from an inactive into an active form by the transfer of 
phosphopantetheinyl moiety from Coenzyme A to the conserved serine (S) at ACP 
domain.  
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1.6     Metabolic engineering for the production of polyketide in S. cerevisiae 
The metabolic engineering of polyketides has begun to prosper in the past decade due to 
the genomic research and the discovery of biosynthetic genes. While the biosynthetic 
pathways and genes for some polyketides have been known for many years, new 
polyketides have been found and known polyketides have been further optimized for 
higher production through metabolic engineering (Ryu et al., 2006).  
 
Metabolic engineering is an approach which has developed to optimize the industrial 
fermentation processes and improve the cellular properties of the strains by introducing 
directed genetic changes in the cells, unlike the classical methods where strains are 
improved by e.g. random mutagenesis or genetic crossing (Nielsen, 2001). Metabolic 
engineering consists of analysis, design and synthesis (Figure 1.10). When the flux 
through the product is to be improved, the characterization or the analysis part of the 
currently applied strain such as fermentation physiology and numerous analytical 
techniques e.g. gene expression and flux analysis are performed. The data from the 
analysis part is interpreted and leads to the design for improving the properties of the 
strains. Subsequently, the synthesis part is performed according to the designed 
characteristics by using molecular biology techniques, gene cloning, transformation, gene 
deletion, and gene overexpression by either increasing the copy number or changing the 
strength of the promoter of the gene. The cycle is performed iteratively until the improved 
strain is achieved. According to Nielsen (2001), the aims of metabolic engineering can be 
categorized into the following groups:  
 
1).  Heterologous expression of genes in other organisms 
2).  Extension of substrate range and substrate utilization 
3).  Introduction of a new pathway or improvement of a pathway leading to a new product 
4).  Improvement of overall cellular physiology 
5).  Improvement of yield and productivity 
6).  Elimination or reduction of by-product formation  
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Figure 1.10. The metabolic engineering cycle (Nielsen, 2001). 
 
There have been several examples of metabolic engineering of polyketide production 
which are mostly conducted in Streptomyces (McDaniel et al., 1994; Khosla, 1999; Zirkle 
et al., 2004; Floss, 2006). Only a few examples were performed in S. cerevisiae (Kealey et 
al., 1998; Mutka et al., 2006; Wattanachaisaereekul et al., 2007). This is likely due to the 
difficulty to express the PKS genes in yeast. However, except from the work presented in 
this thesis, metabolic engineering studies of polyketide production mostly dealt with the 
synthesis part and the important analysis part has largely been ignored, resulting in scarce 
knowledge about effects on strain characteristics and metabolism, hence lacking of 
information for the design of improved polyketide producers.  
 
In order to evaluate the effect of the engineering and to analyze cellular metabolism, the 
metabolic regulation within the cell, which is complex and hierarchical (Figure 1.11), 
must be considered. Several high-throughput methods which cover large parts of an 
‘‘ome’’ and are involved in the analytical part such as gas chromatography coupled with 
mass spectrometry for the analysis of metabolome and fluxome, 2D gel with mass 
spectrometry for proteome, and DNA microarray for transcriptome analysis have been 
developed and applied extensively in recent years in metabolic engineering studies of 
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yeast (Bro, 2003; Villas-Bôas, 2004). However, no reports related to analysis of 
heterologous polyketide production could be found in literature. 
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Figure 1.11. The scheme of the metabolic regulation in a cell. The genes in the genome 
are transcribed into mRNAs (transcriptome) which subsequently are translated into 
proteins (proteome). Proteins can interact with proteins themselves, DNA, or metabolites 
(interactome) and can be enzymes catalyzing the conversion to metabolites (metabolome). 
The conversion of metabolites results in the metabolic network, which can be quantified 
as the fluxes through metabolites (fluxome) (Bro, 2003). 
 
A metabolic engineering approach was applied throughout the present Ph.D. study. The 
design and the synthesis part of metabolic engineering were involved in Chapter 2 and 3 
where the heterologous expression of the 6-MSAS gene from P. patulum in S. cerevisiae 
was demonstrated. In Chapter 2, the 6-MSAS gene was under the control of GAL1 
promoter, and production of 6-MSA was optimized by using two different PPTase from B. 
subtilis and A. nidulans. The promoter of 6-MSA was then changed to an endogeneous 
glucose promoter in order to overcome the problem of slow growth on galactose and 6-
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MSA could be produced during growth on glucose (Chapter 3). Moreover, the promoter of 
ACC1 encoding acetyl-CoA carboxylase was replaced with the strong, constitutive TEF1 
promoter in order to ensure a high amount of malonyl-CoA that is used as a precursor for 
the biosynthesis of 6-MSA (Chapter 3). To improve the stable production of 6-MSA, the 
6-MSAS gene was integrated in the yeast chromosome (Chapter 4). The production of 6-
MSA was optimized in glucose minimal media with different initial glucose 
concentrations from 20-200 g/L in order to evaluate the optimum glucose concentration 
for the production of polyketide in yeast (Chapter 5).  
 
Analysis of two ‘‘omes’’, transcriptome and fluxome of the cells were also performed in 
this study. The genome-wide transcription analysis by microarray technology was used to 
investigate the global transcriptional responses to introduction of the 6-MSAS gene and 
the recombinant strains were compared to the reference strain in batch cultivations 
(Chapter 6). Metabolic flux analysis was performed to further investigate the effect of the 
genetic modification on the fluxes through different parts of metabolism (Chapter 6). The 
high amount of information from the data analysis from Chapter 6 enables us to focus on 
systems of interacting biochemical reactions (a systems biology approach), instead of on 
only single pathways or reactions, which is definitely useful for designing a better strain 
and optimizing the production of polyketides in S. cerevisiae. Furthermore, an in silico 
study with a genome scale metabolic model of S. cerevisiae was applied in order to 
identify further targets for gene deletion for improving the production of 6-MSA (Chapter 
7). Since the 6-MSAS gene from P. patulum was successfully expressed in yeast and high 
production was obtained, it was of interest to clone the 6-MSAS gene from another 
organism to investigate whether the production of 6-MSA is affected by the source of the 
gene. Therefore, the 6-MSAS gene from A. terreus was amplified and heterologous 
expressed in yeast. The outcome of this study is presented in Chapter 8.  
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Abstract 
Polyketides are a group of natural products that have gained much interest due to their use 
as antibiotics, cholesterol lowering agents, immunosuppressors and as other drugs. Many 
organisms that naturally produce polyketides are difficult to cultivate and only produce 
these metabolites in small amounts. It is therefore of general interest to transfer polyketide 
synthase (PKS) genes from their natural sources into heterologous hosts that can over-
produce the corresponding polyketides. In this study we demonstrate the heterologous 
expression of 6-methylsalicylic acid synthase (6-MSAS), naturally produced by 
Penicillium patulum, in the yeast Saccharomyces cerevisiae. In order to activate the PKS a 
4´-phosphopantetheinyl transferase (PPTase) is required. We therefore co-expressed 
PPTases encoded by either sfp from Bacillus subtilis or by npgA from Aspergillus 
nidulans. The different strains were grown in batch cultures. Growth and product 
concentration were measured and kinetic parameters were calculated. It was shown that 
both PPTases could be efficiently used for activation of PKSs in yeast as good yields of 6-
MSA were obtained with both enzymes. 
 
* Corresponding auther: ael@biocentrum.dtu.dk 
1   Center for Microbial Biotechnology, BioCentrum-DTU, Denmark 
2   Department of Biology, University of Iceland, Iceland
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2.1     Introduction 
Polyketides represent a large group of natural products which are found in fungi, bacteria, 
and plants. This diverse group includes not only compounds that exhibit antibacterial, 
antifungal, anticancer, and antihelmintic properties, but also cardiovascular agents, 
cholesterol lowering agents and mycotoxins. Many of them have tremendous economic 
importance. The antibiotic market amounts to almost US$30 billion including about 160 
antibiotics and derivatives such as the macrolide polyketide erythromycin, tetracyclines 
and others. Other important polyketide products are the hypocholesterolemic statins, 
immunosuppressants and antitumor compounds, which together have annual sales 
exceeding US$10 billion (Demain, 2000). For some of these important drugs key patents 
will expire in the coming years and there will therefore be a shift towards production of 
these pharmaceuticals as generics, and this is likely to result in increased production 
volume of many of these compounds. 
 
The biosynthesis of polyketides by polyketide synthases (PKSs) is very similar to the fatty 
acid biosynthesis with the condensation of acetyl-CoA and malonyl-CoA in a reaction that 
is catalyzed by ketosynthase (KS). The result of this reaction is an enzyme-bound β-keto 
thioester. The keto group may be further reduced to a hydroxyl group, an unsaturated 
thioester; and even a saturated thioester. This leads to a distinct difference from the simple 
hydrocarbon fatty acid skeleton in that the resulting compounds display a wide structural 
complexity that is further enhanced by a variety of modifications. PKSs can also use 
different starter and extender units and hereby further increase the molecular diversity. 
The structure of a polyketide also depends on the stereochemistry at each chiral center. 
 
Due to the wide bioactivity within this group of compounds the production of novel 
polyketides has gained much interest in the area of metabolic engineering. Much work has 
already been accomplished through the use of combinatorial biosynthesis or genetic 
alteration of postpolyketide pathways as well as using domain shuffling for production of 
new polyketides using Streptomyces (McDaniel et al., 1994; Oliynyk et al., 1996; 
Menzella et al., 2005). Combinatorial biosynthesis can be obtained through elimination of 
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unwanted catalytic groups and/or addition of specific moieties or functional groups in the 
PKS genes.  
 
Fungal PKSs have not been studied to the same extent as bacterial PKSs. Unexploited 
sources of PKSs are e.g. from lichens, as they are difficult to cultivate. For analysis of 
fungal PKSs it is of interest to develop a fungal expression system that allows further 
study of eukaryotic PKSs, but may also potentially be used for high-level expression of 
polyketides. Yeast is a very suitable system for heterologous expression as it is not only 
generally regarded as safe (GRAS), but also easy to manipulate genetically, well suited for 
industrial fermentation and easy to grow and handle in large scale processes. In addition, 
much knowledge on the genomics and physiology of this organism is available. Although 
S. cerevisiae has no known polyketide biosynthetic pathway, this organism has earlier 
been used with success as a platform for production of chemicals, and due to the relative 
ease of performing genetic engineering the metabolic network may readily be improved 
for enhanced polyketide production. The possibility to expand the range of starter and 
extender units for polyketide biosynthesis in S. cerevisiae has been illustrated by 
introducing pathways for the production of methylmalonyl-CoA (Mutka et al., 2006). 
 
There has already been one report about successful expression of a fungal polyketide in 
yeast by Kealey et al., (1998), who demonstrated that it was possible to heterologously 
produce 6-methylsalicylic acid (6-MSA) in S. cerevisiae. However, no detailed 
physiological characterization was carried out and no details on the production kinetics 
were given.  6-MSA, which has an eight-carbon chain that cyclizes to form an aromatic 
ring, is among the smallest polyketides (Katz and Donadio, 1993) and is naturally 
produced by Penicillium patulum as an intermediate in the biosynthesis of the toxin 
patulin (Staunton and Weissman, 2001). 6-MSA is generally toxic to plants, bacteria and 
fungi in vitro e.g. Colletotrichum acutatum, C. gloeosporioides, Botryosphaeria dothidea, 
B. obtuse and Peltaster fructicola. Treatment of apple fruit with 6-MSA reduced infection 
by C. acutatum. (Venkatasubbaiah and Chilton, 1992; Venkatasubbaiah et al., 1995). In 
solid cultures of P. patulum, 6-MSA was produced only when an aerial mycelium was 
present, indicating that the production is linked to cellular differentiation (Peace, 1981).  
 39
Chapter 2           Optimization of heterologous production of the polyketide 6-MSA in S. cerevisiae 
The PKS that is responsible for the production of 6-MSA, called 6-MSA synthase (6-
MSAS), was the first fungal PKS gene to be cloned and is hence one of the best 
characterized fungal PKSs (Dimroth et al., 1976; Beck et al., 1990). 6-MSAS catalyzes 
three successive condensation reactions to form 6-MSA from one molecule of acetyl-CoA 
and three molecules of malonyl-CoA and uses NADPH as an electron donor (Scott et al., 
1971). Besides being expressed in yeast, 6-MSAS from P. patulum has been 
heterologously expressed in Streptomyces coelicolor (Bedford et al., 1995), in Escherichia 
coli (Kealey et al., 1998) and in tobacco (Yalpani et. al., 2001). 
 
Production of polyketides in yeast requires co-expression of a 4´-phosphopantetheinyl 
transferase (PPTase) (Kealey et al., 1998; Andrésson unpublished data). PPTase transfers 
the 4´-phosphopantetheine (Ppant) moiety from coenzyme A (CoA) to the side chain β-
hydroxyl group of a conserved serine residue within the PKS, resulting in the conversion 
of the Ppant-dependent carrier protein from the inactive apo-form into the active holo-
form. PPTases play an essential role in the biosynthesis of polyketides and nonribosomal 
peptides of which bacteria and fungi are the most distinguished producers. 
 
The objective of this study was to demonstrate high level production of polyketides in 
yeast and at the same time evaluate the use of two different PPTases for activation of 
heterologously expressed PKS in yeast; one PPTase from B. subtilis and the other from A. 
nidulans. We used 6-MSAS as a model PKS and we performed a physiological 
characterization of the yeast strains producing 6-MSA in order to evaluate the use of yeast 
as a general cell factory platform for production of polyketides, e.g. also for expression of 
PKSs originating from unculturable sources. 
 
2.2 Materials and methods 
 
2.2.1     Plasmids and strains 
The yeast strains and plasmids used in this study are listed in Table 2.1. 
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Table 2.1. List of plasmids and strains used in this work 
 Characteristics Reference 
Plasmids   
     pRS424 Yeast episomal vector with TRP1 marker Christianson et al. (1992) 
     pRS425 Yeast episomal vector with LEU2 marker Christianson et al. (1992) 
     pUBS1 Carrying 6-MSAS gene from P. patulum and identical to a pUC 
plasmid with a bluescript polylinker 
Colin Lazarus a
     pDKP4832 Carrying npgA from A. nidulans with GAL1 promoter, and URA3 
marker 
David Keszenman-Pereyra,b
     p424GAL1 Yeast expression vector with GAL1 promoter, CYC1 terminator, and 
TRP1 marker 
Mumberg et al. (1994) 
     p425GAL1 Yeast expression vector with GAL1 promoter, CYC1 terminator, and 
LEU2 marker 
Mumberg et al. (1994) 
     p424sfp Carrying sfp from B. subtilis with GAL1 promoter, CYC1 terminator, 
and TRP1 marker 
This study 
     pGei425U Carrying GAL1 promoter, modified multiple cloning site, Kozak 
sequence and Kluyveromyces lactis URA3. 
This study 
     pGei425HSA-PP Carrying 6-MSAS gene from P. patulum with GAL1 promoter, CYC1 
terminator, and LEU2 marker 
This study 
Strains   
     CEN.PK 111-27B MATa;URA3;HIS3;leu2-3,112;trp1-289;MAL2-8;SUC2 Peter Kötter c
     CEN.PK 102-3A MATa;ura3-52;HIS3;leu2-3,112;TRP1;MAL2-8;SUC2 Peter Kötter c
     IBT100074 CEN.PK 111-27B with empty plasmids pRS424 and pRS425 This study 
     IBT100075 CEN.PK 111-27B with plasmid pGei425HSA-PP and p424sfp This study 
     IBT100076 CEN.PK 102-3A with plasmid pGei425HSA-PP and pDKP4832 This study 
 
a School of Biological Sciences, University of Bristol, England 
b Department of Molecular biology and Biotechnology, University of Sheffield, England 
c Institut für Mikrobiologie, der Johann Wolfgang Goethe-Universität Frankfurt, Germany 
 
2.2.2     Molecular biology techniques 
Transformation of yeast cells was carried out according to Gietz and Woods (2002). E. 
coli DH5α was used for propagation of recombinant plasmids. The preparation of 
competent E. coli and transformation protocol were performed according to Sambrook and 
Russell (2001). 
 
2.2.3     Plasmid construction 
The P. patulum 6-MSAS gene (X55776) (Beck et al., 1990) was received from University 
of Bristol in a pUBS1 plasmid. The pGei425U plasmid carrying K. lactis URA3 was 
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originally constructed from the p425GAL1 plasmid (Mumberg et al., 1994). The ends of 
6-MSAS gene were amplified by PCR with primers: PPmsaF:  5´–CCCTGCAGGTTA 
ATTAAGGAGGTACCTTTAAAATGCATTCCGCTGCAACT–3´ and PPm6HSAR: 5´–
GGCGCGCCATTTAAATTAATGGTGATGGTGATGATGTTTGGCAAGCTTCTCAG
C–3´. The primer PPm6HSAR carried a 6X histidine tag and two additional restriction 
sites, SwaI and AscI and recombination tags for the pGei425U plasmid. The pGei425U 
plasmid was opened with HindIII and the pUBS1 plasmid was cut with XbaI. The opened 
plasmid together with the PCR products bridging the ends of the 6-MSAS gene and the 
flanking plasmid sequences were then transformed into S. cerevisiae W303a (MATα; 
ade2;leu2;his;trp1;ura3) Recombination removed the K. lactis URA3 gene from 
pGei425U inserting the 6X histidine-tagged 6-MSAS gene yielding pGei425HSA-PP. The 
construction was confirmed by sequencing. 
 
To construct the p424sfp plasmid, the sfp gene of B. subtilis strain 1553 (Bacillus genetic 
stock center) was amplified by PCR with primers EcosfpF:  5’–GCCCGAATTCAGAAT 
GAAGATTTACGGAAT–3’ and ClasfpR:  5’–GCGCATCGATTTATAAAAGCTCTTC 
GTA–3’, cut with EcoRI and ClaI and ligated into p424GAL1 plasmid that had been 
opened with EcoRI and ClaI. 
 
2.2.4     Strain construction 
The strain S. cerevisiae IBT100074 was constructed by transformation of the plasmid 
pRS424 and pRS425 into S. cerevisiae CEN.PK111-27B. S. cerevisiae CEN.PK111-27B 
was co-transformed with the plasmid carrying the 6-MSAS gene (plasmid pGei425HSA-
PP) and the plasmid carrying the sfp encoding PPTase from B. subtilis (plasmid p424sfp) 
resulting in S. cerevisiae IBT100075. IBT100076 was constructed by co-transforming the 
plasmid pGei425HSA-PP and the plasmid carrying the npgA encoding PPTase from A. 
nidulans (plasmid pDKP4832) into S. cerevisiae CEN.PK 102-3A. The strains were 
selected on synthetic media lacking leucine/tryptophan and leucine/uracil, respectively, in 
order to obtain the correct transformants. 
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2.2.5     Bioreactors and cultivation conditions 
The strains were cultivated in 100 mL medium in 500 mL baffled shake flasks for 
propagation. The medium consisted of galactose 10 g/L, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 
g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L Antifoam 298 (Sigma-Aldrich, St. Louis, MO, 
USA) and 2 mL/L trace metal solution (FeSO4.7H2O 3 g/L, ZnSO4.7H2O 4.5 g/L, 
CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, CoCl2.6H2O 0.3 g/L, CuSO4.5H2O 0.3 g/L, 
Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 g/L, and Na2EDTA.2H2O 15 g/L), and 2 
mL/L vitamin solution (d-biotin 50 mg/L, Ca-pantothenate 1 g/L, thiamin-HCl 1 g/L, 
pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-aminobenzoic acid 0.2 g/L, and m-inositol 
12.5 g/L). pH of the medium was adjusted to 6.5 by 2M NaOH prior to autoclaving. The 
cultures were incubated at 30 oC, with shaking at 150 rpm (model 3033, GFL, Burgwedel, 
Germany). When the absorbance (A600) reached 13, 0.1 mL of the culture was used as 
inoculum for the batch cultivations. 
 
Batch cultivations were carried out in bioreactors (Biostat Braun Biotech International 
GmbH, Mulsungen, Germany) with a working volume of 2 L. The medium consisted of 
galactose 20 g/L, (NH4)2SO4 10 g/L, KH2PO4 3 g/L, MgSO4.7H2O 1 g/L with 0.05 mL/L 
Antifoam 298 (Sigma-Aldrich, St. Louis, MO, USA), 2 mL/L of trace metal solution and 2 
mL/L of vitamin solution. The compositions of the trace metal and vitamin stock solutions 
were the same as mentioned above. The temperature of the cultivations was kept at 30 oC, 
and the pH was automatically controlled at 5.0 by addition of 2M KOH. The agitation was 
500 rpm and the bioreactors were aerated with 2 L air/min. 
 
2.2.6     Absorbance and biomass measurement 
Absorbance was measured at 600 nm in a Hitachi U-1100 spectrophotometer throughout 
the batch cultivations. Biomass dry weight was determined by filtering a known volume of 
fermentation broth, approximately 10-15 mL depending on the biomass concentration in 
the media, through a dried, pre-weighed nitrocellulose filter (Gelman Science, Ann Arbor, 
MI) with a pore size 0.45 μm. The residue was washed twice with distilled water. The 
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filter was dried to constant weight in a microwave oven at 150 W for 10 minutes, cooled 
down in a desiccator, and the weight gain was measured. 
 
2.2.7     Analysis of galactose, primary metabolites, and 6-MSA 
Fermentation broth was filtered through a 0.45 μm pore-sized cellulose acetate filter (GE 
Osmonics Labstore, Minnetonka, MN) for later analysis of substrate and products. 
Galactose and primary metabolites was analyzed by high-performance liquid 
chromatography (Dionex-HPLC; Sunnyvale, CA), equipped with an Aminex HPX-87H 
ion exclusion column, 300 mm × 7.8 mm (Bio-Rad Laboratories, Hercules, CA), which 
was operated at 60 oC, and a flow rate of 0.6 mL/min of 5 mM H2SO4 using a refractive 
index detector (Shodex RI-71, Tokyo, Japan) and UV detector (UVD340S, Dionex). 6-
MSA was quantified from the filtrate by HPLC (Agilent 1100 series) with Luna C18(2) 
column, 150 × 4.60 mm with 5 micron of the porous silica particles to which the C18 
phase is bonded, using a gradient of 1% acetic acid in milliQ water (solvent A) and 1% 
acetic acid in acetonitrile (solvent B) at a flow rate of 0.5 mL/min. The gradient of the 
solvents was 20% to 80% B in 30 minutes, then 100% of B for 5 minutes, and 20% B for 
the next 10 minutes. 
 
2.3     Results 
 
2.3.1    Maximum specific growth rate, biomass yield, and primary metabolites 
The fermentation physiology of three different yeast strains, the strain with empty 
plasmids (IBT100074), the strain containing the plasmids carrying the gene encoding 6-
MSAS and PPTase gene from B. subtilis (IBT100075) and the strain containing the 
plasmids carrying 6-MSAS and PPTase gene from A. nidulans (IBT100076) were 
characterized in batch cultivations in a galactose minimal medium. The cultivations were 
carried out to estimate the kinetic parameters and to investigate the influence of the two 
different PPTases from B. subtilis and A. nidulans, respectively, on growth and on 
production of primary metabolites as well as of 6-MSA. For each strain two cultivations 
were performed and the mean values were presented. In all cultivations diauxic growth 
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were observed, and the three strains showed very similar growth characteristics but 
different growth kinetics (Figure 2.1). 
 
 (A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Results from batch cultivation with the three different strains. The left panel 
shows the concentrations of biomass, galactose, ethanol and 6-MSA (except for the strain 
with the empty plasmids) and the right panel shows the concentrations of the primary 
metabolites acetate, glycerol, pyruvate and succinate. 
time (hrs)
60 70 80 90 100 110
Bi
om
as
s (
g/
L)
0
2
4
6
8
6-
M
SA
 (m
g/
L)
0
50
100
150
200
250
G
al
ac
to
se
 (g
/L
)
0
5
10
15
20
25
Et
ha
no
l (
g/
L)
time (hrs)
60 70 80 90 100 110
A
ce
ta
te
 (g
/L
)
0.0
.2
.4
.6
.8
1.0
Py
ru
va
te
 (g
/L
)
0.00
.05
.10
.15
.20
.25
.30
G
ly
ce
ro
l (
g/
L)
Su
cc
in
at
e 
(g
/L
)
time (hrs)
60 70 80 90 100 110
Bi
om
as
s (
g/
L)
0
2
4
6
8
G
al
ac
to
se
 (g
/L
)
Et
ha
no
l (
g/
L)
0
5
10
15
20
25
time (hrs)
60 70 80 90 100 110
A
ce
ta
te
 (g
/L
)
0.0
.2
.4
.6
.8
1.0
Py
ru
va
te
 (g
/L
)
0.00
.05
.10
.15
.20
.25
.30
Su
cc
in
at
e 
(g
/L
)
G
ly
ce
ro
l (
g/
L)
(B) 
(C) 
time (hrs)
60 70 80 90 100 110
Bi
om
as
s (
g/
L)
0
2
4
6
8
6-
M
m
SA
 (
g/
L)
0
50
100
150
200
250
G
al
ac
to
se
 (g
/L
)
Et
ha
no
l (
g/
L)
0
5
10
15
20
25
time (hrs)
60 70 80 90 100 110
A
ce
ta
te
 (g
/L
)
0.0
.2
.4
.6
.8
1.0
Py
ru
va
te
 (g
/L
)
0.00
.05
.10
.15
.20
.25
.30
Su
cc
in
at
e 
(g
/L
)
G
ly
ce
ro
l (
g/
L)
 45
Chapter 2           Optimization of heterologous production of the polyketide 6-MSA in S. cerevisiae 
A1. Results with IBT100074, carrying the empty plasmids pRS424 and pRS425. 
B1. Results with IBT100075, carrying 6-MSAS gene from P. patulum and PPTase gene 
from B. subtilis. 
C1. Results with IBT100076, carrying 6-MSAS gene from P. patulum and PPTase gene 
from A. nidulans. 
1) The concentration profiles were very similar for the two cultivations. Data shown is for 
one of the replicates. 
 
After a lag phase, exponential growth was observed for all three strains. During this phase 
the cells grew at a maximum specific growth rate (μmax) until the galactose was exhausted. 
The maximum specific growth rate was approximately 0.22 hr-1 for the reference strain 
(IBT100074) and substantially lower for both strains producing 6-MSA, 0.13 and 0.16, 
respectively (Table 2.2). 
 
Table 2.2. Maximum specific growth rate and product yields during the batch cultures for 
the three different strains. 
 
Strains Maximum specific growth rate 
and yields IBT100074 IBT100075 IBT100076 
μmax  (hr-1) 0.22 ± 0.003 0.13 ± 0.03 0.16 ± 0.006 
YS,X (C-mmol/C-mol gal) 268 ± 8 274 ± 10 294 ± 18 
YS,EtOH (C-mmol/C-mol gal) 348 ± 12 360 ± 10 293 ± 2 
YS,Ace (C-mmol/C-mol gal) 64 ± 1 26 ± 12 18 ± 4 
YS,Pyr (C-mmol/C-mol gal) 0.67 ± 0.16 0.90 ± 0.04 0.89 ± 0.02 
YS,Gly (C-mmol/C-mol gal) 45 ± 3 11 ± 5 52 ± 12 
YS,Suc (C-mmol/C-mol gal) 5.7 ± 0.4 1.4 ± 0.4 16.5 ± 3.4 
YS,CO2 (C-mmol/C-mol gal) 278 ± 0.7 324 ± 54 324 ± 13 
YS,6-MSA (C-mmol/C-mol gal) 0 1.6 ± 0.6 8.6 ± 0.3 
YEtOH,6-MSA (C-mmol/C-mol EtOH) 0 14 ± 2 42 ± 9 
rp (mg 6-MSA/g dw/hr) in gal phase 0 0.6 ± 0.1 2.9 ± 0.4 
rp (mg 6-MSA/g dw/hr) in EtOH phase 0 0.8 ± 0.1 2.9 ± 0.2 
C-blannce (%) 100.9 99.9 100.7 
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In the first exponential growth phase there is over-flow metabolism resulting in formation 
of ethanol (Figure 2.1). Other primary metabolites such as acetate, succinate, glycerol and 
pyruvate were also excreted to the media in this phase but in much smaller amounts. The 
yields of the different primary metabolites produced during the first exponential phase 
were calculated and the results are collected in Table 2.2. The biomass composition was 
calculated based on formula CH 1.8 O 0.5 N 0.2 (Roels, 1983). 
 
For all three cultivations the consumed galactose carbon could be accounted for in the 
product with an error margin of 1%. When galactose was depleted there was a second 
exponential phase. In this phase acetate, glycerol and pyruvate formed during the first 
exponential growth phase were successively consumed, and eventually the cells started to 
consume ethanol resulting in a second exponential phase where biomass and CO2 were 
produced. When all the ethanol was consumed, the CO2 production rapidly decreased to 
zero marking the end of the second exponential growth phase. The CO2 from the exhaust 
gas during one of the batch cultivations is shown in Figure 2.2. After the second 
exponential phase the cultures reached the stationary phase where no more biomass or 
metabolic products were formed. 
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Figure 2.2. CO2 in the exhaust gas during a batch cultivation of IBT100076. The CO2 
profile clearly illustrates the first and the second exponential growth phase of the 
cultivation. 
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2.3.2     6-MSA production and yield 
From the measurements of the 6-MSA concentration, the biomass concentration and the 
specific growth rate it was possible to calculate both the 6-MSA yield and the specific 
production rate of 6-MSA (Table 2.2). Hereby it is possible to evaluate the growth kinetics 
for the two different growth phases and also the influence of the PPTase. As expected, 
there was no production of 6-MSA by the reference strain with the empty plasmids 
(IBT100074), whereas for the two other strains, IBT100075 and IBT100076, there was 6-
MSA production simultaneously with growth.  
 
During the first exponential phase where galactose was consumed, the yield of 6-MSA 
was 8.6 C-mmol/C-mol galactose for the strain with PPTase gene from A. nidulans 
(IBT100076), whereas the strain with PPTase gene from B. subtilis produced 1.6 C-mmol 
6-MSA/C-mol galactose (Table 2.2). In the second exponential growth phase where the 
cells used ethanol as a carbon source, 6-MSA was produced with yields of 42 and 14 C-
mmol 6-MSA/C-mol ethanol, from the strains expressing PPTase from A. nidulans and B. 
subtilis, respectively. After the ethanol was consumed, the cultures reached a stationary 
phase and here the final titer of 6-MSA was above 200 mg/L for the strain expressing the 
PPTase from A. nidulans (Figure 2.1).  
 
2.3.3     Bioinformatics of the PPTases  
In order to obtain some insight into the possible molecular mechanisms resulting in the 
difference in productivity arising from using the two different PPTases, we compared the 
two proteins using bioinformatics. The npgA gene (GenBank accession number, 
AAF12814) is predicted to encode a peptide of 344 amino acids (aa), and is more than 
twice the size of the Sfp peptide (AAC36829) which is only 165 aa in length. A BlastP 
alignment (Altschul et al., 1997) of the two peptides reveals only 23% (46/195) identity 
between the sequences and although this similarity is quite weak, the identical aa 
correspond to conserved residues previously determined, by a combination of 
crystallization and sequence alignment, to be vital domains in Sfp (Reuter et al., 1999). 
Alignment of PPTase homologues from several species confirms that the residues are 
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generally conserved (Keszenman-Pereyra et al., 2003). Since the N-terminal part of NpgA 
seems to have the same domains as Sfp, we took a closer look at the final 100 aa of the C-
terminal in NpgA which are unique when aligned to Sfp. A multiple sequence alignment 
of this region of NpgA with four fungal PPTase homologues (A. fumigatus (EAL93155), A. 
oryzae (BAE65284), A. terreus (XP_001218317), A. niger (Joint Genome Institute, 
ASN211634)) using ClustalX 1.8 (Jeanmougin et al., 1998) showed that the N-terminal of 
these aa sequences are indeed conserved (30%), and contained the conserved motif “A291 
TAARG”. In light of this, it is possible that the conserved N-terminal mediates a specific 
function that is not present in Sfp and that this additional function accounts for the 
improved productivity of 6-MSA in our experiments. Additionally, NpgA is 
phylogenetically closer to the P. patulum PKS than the bacterial Sfp protein. Thus, 
although both Sfp and NpgA can be described as broad-specificity PPTases, the 
Aspergillus protein seems to be slightly better adapted for activation of fungal PKSs.  
 
2.4     Discussion 
In the present study, we demonstrated the heterologous expression of a PKS in S. 
cerevisiae. There are several reasons for the expression of polyketide pathways from a 
natural host in a heterologous host: 1) many useful polyketides originate from a source 
that is difficult or even impossible to cultivate, 2) heterologous expression provides an 
efficient platform for combinatorial biosynthesis, and 3) by using a common cell factory 
platform for production of polyketides, one may optimize the central carbon metabolism 
for efficient production of the precursors required for polyketide biosynthesis, and hereby 
the same cell factory platform may be used for high level expression of several 
polyketides. A fungal polyketide, 6-MSA produced from P. patulum, was chosen as a 
model polyketide in this study due to its simple structure, as it has been well studied, and 
it has been previously established in yeast (Kealey et al., 1998). 
 
In our study we showed that it was possible to produce large amounts of 6-MSA in yeast, 
and we obtained 6-MSA yields as high as 18 mg 6-MSA/g DW corresponding to 200 mg 
of 6-MSA/L with the PPTase from A. nidulans. This yield was superior compared to the 
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natural producers P. griseofulvum IBT3115 and A. terreus IBT12713 which produced 0.2 
and 0.1 mg of 6-MSA/L in minimal media (Wattanachaisaereekul et al.,unpublished data), 
respectively. Furthermore, only 0.58 mg of 6-MSA/plate was produced by P. patulum 
growing on solid glucose-based Czapek-Dox agar (medium volume 40 mL) at 90 hrs after 
inoculation (Peace et al., 1981). The yield from this study is comparable to yields obtained 
for endogeneously produced nystatin by Streptomyces noursei (Jonsbu et al., 2001; 
Nielsen and Eliasson, 2004), which is quite impressive and indicates that it is possible to 
produce even more complex polyketides at reasonable production levels. In terms of strain 
stability the strains constructed and used in this study were found to be stable throughout 
the batch cultivations, as clearly indicated by the constant specific productivity in the 
different growth phases.  
  
In the process of developing our yeast producing polyketide platform we evaluated two 
different PPTases. This class of enzyme has been classified into three groups according to 
their size and substrate selectivity (Lambalot et al., 1996). The first group is the AcpS-type 
referred to as bacterial holo-acyl CP synthases. PPTases of this class are characterized by 
a size of 120-140 amino acids and a restricted substrate tolerance. Many organisms have 
an AcpS-type PPTase for the modification of fatty acid synthase acyl carrier protein such 
as PPT2 in S. cerevisiae and AcpS in E. coli and B. subtilis. The second group of PPTases 
comprises enzymes that are integral parts of eukaryotic FAS, e.g. the yeast PPTase found 
in FAS2. The last group, sfp-type PPTases, contains enzymes that are about twice the size 
of the AcpS-type PPTases (about 240 amino acids). PPTases in this group act as 
monomers have a broad substrate spectrum and are usually closely connected to secondary 
metabolism (Finking and Marahiel, 2004; Mofid et al., 2004; Gross et al., 2005). The best-
characterized representative of this class is the sfp-type PPTase from B. subtilis. 
Additional members of sfp-type PPTases include PPTases of higher organisms, e.g. 
human PPTase (Joshi et al., 2003), Lys5 of S. cerevisiae which is responsible for the 
modification of multifunctional Lys2 (Ehmann et al., 1999; Mootz et al., 2002), and NpgA 
from A. nidulans required for the modification of at least five different enzymes involved 
in both primary and secondary metabolism such as pigment synthesis, lysine biosynthesis, 
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and the biosynthesis of siderophores and penicillin (Mayorga and Timberlake, 1992; 
Oberegger et al., 2003; Keszenman-Pereyra et al., 2003). 
 
Since the PPTases identified in S. cerevisiae are not involved in the production of any 
secondary metabolites and do not activate the P. patulum 6-MSAS (Kealey et al., 1998; 
Andrésson unpublished data), we expressed two different sfp-type PPTases, Sfp from B. 
subtilis and NgpA from A. nidulans. Both enzymes are known to show broad substrate 
specificity, and we were therefore interested in investigating the production kinetics when 
these two different PPTases were used. The results from the batch cultivations showed 
that during the first exponential phase the strain carrying the PPTase from A. nidulans 
(IBT100076) produced higher amounts of all primary metabolites than the strain 
expressing the PPTase from B. subtilis (IBT100075) as shown in Figure 2.1. It is 
interesting that the increased production of primary metabolites also resulted in a 
substantially higher 6-MSA production. As observed in the second exponential phase, 
where the ethanol formed during the first exponential phase was consumed, the yield of 6-
MSA from IBT100076 was 42 C-mmol/C-mol ethanol, whereas IBT100075 yielded 14 C-
mmol 6-MSA/C-mol ethanol. 
 
When the yield of 6-MSA on galactose was compared to the yield of 6-MSA on ethanol, 
we found that the use of ethanol as carbon source resulted in substantially more 6-MSA 
than when galactose was the carbon source. This is likely due to the fact that the use of a 
C2 carbon source may result in a higher level of the precursor (acetyl-CoA) in the cytosol 
(Seker et al., 2005; van den Berg et al., 1996, 1998) for production of 6-MSA. 
Furthermore, during the conversion of ethanol into acetaldehyde and further into acetate 
(that can be converted into acetyl-CoA) NADPH is generated, and NADPH is required as 
an electron donor for production of polyketides in the reduction of the keto group to a 
hydroxyl group or further. Thus, for production of polyketides by yeast it is beneficial to 
use ethanol as carbon source.  
 
In summary we have demonstrated that PPTases from both B. subtilis and A. nidulans can 
be used for the activation of PKSs in S. cerevisiae, but expression of the PPTase from A. 
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nidulans leads to higher production of the polyketide. Furthermore, through the use of 
ethanol as the carbon source the production is more efficient than with galactose (and 
likely other sugars). We reached more than 200 mg/L of 6-MSA in a batch fermentation 
and yields comparable with that obtained for Streptomyces producing endogeneous 
antibiotics. 
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Abstract 
The heterologous production of fungal polyketides was investigated using 6-
methylsalicylic acid synthase (6-MSAS) as a model polyketide synthase and 
Saccharomyces cerevisiae as a host. In order to improve the production of 6-MSA by 
enhancing the supply of precursors, the promoter of the gene (ACC1) encoding acetyl-
CoA carboxylase, which catalyzes the conversion of acetyl-CoA to malonyl-CoA, was 
replaced with a strong, constitutive promoter (TEF1p) in a strain harboring two plasmids 
carrying the genes encoding 6-MSAS from P. patulum and PPTase from Aspergillus 
nidulans, respectively. The strain was characterized in batch cultivations with a glucose 
minimal media (20 g/L), and a 60% increase in 6-MSA titer was observed compared to a 
strain having the native promoter in front of ACC1. The production of 6-MSA was scaled 
up by the cultivation of the ACC1-TEF1 promoter strain in minimal media containing 
50g/L of glucose, and hereby a final titer of 600 mg/L of 6-MSA was obtained. 
 
Keywords: acetyl-CoA carboxylase, malonyl-CoA, polyketides, heterologous expression, 
precursor supply 
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3.1     Introduction 
Polyketides, which are produced through the successive condensation of small carboxylic 
acids, represents a large group of secondary metabolites with a broad range of structures 
and biological activities (Katz and Donadio, 1993). The major sources of these 
compounds are microbial secondary metabolites. Fungi are very potent producers of 
polyketide metabolites and they are often targets in searches for bioactive polyketides that 
can be used in pharmaceutical and agrochemical industries. Examples of such bioactive 
compounds are the antibiotic colletodiol (tetraketide) from Cytospora sp. (O’Neill et al., 
1993), inhibitors for cholesterol biosynthesis such as compactin (nonaketide) and 
squalestatin (hexaketide), from Penicillium citrinum and Phoma sp., respectively 
(O’Hagen, 1991; Dawson et al., 1992), and the antifungal monocerin (heptaketide) from 
Drechslera monoceras (Turner and Aldridge, 1970). 
 
A wide range of structures of fungal polyketides, several of which have unusual features 
that are not found among bacterial metabolites, indicates an enzymological diversity 
which could be exploited in the generation of novel polyketides via combinatorial 
biosynthesis and metabolic engineering. The potential of metabolic engineering of fungal 
polyketides as well as the industrial production of useful polyketides will be greatly 
enhanced if the fungal genes can be heterologously expressed in a well-characterized host 
such as the yeast Saccharomyces cerevisiae. Unlike filamentous fungi, S. cerevisiae is a 
unicellular organism which is easy to work with in terms of large scale fermentation, and 
as molecular biological techniques are far more advanced for S. cerevisiae than for 
filamentous fungi, S. cerevisiae is a very attractive cell factory for heterologous 
production of fungal polyketides. There are, however, some challenges for the 
heterologous production of fungal polyketides in S. cerevisiae, e.g. the requirement for 
post-translational modification of the synthases by phosphopantetheinylation, but this has 
been solved and it has been demonstrated possible to heterologously produce the 
polyketide, 6-methylsalicylic acid (6-MSA), in S. cerevisiae (Kealey et al., 1998). More 
recently, S. cerevisiae carrying the 6-MSAS gene from P. patulum has been elaborately 
characterized in batch cultivations using galactose minimal media and a good yield of 6-
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MSA was obtained by the co-expression of the gene npgA encoding the enzyme 
phosphopantetheinyl transferase (PPTase) from A. nidulans (Wattanachaisaereekul et al., 
2007).  
 
Despite the success in the above mentioned stories we were, however, interested to further 
increase the productivity and titer of 6-MSA in order to evaluate whether S. cerevisiae 
could serve as a platform for heterologous production of fungal polyketides. We therefore 
applied metabolic engineering to increase the supply of precursors required for polyketide 
production. Furthermore, to circumvent the problem of slow growth on galactose we 
replaced the expression promoter for the polyketide synthase with an endogeneous glucose 
promoter such that the polyketide 6-MSA could be produced during growth on glucose. 
As in our previous study the model polyketide used is 6-MSA. To increase the precursor 
supply we overexpressed the gene encoding the enzyme acetyl-CoA carboxylase (ACC1), 
which catalyzes the carboxylation of acetyl-CoA to form malonyl-CoA. The over-
expression of ACC1 was done by replacing the native promoter of ACC1 with the TEF1 
promoter, which is considered as a strong, constitutive promoter. We then performed a 
physiological characterization of the ACC1 promoter recombinant strain, the native ACC1 
promoter strain, and a non-producing reference strain in order to build a solid platform for 
the production of polyketides in S. cerevisiae. 
 
3.2     Materials and methods 
 
3.2.1     Plasmids and strains 
The plasmids and stains used in this study are listed in Table 3.1. 
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Table 3.1. List of plasmids and strains 
 Characteristics Reference 
Plasmids   
     pRS424 Yeast episomal vector with TRP1 marker Christianson et al. (1992) 
     pRS426 Yeast episomal vector with URA3 marker Christianson et al. (1992) 
     pDKP4832 Carrying npgA from A. nidulans with GAL1 promoter, and URA3 
marker 
David Keszenman-Pereyra a
     pWJ1042 Plasmid containing Kl URA3 flanked by direct repeats In our laboratory 
     pRS306CRUDT Integrating vector carrying CYC1 terminator, direct repeat, Up-
Down sequence of integration site – YMLCΔ2, TEF1 promoter, 
and URA3 marker 
Chapter 4 
     pRS306CRUDTMSA-PP Integrating vector carrying CYC1 terminator, direct repeats, Up-
Down sequence of integration site – YMLCΔ2, TEF1 promoter, 
URA3 marker and 6-MSAS gene from P. patulum 
Chapter 4 
     pRS426CT Expression vector containing TEF1 promoter, CYC1 terminator, 
and URA3 marker 
This study 
     pRS424CT Expression vector containing TEF1 promoter, CYC1 terminator, 
and TRP1 marker 
This study 
     pRS426CTMSA-PP Expression vector containing TEF1 promoter, CYC1 terminator, 
URA3 marker, and 6-MSAS gene from P. patulum 
This study 
     pRS424CTnpgA Expression vector containing TEF1 promoter, CYC1 terminator, 
TRP1 marker, and npgA from A. nidulans 
This study 
Strains   
     CEN.PK113-9D MATa;ura3-52;HIS3;LEU2;trp1-289;MAL2-8;SUC2 Peter Kötter b
     CEN.PK ACC CEN.PK 113-9D which promoter of ACC1 has been changed to 
TEF1 promoter 
This study 
     IBT100081 CEN.PK 113-9D with empty plasmids pRS426 and pRS424 This study 
     IBT100082 CEN.PK 113-9D with plasmids pRS426CTMSA-PP and 
pRS424CTnpgA 
This study 
     IBT100083 CEN.PK ACC with plasmids pRS426CTMSA-PP and 
pRS424CTnpgA 
This study 
 
a Department of Molecular biology and Biotechnology, University of Sheffield, England 
b Institut für Mikrobiologie, der Johann Wolfgang Goethe-Universität Frankfurt, Germany 
 
Oligonucleotides were synthesized by MWG-Biotech AZ, Germany (Table 3.2). PCR 
reactions were performed using Phusion polymerase (Finnzymes Oy, Espoo, Finland) 
according to the manufacturer’s guideline. GFX spin columns from Amersham 
Biosciences (Buckinghamshire, UK) were used for purification of DNA from either gel 
band or solution. Total genomic DNA extraction from S. cerevisiae for PCR template, 
DNA ligation, restriction endonuclease digestion and analysis were done in accordance 
with standard protocols (Sambrook and Russell, 2001) 
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Transformation of yeast cells was carried out according to Gietz and Woods (2002). E. 
coli DH5α was used for propagation of recombinant plasmids. The preparation of 
competent E. coli and transformation protocol were performed according to Sambrook and 
Russell (2001). 
 
Table 3.2. List of primers used in this study. The underline sections indicate the restriction 
sites introduced to facilitate cloning. 
 
DNA fragment Primer Sequence 5´- 3´ 
SWA1 GGACTAGTAAGCTTGGTACCTTCCACAAGCCT npgA of A. nidulans 
SWA2 CCATCGATATTGGACTCATATACCCTGCGAGC 
SWA3 CACAATTGTTATCGGTTCTAC Upstream of ACC1 promoter 
SWA4 GCAGGGATGCGGCCGCTGACCTTGCTCTGAATCTGAATTCC 
SWA5 GTCAGCGGCCGCATCCCTGCTTCGGCTTCATGGCAA Direct repeat1 and Kl. URA3 
SWA6 GAGCAATGAACCCAATAACGAAATC 
SWA7 CTTGACGTTCGTTCGACTGATGAGC Direct repeat 2 and Kl. URA3 
SWA8 CACGGCGCGCCTAGCAGCGGTAACGCCAGGGTTTTC 
SWA9 CGCTGCTAGGCGCGCCGTGCACACACCATAGCTTCAAAATGTT TEF1 promoter 
SWA10 AATAAGCTTTCTTCGCTCATTTTGTAATTAAAACTTAGATTAGA 
SWA11 ATGAGCGAAGAAAGCTTATTCGAGTCTTCTCCACAGAAGATGGA Downstream of ACC1 promoter 
SWA12 TCTCGGAGGCGTGACCCCAG 
 
 
3.2.2     Bioreactors and cultivation conditions 
The strains were cultivated in 100 mL medium in 500 mL baffled shake flasks for 
propagation. The medium consisted of glucose 10 g/L, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 
g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L Antifoam 298 (Sigma-Aldrich, St. Louis, MO, 
USA) and 2 mL/L trace metal solution (FeSO4.7H2O 3 g/L, ZnSO4.7H2O 4.5 g/L, 
CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, CoCl2.6H2O 0.3 g/L, CuSO4.5H2O 0.3 g/L, 
Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 g/L, and Na2EDTA.2H2O 15 g/L), and 2 
mL/L vitamin solution (d-biotin 50 mg/L, Ca-pantothenate 1 g/L, thiamin-HCl 1 g/L, 
pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-aminobenzoic acid 0.2 g/L, and m-inositol 
12.5 g/L). pH of the medium was adjusted to 6.5 by 2M NaOH prior to autoclaving. The 
cultures were incubated at 30 oC, with shaking at 150 rpm. When the absorbance (A600) 
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reached 13 (2.3 g biomass/L), 0.1 mL of the culture was used as inoculum for the batch 
cultivations. 
 
Batch cultivations were carried out in bioreactors (Biostat Braun Biotech International 
GmbH, Mulsungen, Germany) with a working volume of 2 L. The medium consisted of 
glucose 20 g/L or 50 g/L depending on the experiment, (NH4)2SO4 10 g/L, KH2PO4 3 g/L, 
MgSO4.7H2O 1 g/L with 0.05 mL/L Antifoam 298, 2 mL/L of trace metal solution and 2 
mL/L of vitamin solution. The compositions of the trace metal and vitamin stock solutions 
were the same as mentioned above. The temperature of the cultivations was kept at 30 oC, 
and the pH was automatically controlled at 5.0 by addition of 2M KOH. The agitation was 
500 rpm and the bioreactors were aerated with 2 L air/min. 
 
3.2.3     Biomass measurement 
Biomass dry weight was determined by filtering a known volume of fermentation broth, 
approximately 10-15 mL depending on the biomass concentration in the medium, through 
a dried, pre-weighed nitrocellulose filter (Gelman Science, Ann Arbor, MI) with a pore 
size of 0.45 μm. The residue was washed twice with distilled water. The filter was dried to 
constant weight in a microwave oven at 150 W for 10 minutes, cooled down in a 
desiccator, and the weight gain was measured. 
 
3.2.4     Analysis of glucose, primary metabolites and 6-MSA 
Fermentation samples were filtered through a 0.45 μm pore-sized cellulose acetate filter 
(GE Osmonics Labstore, Minnetonka, MN) for later analysis of substrate and products. 
Glucose and primary metabolites were analyzed by high-performance liquid 
chromatography (Dionex-HPLC; Sunnyvale, CA), equipped with an Aminex HPX-87H 
ion exclusion column, 300 mm × 7.8 mm (Bio-Rad Laboratories, Hercules, CA), which 
was operated at 60 oC, and a flow rate of 0.6 mL/min of 5 mM H2SO4 using a refractive 
index detector (Shodex RI-71, Tokyo, Japan) and UV detector (UVD340S, Dionex, 
Softron GmbH, Germering, Germany). 6-MSA was quantified from the filtrate by HPLC 
(Agilent 1100 series) with a Luna C18(2) column, 150 × 4.60 mm with 5 micron of the 
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porous silica particles to which the C18 phase is bonded, using a gradient of 50 ppm 
trifluoroacetic acid (TFA) in milliQ water (solvent A) and 50 ppm TFA in acetonitrile 
(solvent B) at a flow rate of 1 mL/min. The gradient of the solvents was 20% to 60% B in 
10 minutes, then 20% B for the next 2 minutes. 
 
3.3     Results 
The results are divided into three parts. The first part describes the construction of the 
plasmids and strains. The second part describes characterization in batch cultivations of 
the three different strains, namely the reference strain (IBT100081) carrying the empty 
plasmids, the ACC1-native promoter strain (IBT100082) and the ACC1-TEF1 promoter 
strain (IBT100083). The last two strains were carrying the 6-MSAS gene from P. patulum 
and the npgA gene encoding the enzyme phosphopantetheinyl transferase from A. nidulans 
under expression of the TEF1 promoter. The third part of the result section describes the 
influence of different glucose concentration (20 and 50 g/L) on the physiology and 6-MSA 
production of the S. cerevisiae ACC1-TEF1 promoter strain (IBT100083).  
 
3.3.1     Plasmid construction 
The TEF1 promoter and CYC1 terminator fragment was released together from 
pRS306CRUDT by KpnI and NotI, and ligated into KpnI/NotI sites of pRS424 and 
pRS426 to yield the expression vectors pRS424CT and pRS426CT, respectively. The 
plasmid pRS426CT was opened by NotI and ClaI and ligated to the fragment of the 6-
MSAS gene which was obtained from plasmid pRS306CRUDTMSA-PP by NotI and ClaI. 
The resulting plasmid was designated as plasmid pRS426CTMSA-PP. To construct 
pRS424CTnpgA, the npgA gene which encodes the enzyme phosphopantetheinyl 
transferase was amplified from pDKP4832 with primers SWA1 and 2. After digestion of 
the PCR product by SpeI and ClaI, it was ligated into pRS424CT which had been cut with 
the same restriction enzymes, SpeI and ClaI (Figure 3.1) 
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Figure 3.1. Diagram illustrating the construction of plasmids. 
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3.3.2     Strain construction 
S. cerevisiae IBT100081 was constructed by transformation of the empty plasmids 
pRS424 and pRS426 into S. cerevisiae CEN.PK 113-9D. The plasmid carrying the 6-MSA 
gene from P. patulum (pRS426CTMSA-PP) and the plasmid carrying npgA encoding 
PPTase from A. nidulans (pRS424CTnpgA) which both have the genes under the control 
of TEF1 promoter were co-transformed in S. cerevisiae CEN.PK 113-9D leading to the 
strain S. cerevisiae IBT100082. 
 
The system that was applied for the construction of S. cerevisiae IBT100083 was the 
bipartite gene-targeting technique (Erdeniz et al., 1997). This system is based on a 
bipartite substrate in which each of the two fragments carries a target sequence, a 
sequence which needs to be inserted, and a selectable marker gene which is unfunctional 
but homologous to some part of the same marker in the second fragment. (Figure 3.2) 
 
 
 
 
 
5-FOA 
Up stream 
Down stream
DR  Kl UR
Up stream ACC1 promoter
TEF1 promoterDR RA3
Kl URA3Up stream DR TEF1 promoter
TEF1 promoterUp stream DR 
DR 
ACC1
ACC1
ACC1
Bipartite substrate 
Chromosomal DNA 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. The homologous recombination of up and down stream sequences from the 
bipartite gene-targeting substrate to the chromosomal locus results in the exchange of 
ACC1 promoter to TEF1 promoter and the insertion of Kl URA3 flanked by direct repeats 
(DR). The Kl URA3 was later removed by plating the strains on medium containing 5-
fluoroorodic acid (5-FOA). 
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The first fragment contained the upstream sequence of ACC1, direct repeat and the 
upstream 2/3 Kluvyromyces lactis (Kl) URA3. The upstream which corresponded to the 
sequence in front of ACC1 promoter was amplified by primers SWA3 and 4 using 
genomic DNA of wild type S. cerevisiae as a template. Direct repeat with the upstream 2/3 
Kl URA3 was amplified from pWJ1042 as template with primers SWA5 and 6. Two PCR 
products were then fused together by primers SWA3 and 6. 
 
To obtain the second fragment, three PCR products were generated. The downstream 2/3 
Kl URA3, which was homologous to 1/3 of Kl URA3 in the first fragment, was amplified 
by using primer SWA7 and 8 from pWJ1042. The TEF1 promoter sequence and the 
downstream fragment that was homologous to the front part of ACC1 were amplified from 
yeast genomic DNA by using primers SWA9/10 and SWA11/12, respectively. The three 
PCR products were then fused by another PCR reaction using primers SWA7 and 12.  
 
After the fusion, two fragments were transformed into S. cerevisiae CEN.PK 113-9D, and 
integrated into the yeast chromosome by homologous recombination resulting in the 
changing of the ACC1 promoter to the TEF1 promoter. The transformants were plated on 
the medium containing 5-fluoroorodic acid (5-FOA) in order to pop out the URA3 so that 
URA3 can be used as a marker for the selection again. Since Ura3 metabolises 5-FOA into 
a toxic compound (Boeke et al., 1984), yeast that maintain URA3 are killed, whereas yeast 
lacking URA3 are resistant to 5-FOA and stay alive, designated as S. cerevisiae CEN.PK 
ACC. Plasmids pRS426CTMSA-PP and pRS424CTnpgA were co-transformed in S. 
cerevisiae CEN.PK ACC to give the strain S. cerevisiae IBT100083. 
 
3.3.3   Characterization of IBT100081, 100082 and 100083 in batch cultivations 
The physiology of S. cerevisiae IBT100081, 100082, and 100083 were characterized in 
batch cultivations in glucose minimal media with two replicates. Samples were taken 
during the fermentations for the analysis of biomass dry weight, 6-MSA, and primary 
metabolites namely ethanol, acetate, succinate, glycerol, and pyruvate in order to 
determine the kinetics and stoichiometry of the microbial growth. The results from the 
batch cultivations of the three different strains are shown in Figure 3.3.  
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Not surprisingly the reference strain had a shorter lag phase than the other strains as it was 
not burdened by expressing the 6-MSAS and npgA genes. The maximum specific growth 
rate on glucose of the reference strain (IBT100081) was 0.33 hr-1 which was higher than 
for the other two strains, which had specific growth rates of 0.26 and 0.27 hr-1 for 
IBT100082 and IBT100083, respectively.  
 
In the first exponential phase where glucose was being consumed, the production of 
primary metabolites e.g. ethanol, pyruvate, succinate, glycerol, acetate as well as biomass, 
CO2 and 6-MSA were used to calculate yields as C-mmol/C-mol glucose and the results 
are listed in Table 3.3. The formula CH1.8O0.5N 0.2 was used for the biomass composition 
(Roels, 1983). Based on the calculated yields the carbon balance was found to close within 
0.4%. Comparison of the three strains showed that there was a positive correlation 
between the yield of pyruvate, succinate, and glycerol and the yield of 6-MSA, e.g. the 
yield of pyruvate, succinate and glycerol increased when the yield of 6-MSA on glucose 
increased. As expected, the yield of 6-MSA was improved when ACC1 was expressed 
from the TEF1 promoter (IBT100083), 3.4 C-mmol/C-mol glucose compared with  2.4 C-
mmol 6-MSA/C-mol glucose for the other 6-MSA producing strain (IBT100082). No 6-
MSA was produced from the reference strain as it was only carrying the empty plasmids.  
 
Considering only the 6-MSA producing strains, the maximum specific growth rate of the 
ACC-TEF1 promoter strain (IBT100083) and ACC-native promoter (IBT100082) were 
about the same (0.27 and 0.26 hr-1). The amount of biomass dry weight formed during the 
fermentations was therefore approximately the same for both strains, e.g. approximately 
145 C-mmol biomass/C-mol glucose. However the yield of 6-MSA and all primary 
metabolites was higher for IBT100083 than for IBT100082. In contrast, the yield of CO2 
from IBT100083 was significantly lower than that of IBT100082, e.g. 259 and 283 C-
mmol CO2/C-mol glucose, respectively.  
 
After glucose was exhausted, a short lag phase was observed, followed by a second 
exponential growth phase where the cells were growing on ethanol. During the batch 
cultivations, samples were also taken from this phase for biomass dry weight, 6-MSA and 
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primary metabolites (Figure 3.3). The maximum specific growth rate of each strain, as 
well as the yields of 6-MSA and succinate was also calculated for this growth phase and 
the results are shown in Table 3.4. In this phase the specific growth rates of the three 
strains were approximately five times lower than those of the first growth phase. This 
happens because ethanol is a poorer carbon source than glucose. In contrast, the yield of 
biomass, succinate and 6-MSA in the ethanol phase were higher than those found in the 
glucose growth phase. Especially the 6-MSA yield of the IBT100083 strain was much 
higher (41 C-mmol/C-mol ethanol) compared to the IBT100082 strain (23 C-mmol 6-
MSA/C-mol ethanol). Thus the impact of over-expression of the ACC1 gene is much 
higher than during growth on glucose, where the yield only increased from 2.4 C-mmol 6-
MSA/C-mol glucose to 3.4 C-mmol 6-MSA/C-mol glucose upon over-expression of 
ACC1. Thus, ethanol is clearly a favorable carbon source for the production of 6-MSA. 
The maximum titer of 6-MSA for IBT100083 was 250 mg/L which was 60% higher than 
the titer of 150 mg 6-MSA/L obtained with the strain having the native ACC1-promoter. 
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Figure 3.3. Results from batch cultivations on glucose minimal medium with the three 
different strains. The left panel shows the concentrations of biomass, glucose, ethanol and 
6-MSA (except for the strain with the empty plasmids) and the right panel shows the 
concentrations of the primary metabolites acetate, glycerol, pyruvate and succinate. 
A1,2. Results with IBT100081, carrying the empty plasmids pRS424 and pRS426. 
B1,2. Results with IBT100082, carrying 6-MSAS gene from P. patulum and PPTase gene 
from A. nidulans. 
C1,2. Results with IBT100083, carrying 6-MSAS gene from P. patulum and PPTase gene 
from A. nidulans, promoter of ACC1 was changed to TEF1 promoter. 
D1,3. Results with IBT100083, carrying 6-MSAS gene from P. patulum and PPTase gene 
from A. nidulans, promoter of ACC1 was changed to TEF1 promoter. 
1) The concentration profiles were very similar for the two cultivations. Data shown is for 
one of the replicates. 
2) The glucose concentration was 20 g/L. 
3) The glucose concentration was 50 g/L. 
 
Table 3.3. Maximum specific growth rate and product yields in the batch cultivations for 
three different strains during the first exponential phase where glucose was consumed 
 
Strains / concentration of glucose 
IBT100081  IBT100082  IBT100083 
Maximum specific growth  
and yields in the first 
exponential phase 20 g/L  20 g/L  20 g/L 50 g/L 
μmax (hr-1) 0.33 ± 0.01  0.26 ± 0.01  0.27 ± 0.00 0.27 ± 0.01 
YS,X (C-mmol/C-mol glc) 151.8 ± 2.8  145.4 ± 0.1  145.7 ± 1.6 142.6 ± 1.4 
YS,EtOH (C-mmol/C-mol glc) 498.6 ± 1.9  495.1 ± 14.5  504.7 ± 2.1 506.7 ± 3.2 
YS,Ace (C-mmol/C-mol glc) 10.2 ± 0.3  9.1 ± 1.1  11.2 ± 0.7 11.3 ± 0.9 
YS,Pyr (C-mmol/C-mol glc) 4.4 ± 0.0  5.6 ± 0.6  6.1 ± 0.2 6.1 ± 0.2 
YS,Gly (C-mmol/C-mol glc) 59.3 ± 1.2  61.2 ± 7.0  63.4 ± 0.0 35.4 ± 0.6 
YS,Suc (C-mmol/C-mol glc) 1.4 ± 0.2  1.8 ± 0.2  1.9 ± 0.1 1.3 ± 0.2 
YS,CO2 (C-mmol/C-mol glc) 277.4 ± 6.0  283.4 ± 5.6  259.8 ± 2.7 272.7 ± 3.6 
YS,6-MSA (C-mmol/C-mol glc) 0.0  2.4 ± 0.1  3.4 ±0.0 2.4 ± 0.1 
C-balance (%) 100.3  100.4  99.6 97.9 
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Table 3.4. Maximum specific growth rate and product yields in the batch cultivations for 
three different strains during the second exponential phase where ethanol was consumed 
 
Strains / concentration of glucose 
IBT100081  IBT100082  IBT100083 
Maximum specific growth  
and yields in the second 
exponential phase 20 g/L  20 g/L  20 g/L 50 g/L 
μmax (hr-1) 0.06 ± 0.00  0.05 ± 0.00  0.06 ± 0.00 0.03 ± 0.00 
YS,X (C-mmol/C-mol EtOH) 535.8 ± 18.3  462.9 ± 34.6  487.0 ± 20.0 464.2 ± 25.6 
YS,Pyr (C-mmol/C-mol EtOH) 0.4 ± 0.0  0.3 ± 0.1  0.3 ± 0.0 0.3 ± 0.0 
YS,Suc (C-mmol/C-mol EtOH) 1.5 ± 0.0  2.3 ± 0.3  2.1 ± 0.1 1.4 ± 0.2 
YS,6-MSA (C-mmol/C-mol EtOH) 0.0  23.4 ± 5.7  40.9 ± 0.0 36.8 ± 1.5 
 
 
3.3.4     Theoretical calculation of acetyl-CoA drain for 6-MSA production 
Normally the cytosolic acetyl-CoA generated in yeast is mainly used for synthesis of fatty 
acids that are polymerized to lipids and used in biomass formation. Synthesis of 1 g yeast 
lipids requires 25.1 mmol of acetyl-CoA (Oura, 1972) and the lipid content is typically 
between 3 and 12% of the yeast biomass (Verduyn, 1991). However, when 6-MSA 
production is taking place acetyl-CoA is also needed for 6-MSA biosynthesis. In order to 
produce 1 mol 6-MSA, in total 4 mol acetyl-CoA is required.  To get an idea of how much 
6-MSA production would affect the metabolism we calculated the ratio of acetyl-CoA 
needed for 6-MSA biosynthesis in relation to the need for biomass (Table 3.5). There 
seems to be a significant drain of acetyl-CoA for 6-MSA biosynthesis since as much as 
66% of the amount needed for biomass was used for 6-MSA production in strain 
IBT100083 when grown on ethanol even if a high lipid content of 10% was assumed for 
the yeast biomass.  
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Table 3.5 Theoretical calculation of amount of acetyl-CoA needed for 6-MSA production 
in relation to amount of acetyl-CoA needed for biomass. 
 
% of AcCoA to 6-MSA compared to amount that is 
used for lipid biosynthesis if lipid content is 
Strain Phase Yx,AcCoA 
(mmol AcCoA for 6-MSA 
production / g DW) 3% 5% 10% 
IBT100083 Glucose 0.45 60 36 18 
 Ethanol 1.67 222 133 66 
IBT100082 Glucose 0.33 44 27 13 
 Ethanol 0.85 114 68 34 
 
 
3.3.5     The effect on 6-MSA production by a higher glucose concentration 
As the 6-MSA production was substantially higher with the IBT100083 strain than with 
any of the other strains, IBT100083 was further characterized by cultivating it in minimal 
media with 50 g/L of glucose. Samples were taken throughout the batch cultivations for 
biomass, primary metabolites and 6-MSA analysis (Figure 3.3-D). This data were used to 
calculate yields on glucose and they are collected in Table 3.3 and compared with the 
batch cultivation data of the same strain when 20 g/L of glucose was used as a carbon 
source.  
 
In the first exponential phase, IBT100083 attained the same maximum specific growth 
rate of about 0.27 hr-1 when it was growing in the media containing 20 and 50 g/L glucose. 
Furthermore, the yields on glucose for most of the primary metabolites such as pyruvate, 
ethanol and acetate, as well as biomass, were pretty much the same in both fermentations. 
The yields of succinate and glycerol were significantly higher in the cultivations with 20 
g/L than with 50 g/L of glucose, but the yield of CO2 showed the opposite result as it was 
higher in the 50 g/L glucose cultivation. However, the yield of 6-MSA dropped from 3.35 
to 2.41 C-mmol/C-mol glucose when the initial glucose concentration was increased from 
20 and 50 g/L.  
 
In the second exponential growth phase where the cells consumed ethanol, the maximum 
specific growth rate was approximately 50% lower (0.03 compared with 0.06 hr-1) in the 
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cultivation with the initial glucose concentration of 20 compared with that of 50 g/L of 
glucose. Moreover, a decrease in the biomass, succinate, and 6-MSA yields were observed 
when 50 g/L of glucose was applied. However, still a high final titer of 6-MSA was 
obtained, namely 600 mg/L. 
 
3.4     Discussion 
Due to its GRAS status, well-established molecular biology and fermentation techniques, 
S. cerevisiae is a popular model organism for eukaryotic cell biology, but it is also a 
widely used cell factory for the production of proteins, and various kinds of metabolites 
ranging from the primary metabolites such as ethanol and succinic acid to secondary 
metabolites like 6-MSA (Keyley et al., 1998; Wattanachaisaereekul et al., 2007), lycopene 
(Yamano et al., 1994), and the antimalarial drug precursor or artemisinic acid (Ro et al., 
2006). Several recombinants of S. cerevisiae have been successfully used for the over-
expression of these products. This can be achieved by regulating the expression or co-
expression of the genes using replicating expression vectors that are maintained at high 
copy numbers in the cells and using strong promoters that are either inducible or 
constitutive to allow the expression of the genes at a high level. 
 
The GAL1 promoter which is considered as a very strong inducible promoter has been 
extensively used for expression of heterologous genes in S. cerevisiae. It was also used in 
our previous study for the heterologous expression of 6-MSAS from P. patulum and 
PPTase from Bacillus subtilis and A. nidulans in S. cerevisiae (Wattanachaisaereekul et al., 
2007). The GAL1 promoter is tightly repressed by glucose but it is strongly induced by 
galactose. Therefore, in order to express the genes, galactose, which is an expensive 
carbon source, must be added. Even more, the expression of the strong GAL1 promoter 
may lead to toxic effects (Mumberg et al., 1994) as it has been observed that a steady state 
could not be obtained in chemostat cultivations while GAL1 promoter was used for 
expression of 6-MSAS and PPTase (Chapter 4). All these reasons made us construct a new 
vector system that involved a glucose-based promoter.  
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For this purpose the TEF1 promoter, the promoter of a translation elongation factor gene 
was used. This is a strong constitutive promoter, and the advantage of using the TEF1 
promoter over the GAL1 promoter is that the heterologous gene could be expressed during 
growth on glucose which is a cheap carbon source, and one of the most abundant sugars in 
nature. Moreover, the specific growth rate of S. cerevisiae is much higher during growth 
on glucose compared with growth on galactose. Comparison of using the TEF1 promoter 
(IBT100082) in this study and using the GAL1 promoter to express 6-MSA and PPTase 
gene in our previous study (Wattanachaisaereekul et al., 2007), illustrates that although the 
yield of 6-MSA in the first exponential phase is higher with galactose as carbon source 
(8.6 C-mmol/C-mol galactose) than with glucose as carbon source (2.4 C-mmol/C-mol 
glucose), the glucose promoter results in the same final titer of about 150 mg/L, but as the 
specific growth rate is faster this final titer is reached faster, e.g. the productivity is higher 
with glucose as carbon source.  
 
To further increase the production of 6-MSA we aimed for increasing the supply of the 
precursors for 6-MSA biosynthesis. The precursors of 6-MSA biosynthesis are acetyl-CoA, 
malonyl-CoA, and NADPH. Therefore, in order to have a strain producing more 6-MSA, 
these precursors must be increased by for example performing the genetic modification 
that can redirect the fluxes towards these precursors. In S. cerevisiae, the acetyl-CoA pool 
is prolific, whereas sources of malonyl-CoA are generally limited. For that reason, the 
ACC1 gene which encodes the enzyme acetyl coenzyme A carboxylase was chosen in this 
study to be overexpressed, as it catalyzes the conversion of acetyl-CoA to malonyl-CoA. 
Over-expression of ACC1 by changing its promoter to the strong constitutive TEF1 
promoter enhanced the biosynthesis of malonyl-CoA, leading to the high level production 
of 6-MSA as shown in Table 3.3 and 3.4. In other words, by changing the promoter of 
ACC1 to TEF1 promoter in S. cerevisiae carrying plasmids with the 6-MSAS gene and 
npgA (IBT100083), the production of 6-MSA was increased by about 60%. The positive 
effect of overexpressing ACC1 was more pronounced during growth on ethanol compared 
to growth on glucose. Snf1 is known to be activated during growth in glucose-
derepressing conditions. Snf1 deactivates Acc1 by phosphorylation (Woods et al 1994; 
Shirra et al., 2001) and hence more of Acc1 is likely to be inactivated in ethanol growth 
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conditions. Overexpression of acetyl-CoA carboxylase in Streptomyces coelicolor has also 
been seen to result in an improved polyketides production (Ryu et al., 2006).  
 
IBT100083 was further studied in batch cultivations containing 50 g/L of glucose, and the 
results revealed that by using 50 g/L of glucose, the yeast was stressed and therefore the 
yield of 6-MSA decreased, but still the overall production of 6-MSA was good as a final 
titer of 600 mg/L could be reached. Thus, we conclude that it is possible to produce high 
levels of fungal polyketides in S. cerevisiae, and this organism hence represent an 
interesting platform for future production of novel fungal polyketides.  
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Chapter 4  
Towards Stable Production of 6-MSA by 
 S. cerevisiae in Chemostat Cultivation 
 
 
Abstract 
Saccharomyces cerevisiae has become increasingly interesting for being employed as a 
cell factory for the heterologous production of several different metabolites, e.g. 
polyketides. Usually foreign genes encoding the enzymes required for biosynthesis can be 
expressed in yeast by the introduction of shuttle vectors or plasmids. In continuous 
cultivations, however, plasmid instability leading to the loss of the plasmids from the cells 
and a decline in product formation may occur. Therefore, construction of stable plasmids 
and strains which maintain stable expression of the genes during the cultivation is of 
interest. In this study, the stability of a plasmid-based strain producing the polyketide 6-
MSA was examined. It was found that continuous cultivations with S. cerevisiae 
IBT100075 carrying two plasmids containing genes encoding 6-MSAS and PPTase, 
respectively, with both genes under the control of the GAL1 promoter, did not allow for 
stable production of 6-MSA. Even at low dilution rates the production of 6-MSA 
dramatically decreased after a maximum production that only lasted a few generations. In 
order to construct a stable production strain, the 6-MSAS gene was integrated into the 
chromosome with the co-expression of npgA, encoding PPTase from A. nidulans, and 
using the TEF1 promoter for controlling the expression of the genes. This resulted in a 
stable production strain which could be cultivated at high dilution rates on a glucose 
minimal medium with a stable production of 6-MSA for several generations. 
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4.1     Introduction 
In commercial production of heterologous proteins using S. cerevisiae as production host, 
plasmid based expression of the biosynthetic genes is often used, and a key problem 
associated with this is plasmid instability. Plasmid stability is defined as the ability of 
transformed cells to maintain the plasmid unchanged during their growth, manifesting 
their phenotypic characteristics (Imanaka and Aiba, 1981), and therefore, instability is the 
tendency of the transformed cells to lose their engineered properties because of changes to 
or loss of plasmids. This problem is especially significant for recombinant yeasts as 
almost all yeast plasmid vectors are hybrid plasmids or shuttle vectors that are relatively 
unstable. In addition, the instability can be caused by uneven partitioning of plasmids 
during cell division (Primrose and Ehrlich, 1981). The stability of a plasmid is also a 
function of other genetics factors such as the plasmid copy number, the presence of 
selective markers, the strength of promoter used in the plasmid, and environmental factors 
like medium composition, temperature and dilution rate (DiBiasio and Sardonini, 1986). 
The combination of these factors may result in instability of the plasmid, and this can be 
an important factor in the use of a recombinant strain for large scale production.  
 
As mentioned before, almost all plasmid vectors for S. cerevisiae are shuttle vectors. In 
fact they are both yeast and E. coli vectors that can replicate in either of the two organisms. 
This kind of vectors usually consists of all or part of an E. coli vector and a yeast 
replication system. Yeast autonomous plasmid vectors are based on one of two replication 
systems, either the sequence derived from the endogenous yeast 2 μm plasmid or a 
chromosomal DNA fragments that can replicate autonomously. (Kingsman et al., 1979; 
Stinchcomb et al., 1979). The later type is usually the autonomously replicating sequence 
(ARSs) which presumably acts as origins of replication in yeast chromosomes. Several 
types of yeast vectors have been reported by Panchal (1987). The principal types and 
properties of yeast vectors are summarized in Table 4.1. 
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Table 4.1. Type and properties of vectors used in S. cerevisiae1
 
       Vector 
Transformation 
efficiency/ 
μg of DNA 
Copy  
number  
per cell 
Mitotic stability Elements of yeast DNA present 
Yeast Integrating 
plasmid (YIp) 
1-10 1 Very stable Selectable marker, chromosomal 
fragment 
Yeast Episomal 
plasmid (YEp) 
103 - 105 5-40 Slightly unstable Selectable marker, 2 μm origin 
Yeast Replicating 
plasmid (YRp) 
103 - 105 3-30 Very unstable Selectable marker, chromosomal 
origin (ARS) 
Yeast Centromeric 
plasmid (YCp) 
103 – 104 1 Stable Selectable marker, chromosomal or  
2 μm origin, centromere (CEN) 
Yeast Linear 
plasmid  (YLp) 
103 – 104 5-30 Very unstable Selectable marker, chromosomal or 
2 μm origin, telomere (TEL) 
 
1Modified from Saunders et al. (1986)  
 
The most widely used plasmid and the best compromise in terms of stability and 
transformation efficiency appears to be offered by YEps. However, these plasmids are 
slightly unstable when the recombinant yeast carrying this kind of plasmid undergoes 
many rounds of duplication. This leads to problems for large scale production situations 
where it is necessary to propagate to high biomass concentrations. An alternative plasmid 
for introduction of DNA into yeast is the integrating plasmids (YIps). Even though the 
DNA integrated into the host genome by recombination shows low transformation 
efficiency the result is a high stability. In this case, however, the copy number of the 
introduced DNA is only one, so the expression levels are generally lower than for high 
copy number plasmids.  
 
In this study we investigate the stability of heterologous production of the polyketide 6-
MSA in S. cerevisiae during growth in continuous cultures The strain IBT100075, which 
is carrying the YEp plasmids harbouring the 6-MSAS gene from P. patulum and the sfp 
gene encoding the enzyme phosphopantetheinyl transferase (PPTase) from B. subtilis, 
both under control of the strong inducible GAL1 promoter, was earlier constructed and 
characterized in batch cultures (Wattanachaisaereekul et al., 2007). In chemostat 
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cultivation, however, this strain turned out to be unstable, possibly due to the reasons 
mentioned above, and furthermore the use of multiple copies of the GAL1 promoter 
resulted in very slow growth of the strain, and hence it could only be operated at very low 
dilution rates. We therefore constructed another strain (IBT100084) by using an 
integrating vector for the insertion of the 6-MSAS gene into the yeast chromosome at the 
YMLCΔ2 site. However, the IBT100084 strain was still carrying the gene encoding 
PPTase (npgA from A. nidulans) on a plasmid. In IBT100084 both the 6-MSAS and the 
PPTase encoding genes are under control of the TEF1 promoter, allowing the strain to 
grow and produce 6-MSA in glucose minimal media and at high dilution rates. The 
production of 6-MSA from IBT100084 was investigated as well as the stability of the 
strain was assessed and compared to the strain IBT100075 in order to build a yeast based 
cell factory platform for the production of polyketides. 
 
4.2     Materials and methods 
 
4.2.1     Molecular biology techniques 
Oligonucleotides used were synthesized by MWG-Biotech AZ, Germany, and are listed in 
Table 4.2. PCR reactions were performed using Phusion polymerase and Taq polymerase 
according to the manufacturer’s guideline. GFX spin columns from Amersham Pharmacia 
were used for purification of DNA from either gel bands or solution. Total genomic DNA 
extraction from S. cerevisiae for PCR template, DNA ligation, restriction endonuclease 
digestion and analysis were done according to the standard protocols.  
 
Transformation of yeast cells was carried out according to Gietz and Woods (2002). E. 
coli DH5α was used for propagation of recombinant plasmids. The preparation of 
competent E. coli and transformation protocol were performed according to Sambrook and 
Russell (2001). 
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Table 4.2. List of primers used in this study. The underline sections indicate the restriction 
sites introduced to facilitate cloning. 
 
DNA fragment primers Sequence 5´-3´ 
 
SWA13 
   ClaI 
CCATCGATTCATGTAATTAGTTATGTCACGCT 
 
CYC1 terminator 
 
SWA14 
   KpnI 
GGGGTACCGGCCGCAAATTAAAGCCTTCGAGC 
 
SWA15 
  SacI 
CGAGCTCCAGTCGGGAAACCTGTCGTGCCAG 
 
Direct repeat of pRS306 
 
SWA16 
     NotI    FseI   AsiSI 
AAAGCGGCCGCGGCCGGCCGCGATCGCTCGTGCACACAGCCCAGCTTGGAG 
 
SWA17 
                          FseI 
ATCGCGAGTCTTCATTCACCAGTCGGCCGGCCGGTGATCCTTCCGATGTATGCGTG 
 
Upstream of YMLCΔ2  
 
SWA18 
     NotI 
AAAGCGGCCGCATGGATTCCTAAATCCTCGAGGAG   
 
SWA19 
  AsiSI 
GCGATCGCCAATCCTTGCGTTTCAGCTTCCAC 
 
Downstream of YMLCΔ2 
 
SWA20 
  FseI 
GGCCGGCCGACTGGTGAATGAAGACTCGCGATTGCATCACAAGCACCCGGTACTGC 
 
SWA21 
            NotI 
AAGGAAAAAAGCGGCCGCCACACACCATAGCTTCAAAATGTT 
 
TEF1 promoter 
 
SWA22 
   XbaI 
GCTCTAGATTTGTAATTAAAACTTAGATTAGA 
 
4.2.2     Plasmids and strains 
The plasmids and stains used in this study are listed in Table 4.3. 
 
Table 4.3. List of plasmids and strains used in this study 
 
 Characteristics Reference 
Plasmids   
     pRS306 Yeast integrating shuttle vector with URA3 marker Sikorski and Hieter (1989) 
     pRS424CTnpgA Expression vector containing TEF1 promoter, CYC1 terminator, 
TRP1 marker, and npgA from A. nidulans 
Wattanachaisaereekul et al. 
(submitted) 
     pGEM-7Zf(+)/LIC-F Vector permitting visual detection of recombinants  Haun et al. (1992) 
     pGei425HSA-PP Carrying 6-MSAS gene from P. patulum with GAL1 promoter, 
CYC1 terminator, and LEU2 marker 
Wattanachaisaereekul et al. 
(2007) 
     pRS306CRUDTMSA-PP Integrating vector carrying CYC1 terminator, direct repeats, Up-
Down sequence of integration site – YMLCΔ2, TEF1 promoter, 
URA3 marker and 6-MSAS gene from P. patulum 
This study 
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Strains 
     CEN.PK113-9D MATa;ura3-52;HIS3;LEU2;trp1-289;MAL2-8;SUC2 Peter Kötter a
     IBT100075 CEN.PK 111-27B with plasmids pGei425HSA-PP and p424sfp Wattanachaisaereekul et al. 
(2007) 
     IBT100084 CEN.PK 11-39 with 6-MSAS integrated at YMLCΔ2 and 
pRS424CTnpgA 
This study 
 
a Institut für Mikrobiologie, der Johann Wolfgang Goethe-Universität Frankfurt, Germany 
 
4.2.3     Construction of an integrating vector expressing 6-MSAS 
A plasmid for integration into the yeast chromosome was constructed (Figure 4.1). The 
CYC1 terminator was amplified from the genomic DNA of the wild type S. cerevisiae 
CEN.PK 113-7D with primers SWA13 and 14. The PCR product was digested with ClaI 
and KpnI, and ligated into pRS306 in the ClaI/KpnI sites, resulting in the plasmid 
pRS306C. The direct repeat was amplified using pRS306 as a template with primers 
SWA15 and 16 by Taq polymerase. In order to facilitate the ligation in the next step, the 
PCR product was first ligated into pGEM-T easy vector systemI (Promega Corporation, 
Madison, WI, USA) and digested by SacI and NotI. The released SacI-NotI fragment was 
then ligated into SacI/NotI of the plasmid pRS306C to yield pRS306CR. Introduction of 
the direct repeat enables looping out of the URA3 marker after integration so that the same 
vector and marker may be used repeatedly  
 
The upstream and downstream, which are homologous to the upstream and downstream of 
the YMLCΔ2 integration site, were amplified by the primer pairs SWA17/18 and 
SWA19/20, respectively. The fragments were fused together using primer SWA18 and 19, 
so that the starting point of the upstream fragment was followed by the end of the 
downstream fragment with a restriction site, FseI, in between. After the fusion, the 
fragment was subcloned into pGEM-T easy vector systemI and cut by NotI and AsiSI. The 
NotI-AsiSI fragment was introduced into pRS306CR to obtain pRS306CRUD. To 
construct plasmid pRS306CRUDT, the TEF1 promoter was amplified from yeast genomic 
DNA by primers SWA21 and 22. The PCR product was cut by NotI and XbaI and ligated 
into the plasmid pRS306CRUD.  
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6-MSAS gene 
XhoI XbaI XhoI 
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Figure 4.1. Diagram illustrating the  
construction of the integrative plasmid 
pRS306CRUDTMSA-PP 
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The gene encoding 6-MSAS from P. patulum was excised from p425GeiHSA-PP by 
completed digestion with XbaI and partial digestion with XhoI, as a XhoI restriction site 
also is present inside the gene. The fragment with the 6-MSAS gene was subcloned into 
the XbaI/XhoI site of plasmid pGEM-7Zf(+)/LIC-F in order to change the restriction sites 
to enable ligation into the plasmid pRS306CRUDT. The 6-MSA gene was cut out by XbaI 
and ClaI and introduced into pRS306CRUDT to yield the integrative plasmid 
pRS306CRUDTMSA-PP. Restriction enzyme digestions verified the map of the 
constructed vector. 
 
4.2.4     Bioreactor and cultivation conditions 
The strains were cultivated in 100 mL medium in 500 mL baffled shake flasks for 
propagation. The medium consisted of glucose or galactose 10 g/L depending on the 
experiment, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L 
Antifoam 298 (Sigma-Aldrich, St. Louis, MO, USA) and 2 mL/L trace metal solution 
(FeSO4.7H2O 3 g/L, ZnSO4.7H2O 4.5 g/L, CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, 
CoCl2.6H2O 0.3 g/L, CuSO4.5H2O 0.3 g/L, Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 
g/L, and Na2EDTA.2H2O 15 g/L), and 2 mL/L vitamin solution (d-biotin 50 mg/L, Ca-
pantothenate 1 g/L, thiamin-HCl 1 g/L, pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-
aminobenzoic acid 0.2 g/L, and m-inositol 12.5 g/L). pH of the medium was adjusted to 
6.5 by 2M NaOH prior to autoclaving. The cultures were incubated at 30 oC, with shaking 
at 150 rpm (model 3033, GFL, Burgwedel, Germany). When the absorbance (A600) 
reached 13 (2.3 g biomass/L), 0.1 mL of the culture was used as inoculum for the initial 
batch cultivations. 
 
The initial batch cultivations were carried out in bioreactors (Biostat Braun Biotech 
International GmbH, Mulsungen, Germany) with a working volume of 1 L. When the 
concentration of CO2 measured in the off-gas by a gas analyzer (Innova AirTech 
Instruments A/S, Ballerup, Denmark) after peaking decreased to 0.8%, the cultures were 
switched from the initial batch phase to chemostat mode with a dilution rate of 0.03 hr-1 
for chemostat no.1, 2 and 3, and 0.1 hr-1 for chemostat no. 4. The cultures were fed with 
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minimal medium containing glucose or galactose 20 g/L, (NH4)2SO4 10 g/L, KH2PO4 3 
g/L, MgSO4.7H2O 1 g/L with 0.05 mL/L Antifoam 298, 2 mL/L of trace metal solution 
and 2 mL/L of vitamin solution. The compositions of the trace metal and vitamin stock 
solutions were the same as mentioned above. The temperature of the cultivations was kept 
constant for the whole cultivation at 30 oC, and the pH was automatically controlled at 5.0 
by automatic addition of 2M KOH. Aerobic conditions were maintained by sparging the 
cultures with air, 1 L/min, and by having an agitation of 500 rpm. After starting the feed, 
the steady states were determined by constant biomass dry weight, absorbance of the 
cultures and concentration of CO2. 
 
4.2.5     Absorbance and biomass measurement 
Absorbance was measured at 600 nm in a Hitachi U-1100 spectrophotometer (Tokyo, 
Japan) for biomass determination of the inoculum before initial batch cultivations. 
Biomass dry weight was determined throughout the cultivations by filtering a known 
volume of fermentation broth through a dried, pre-weighed nitrocellulose filter (Gelman 
Science, Ann Arbor, MI, USA) with a pore size 0.45 μm. The residue was washed twice 
with distilled water. The filter was dried to constant weight in a microwave oven at 150 W 
for 10 minutes, cooled down in a desiccator, and the weight gain was measured. 
 
4.2.6     Analysis of glucose, galactose and 6-MSA 
Fermentation broth was filtered through a 0.45 μm pore-sized cellulose acetate filter (GE 
Osmonics Labstore, Minnetonka, MN, USA) for later analysis of substrate and products. 
Glucose and galactose were analyzed by high-performance liquid chromatography 
(Dionex-HPLC; Sunnyvale, CA), equipped with an Aminex HPX-87H ion exclusion 
column, 300 mm × 7.8 mm (Bio-Rad Laboratories, Hercules, CA), which was operated at 
60 oC, and a flow rate of 0.6 mL/min of 5 mM H2SO4, using a refractive index detector 
(Shodex RI-71, Tokyo, Japan). 6-MSA was quantified from the filtrate by HPLC (Agilent 
1100 series) equipped with a Luna C18(2) column (150 × 4.60 mm, 5 micron particles), 
using a gradient of 50 ppm trifluoroacetic acid (TFA) in milliQ water (solvent A) and 50 
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ppm TFA in acetonitrile (solvent B) at a flow rate of 1 mL/min. The gradient of the 
solvents was 20% to 60% B in 10 minutes, then 20% B for the next 2 minutes. 
 
4.3     Results 
 
4.3.1  Characterization of the plasmid-based strain producing 6-MSA in 
chemostat cultivation 
 
The cultivations of S. cerevisiae IBT100075 was initiated with glucose minimal medium 
in order to prove that 6-MSA production was repressed by glucose (Figure 4.2). Another 
reason was to assess the stability of the strain when no 6-MSA was produced from the cell. 
In the end of the batch phase, upon glucose exhaustion, feeding of a minimal medium 
containing 20 g/L of glucose was started to inititate the chemostat cultivation. The strain 
IBT100075 have previously been characterized in batch cultivations 
(Wattanachaisaereekul et al., 2007), and the maximum specific growth rate (μmax) of this 
strain in a galactose minimal medium was 0.1 hr-1. The dilution rate for the chemostat 
cultivation was therefore chosen to be quite low, 0.03 hr-1. For a short period, from 150 hr 
to 200 hr, constant conditions were achieved when glucose was the carbon source (Figure 
4.2). However, the biomass concentration then started to decrease even though no 6-MSA 
was produced. After 340 hours, corresponding to approximately 10 generations, in the 
glucose minimal medium, the feed was switched to a galactose minimal medium 
containing 20 g/L of galactose (Figure 4.2). The dilution rate was kept at 0.03 hr-1. As 
expected, 6-MSA started to be produced just after the switch to galactose with the 
maximum titer being 110 mg/L between 400-430 hours. Shortly after this both biomass 
and 6-MSA concentrations dramatically dropped, indicating that no steady state could be 
obtained from this cultivation. 
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Figure 4.2. The amount of biomass dry weight and 6-MSA produced by S. cerevisiae 
IBT100075 in chemostat cultivation (no.1) using glucose and galactose minimal media 
(carbon source 20 g/L) with a dilution rate of 0.03 hr-1. 
 
The next chemostat cultivation was performed using the same strain and it was also 
initiated with a glucose minimal medium (glucose 20 g/L) and the glucose phase was kept 
for longer to see whether a steady state could be achieved when no production was taking 
place (Figure 4.3). After 1250 hours, the feed was changed to a galactose minimal medium 
(galactose 20 g/L). The dilution rate was constant 0.03 hr-1 throughout the cultivation. The 
cell mass dry weight concentration profile shows that a steady state could be obtained on 
the glucose minimal medium but not on the galactose minimal medium. Yet, even for 
growth on glucose the pattern indicated occurrence of instability phenomena. 6-MSA was 
produced after the feed was changed to the media containing galactose and the maximum 
level of 6-MSA was 150 mg/L at 1400 hours. This production level was, however, only 
kept for a very short period of time, thereafter the production of 6-MSA decreased to zero 
and the cellmass concentration increased, but then started to decrease again. 
 
In order to check if the plasmids were lost from the cells, and hence contributing to the 
observed instability, samples taken from the fermentation were plated on both YPD and a 
synthetic medium without leucine and tryptophan, and the total number of yeast colony 
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forming unit were counted on both plates. Cells that have lost the plasmids can grow on 
YPD medium, which contains all amino acids, but not on a synthetic medium without 
leucine and tryptophan, which are required for the survival of the cells. It seemed as if the 
plasmids were lost during the fermentation since the number of yeast colony forming units 
on the synthetic media was much lower than the number on YPD medium plates. The total 
number of cells per mL in the sample harvested from the chemostat cultivation (no. 2) at 
1570h that could grow on YPD and a synthetic medium, respectively, were about 
1.70×108 and 8×106 colonies/ml. 
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Figure 4.3. The amount of biomass dry weight and 6-MSA produced by S. cerevisiae 
IBT100075 in chemostat cultivation (no.2) using glucose and galactose minimal media 
(carbon source 20 g/L) with the dilution rate of 0.03 hr-1. 
 
The last 1L chemostat cultivation performed with the plasmid-based strain (IBT100075) 
was started directly with a galactose minimal medium (galactose 20 g/L), still with a 
dilution rate of 0.03 hr-1. The results of the biomass dry weight and production of 6-MSA 
from this cultivation are shown in Figure 4.4, which shows that the strain produced 6-
MSA and that a steady state of 6-MSA production could be obtained, for a short period of 
time, approximately 150 hours corresponding to 4.5 generations. At this period, the strains 
yielded 125.5±1.6 mg of 6-MSA/L, after that the concentration of 6-MSA decreased until 
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the end of the cultivation. To our surprise, during the period of stable 6-MSA production, 
the cellmass concentration was not stable, but had an increasing trend. 
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Figure 4.4. The amount of biomass dry weight and 6-MSA produced by S. cerevisiae 
IBT100075 in chemostat cultivation (no.3) using galactose minimal media (20 g/L) with 
the dilution rate of 0.03 hr-1. 
 
4.3.2     Construction of a recombinant strain expressing 6-MSAS 
Since S. cerevisiae IBT100075 carrying YEp plasmids with the genes encoding 6-MSAS 
from P. patulum and PPTase from B. subtilis, both under the control of the GAL1 
promoter, was unstable in chemostat cultivation, the gene encoding 6-MSAS was 
integrated into the yeast chromosome. An integrative vector pRS306CRUDTMSA-PP, 
carrying the 6-MSAS gene from Penicillium patulum under expression of the TEF 
promoter and URA3 as selectable marker was constructed (Figure 4.1). To construct the 
strain IBT100084, the plasmid pRS306CRUDTMSA-PP was linearized with FseI and 
transformed into S. cerevisiae CEN.PK 113-9D, resulting in the integration of the 6-
MSAS gene in the chromosome by homologous recombination. The integration of the 6-
MSAS gene was checked by colony PCR using the primer SWA22 and the primer 
homologous to the sequence outside the upstream region. The size of PCR was correct 
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(data not shown) indicating that the plasmid was indeed integrated in the right site. The 
strain was subsequently transformed by plasmid pRS424CTnpgA, a multi-copy vector 
carrying a gene encoding phosphopantetheinyl transferase and transformants were selected 
on medium without uracil and tryptophan. 
 
4.3.3     Characterization of the 6-MSA integrated strain  
In order to verify that the effect of the integration itself, an integrating vector without the 
6-MSAS gene was also integrated at the YMLCΔ2 site of S. cerevisiae CEN.PK 113-5D 
and this strain was used as reference. Batch cultivation with a glucose minimal medium 
(glucose 20 g/L) was performed in order to check whether the integration has an effect on 
the growth and compare to the growth of the wild type strain (CEN.PK 113-7D). The 
results showed that the maximum specific growth rate (μmax) of the integrated strain 
without the 6-MSAS gene was 0.34±0.020 hr-1, whereas that of wild type was 0.37±0.004 
hr-1. This means that the integrated plasmid, and thereby the deletion of the YMLCΔ2 site, 
did not seem to cause any severe phenotype on the strain.  
 
S. cerevisiae IBT100084 was able to produce 6-MSA during growth in a glucose minimal 
medium as the integrated 6-MSAS gene and the gene encoding PPTase on the plasmid 
were under control of the strong constitutive TEF1 promoter. The strain was first 
characterized in a batch cultivation with a glucose minimal medium (glucose 20 g/L) and 
this resulted in maximum production of 6-MSA of 16.0±0.8 mg/L with a μmax of 
0.31±0.011 hr-1 (data not shown), which is considerably higher than the growth rate 0.1  
hr-1 obtained on galactose for the plasmid strain, hence enabling chemostat cultivations 
with higher dilution rates. Chemostat cultivation in a glucose minimal medium (20 g/L) 
was then carried out with a working volume of 1L and a dilution rate of 0.1 hr-1. The result 
from this chemostat cultivation shown in Figure 4.5 demonstrates that it was possible to 
obtain steady-state. The cultivation lasted for approximately 20 generations from 50-250 
hours with a production of 6-MSA resulting in a titer of 14.3±0.8 mg/L.  One might argue 
that there was a slight increase in the values both for cellmass and 6-MSA, and hence that 
two different steady-states were seen over the time period (Figure 4.5). The first steady 
 92
Chapter 4                 Towards stable production of 6-MSA by S. cerevisiae in chemostat cultivation 
state would then be from 50 -100 hours with a cellmass concentration of 5.7±0.06 g/L and 
the second one 170-245 hours with a cellmass concentration of 6.4±0.05 g/L.  
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Figure 4.5. The amount of biomass dry weight and 6-MSA produced by S. cerevisiae 
IBT100084 (6-MSAS integrated strain) in chemostat cultivation (no.4) using glucose 
minimal media (glucose 20 g/L) with the dilution rate of 0.1 hr-1. 
 
4.4     Discussion 
Plasmid stability is clearly desirable for application of recombinant strains in the 
production of new products. Here we examined the stability of S. cerevisiae producing the 
polyketide 6-MSA. We found that S. cerevisiae IBT100075 carrying two YEp plasmids 
with the 6-MSAS gene from P. patulum and the PPTase gene from B. subtilis, did not 
allow stable production in a chemostat cultivation with neither glucose nor galactose 
minimal media, even though the plasmids used in this strain contained the endogenous 
yeast 2 μm, which should ensure a high copy number and is generally considered to be the 
best replication of origin for maintaining stability. However, there are several factors 
involved in causing instability of this strain, such as the copy number of the plasmid, the 
partition system, the expression level or transcription efficiency effect and the dilution rate.  
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From the literature it is known that the stability of plasmids in S. cerevisiae is affected by 
the plasmid copy number. Because the desired gene is usually inserted into the plasmid, 
the copy number of the plasmid determines the dosage of the gene in the cell. In general, 
plasmids showing high copy number have been shown to exhibit greater stability than 
those with low copy number (Futcher and Cox, 1984). During cell division, efficient 
partitioning of plasmids between mother and daughter cells will prevent emergence of 
plasmid-free cells. On the other hand, inefficient partitioning will result in plasmid-free 
cells. Based on this concept, Walmsley et al. (1983) reasoned that a plasmid with a high 
copy number should generate plasmid-free cells with a lower frequency than when the 
plasmid copy number is low. However, there do not seem to be a direct effect of copy 
number on stability as it has been found that the stability of a YRp plasmid (YRp7M) in a 
haploid strain was significantly lower than that of a YEp plasmid (pMA3a), although the 
former contained 952±391 copies of YRp7M per haploid genome, whereas the latter 
which was more stable contained only contains 133±59 copies of pMA3a (Spalding and 
Tuite, 1989). Thus, a high copy number does not necessarily guarantee the stability of the 
plasmid, but it seems to be more important with an effective partitioning system. 
Therefore, the instability of the strain harboring the plasmids with the 6-MSAS gene and 
the PPTase gene in the chemostat cultivations performed here might partly be due to a 
defect in the partitioning of the plasmid DNA between daughter and mother cells during 
cell division, which will result in a gradual reduction in the copy number, and eventually a 
loss of the plasmid from the cells and hereby a decline in the production of 6-MSA. 
 
The effect of dilution rate on plasmid stability in chemostat cultivation has been 
extensively studied. Since the dilution rate corresponds to the specific growth rate in the 
continuous culture, the chemostat cultivation provides an easy method for elucidating the 
relationship between specific growth rate and plasmid stability. Several studies showed 
that plasmid stability increased with increasing dilution rate when S. cerevisiae containing 
a plasmid was continuously cultivated in a selective media (DiBiasio and Sardonini, 1986; 
Lee and Hassan, 1987; Parker and DiBiasio, 1987; Lee and Hassan, 1988; Caunt et al., 
1989). One reason being that the partitioning of the plasmid DNA between daughter and 
mother cells during cell division breaks down during slow, glucose-limited growth 
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(Bugeja et al., 1989). Furthermore, at low growth rates normally a higher copy-number 
and hence increase in plasmid expression is observed. This indicates that replication and 
transcription of the plasmid have the potential to damage the plasmid DNA (Parker and 
DiBiasio, 1987). In this case, plasmid stability would depend on the cell’s DNA repair 
capabilities. Because many of the enzymes required for DNA repair are synthesized in 
different periods of time, the repair capability or stability of plasmid is likely to vary with 
the stage of growth cycle. Also the higher protein burden resulting from the higher 
expression level probably contributed to the instablility. Plasmid-strains with high 
expression of recombinant enzymes have earlier been shown to be more unstable that 
strains with low expression (Meinander and Hahn-Hägerdal, 1997). In accordance, the 
large size of the 6-MSA expressing plasmid could be another instablility issue. It has 
earlier been demonstrated that larger plasmids are considerably more instable (Futcher and 
Cox, 1984; Gerbaud et al., 1981). Moreover, it has been reported that the expression of the 
strong GAL1 promoter could lead a toxic effects in the cells, probably due to an out-
titration of GAL4 (Mumberg et al., 1994). This could also contribute to the instability of 
plasmids in the cells observed in this study. 
 
Due to the difficulty to maintain the steady state of the plasmid-harboring strain producing 
6-MSA in chemostat cultivation, we constructed a new strain (IBT100084). Instead of 
using YEp plasmids, we used a very stable integrative YIp plasmid (pRS306) for the 
integration of the 6-MSAS gene into the chromosome. We used YMLCΔ2 as the 
integration site since it is located in a well-expressed area, close to the GAL80 gene on 
chromosome XIII. It is also a non-functional open reading frame, and no function will 
therefore be lost when the gene encoding 6-MSAS is integrated at this site. Moreover, 
there are many more of this type integration sites in chromosome, so if more than one 
copy of the 6-MSAS gene is needed, it can be integrated into other sites by changing the 
homologous sequence according to the sequence of the site. However, the new strain 
(IBT100084) was still carrying PPTase on a plasmid. The gene encoding for PPTase in the 
plasmid had been changed from sfp in the previous strain (IBT100075) to npgA in this 
strain (IBT100084) as we reported before that the expression of PPTase from A. nidulans 
(NpgA) leaded to substantially higher production of polyketide than Sfp from B. subtilis 
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(Wattanchaisaereekul et. al., 2007). In addition, we also changed the promoter of the 6-
MSAS gene and the gene encoding for PPTase from the GAL1 promoter to the strong 
constitutive TEF1 promoter in the new strain. This was done in order to avoid the 
potential toxic effects to the cells from the use of GAL1 promoter and to be able to 
cultivate the strain in a glucose minimal medium and hence apply higher dilution rates.    
 
After cultivating the strain IBT100084 in the chemostat with a dilution rate of 0.1 hr-1, we 
found that it was possible to obtain a steady state. When comparing the production of 6-
MSA between the integrated strain and the plasmid containing strain, the integrated strain 
yielded 14.3 mg of 6-MSA/L or 0.23 mg 6-MSA/g dw/hr, whereas the plasmid strain 
yielded 125.5 mg of 6-MSA/L or 0.47 mg of 6-MSA/g dw/hr. Even though the titer was 
much lower with the integrated strain, the productivity of 6-MSA was only two-fold lower. 
One should also take into consideration that the integrated strain only contains a single 
copy of the 6-MSAS gene in the genome, whilst there are more copies of the plasmid in 
the plasmid strain. This indicates the advantage of the integrated strain cultivating in a 
glucose minimal medium at a high dilution rate and possibly also the use of the PPTase 
from A. nidulans.  
 
In summary, we obtained a stable S. cerevisiae strain, which could produce 6-MSA in 
chemostat cultivations. The problem with the instability of the plasmids from the plasmid-
based strain was overcome by the integration of the 6-MSAS gene into the chromosome 
Both the 6-MSAS gene and the PPTase gene were under control of the strong constitutive 
TEF1 promoter instead of using GAL1 promoter in order to be able to produce 6-MSA in 
glucose-based medium and with a high dilution rate. This strain is suitable to apply in 
industrially relevant conditions, e.g. long time fed-batch processses to obtain high biomass 
concentrations and hence high 6-MSA titers with glucose based media. The 6-MSA titer 
obtained with the integrated strain was much lower than that with the plasmid containing 
strain, but as the strain could be operated at a higher dilution rate and the productivity was 
only slightly lower and it may probably be improved through integration of additional 
copies of the polyketide synthetase encoding gene into the chromosome.   
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Chapter 5  
Effect of Glucose Concentration on the Production of the    
Polyketide 6-MSA by S. cerevisiae in Batch Cultivations 
 
 
Abstract 
In a previous study it was shown possible to obtain high titers of the heterologously 
produced 6-MSA using the yeast S. cerevisiae as cell factory. This was obtained during 
growth on glucose, which is the preferred carbon source for industrial fermentations. In 
order to evaluate whether the final titer could be further enhanced we therefore optimized 
the production of 6-MSA by cultivating the S. cerevisiae IBT100083 in glucose minimal 
media with different initial glucose concentration; 20, 50, 100, 150 and 200 g/L. In these 
fermentations there will be formed different levels of ethanol during the initial 
fermentative growth phase. Ethanol was earlier shown to be a good carbon source for the 
polyketide 6-MSA, but high ethanol concentrations will also be toxic for the cells. We 
found that at an initial glucose concentration between 100-200 g/L, there was poor 
production of 6-MSA in both the glucose and the ethanol growth phase, possibly due to 
the hyperosmotic pressure imposed by the high glucose concentration as well as toxicity 
from ethanol and other byproducts that are formed during the cultivation. In contrast, the 
yeast presented the high specific growth rate and yielded better 6-MSA in the media with 
lower concentration of initial glucose, and optimum was found to be around 20-50 g/L.  
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5.1      Introduction 
In the fermentation industry, the yeast S. cerevisiae is widely used not only for baking and 
brewing, but for the production of various primary metabolites such as ethanol and 
glycerol, heterologous proteins and being used as a host for the production of secondary 
metabolites, e.g. polyketides. The growth of S. cerevisiae depends very much on the 
substrate especially the carbon source like glucose. Since it is the primary fuel used by 
most living cells to generate the energy that is needed to be carried out cellular function, 
glucose plays an essential role in the regulation of the genes and metabolism inside the 
cell (Fiechter et al., 1981). Like most eukaryotes, S. cerevisiae prefers glucose over other 
sugars, and it rapidly converts glucose into ethanol and CO2 at both anaerobic and aerobic 
conditions (Käppeli, 1986; Pronk et al., 1996). At anaerobic conditions, acetaldehyde is 
the final electron acceptor and fermentation is the only way to generate Gibbs free energy 
and hereby sustain growth. At aerobic conditions, oxygen may serve as the final electron 
acceptor through the respiratory pathway, but S. cerevisiae still exhibits alcoholic 
fermentation due to glucose repression of respiration. At these conditions, fermentation 
and respiration co-exist and the metabolism is referred to as oxido-reductive or respiro-
fermentative (Käppeli, 1986).  
 
For heterologous production of the polyketide 6-MSA by S. cerevisiae, the cells need not 
only to express the polyketide synthase gene, but they need to be cultivated aerobically in 
order to obtain sufficient energy for the biomass synthesis and for formation of the 
precursors such as acetyl-CoA, malonyl-CoA and NADPH for 6-MSA biosynthesis. We 
previously reported that the use of C2 carbon source such as ethanol by S. cerevisiae 
resulted in the higher production of acetyl-CoA and NADPH, leading to the substantially 
higher production of 6-MSA in the ethanol phase, as the maximum yield of 6-MSA from 
the strain IBT100083 was 34 mg 6-MSA/g ethanol, whereas the yield of 6-MSA on 
glucose was only 2 mg/g glucose (Chapter 3). This indicates that the occurrence of 
alcoholic fermentation in aerobic conditions, even though it is definitely undesirable in the 
biomass-directed applications, provides to a certain extent benefits to the production of 
polyketides. 
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The appearance of ethanol in the aerobic conditions is dependent on the initial 
concentration of glucose. Therefore the objective of this study was to investigate the 
production of the polyketide 6-MSA at different glucose concentrations in the media, 
resulting in different levels of production of ethanol which can then be used for polyketide 
production as previously described. In this study we used 6-MSA as a model polyketide, 
produced by S. cerevisiae IBT100083 with the co-expression of npgA from A. nidulans 
and the promoter of ACC1 of this strain was changed to TEF1 promoter in order to ensure 
an efficient supply of malonoyl-CoA. Physiological characterizations of the 6-MSA 
producing strain was performed during the batch cultivations and the yields of 6-MSA on 
each cultivation were evaluated.  
 
5.2     Materials and methods 
 
5.2.1     Strains 
The strain used throughout this study was S. cerevisiae IBT100083. The strain is carrying 
the two plasmids with the 6-MSAS gene from P. patulum and the npgA encoding PPTase 
from A. nidulans, and with the ACC1 promoter being changed to the TEF1 promoter as 
previously described in Chapter 3. 
 
5.2.2     Bioreactors and cultivation conditions 
The strain was cultivated in 100 mL medium in 500 mL baffled shake flasks for 
propagation. The medium consisted of glucose 10 g/L, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 
g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L Antifoam 298 (Sigma-Aldrich, St. Louis, MO, 
USA) and 2 mL/L trace metal solution (FeSO4.7H2O 3 g/L, ZnSO4.7H2O 4.5 g/L, 
CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, CoCl2.6H2O 0.3 g/L, CuSO4.5H2O 0.3 g/L, 
Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 g/L, and Na2EDTA.2H2O 15 g/L), and 2 
mL/L vitamin solution (d-biotin 50 mg/L, Ca-pantothenate 1 g/L, thiamin-HCl 1 g/L, 
pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-aminobenzoic acid 0.2 g/L, and m-inositol 
12.5 g/L). pH of the medium was adjusted to 6.5 by 2M NaOH prior to autoclaving. The 
cultures were incubated at 30 oC, with shaking at 150 rpm (model 3033, GFL, Burgwedel, 
 103
Chapter 5                  Effect of glucose concentration on the production of the polyketide 6-MSA… 
Germany). When the absorbance (A600) reached 13 (2.3 g biomass/L), 0.1 mL of the 
culture was used as inoculum for the batch cultivations. 
 
Batch cultivations were carried out in bioreactors (Biostat Braun Biotech International 
GmbH, Mulsungen, Germany) with a working volume of 2 L. The medium consisted of 
glucose 20, 50, 100, 150 and 200 g/L for each cultivation, (NH4)2SO4 10 g/L, KH2PO4 3 
g/L, MgSO4.7H2O 1 g/L with 0.05 mL/L Antifoam 298, 2 mL/L of trace metal solution 
and 2 mL/L of vitamin solution. The compositions of the trace metal and vitamin stock 
solutions were the same as mentioned above. The temperature of the cultivations was kept 
at 30 oC, and the pH was automatically controlled at 5.0 by addition of 2M KOH. The 
agitation was 500 rpm and the bioreactors were aerated with 2 L air/min. 
 
5.2.3     Biomass measurement 
Biomass dry weight was determined by filtering a known volume of fermentation broth, 
approximately 10-15 mL depending on the biomass concentration in the media, through a 
dried, pre-weighed nitrocellulose filter (Gelman Science, Ann Arbor, MI) with a pore size 
0.45 μm. The residue was washed twice with distilled water. The filter was dried to 
constant weight in a microwave oven at 150 W for 10 minutes, cooled down in a 
desiccator, and the weight gain was measured. 
 
5.2.4     Analysis of glucose, primary metabolites and 6-MSA 
Fermentation broth was filtered through a 0.45 μm pore-sized cellulose acetate filter (GE 
Osmonics Labstore, Minnetonka, MN) for later analysis of substrate and products. 
Glucose and primary metabolites were analyzed by high-performance liquid 
chromatography (Dionex-HPLC; Sunnyvale, CA), equipped with an Aminex HPX-87H 
ion exclusion column, 300 mm × 7.8 mm (Bio-Rad Laboratories, Hercules, CA), which 
was operated at 60 oC, and a flow rate of 0.6 mL/min of 5 mM H2SO4 using a refractive 
index detector (Shodex RI-71, Tokyo, Japan) and UV detector (UVD340S, Dionex, 
Softron GmbH, Germering, Germany). 6-MSA was quantified from the filtrate by HPLC 
(Agilent 1100 series) with Luna C18(2) column, 150 × 4.60 mm with 5 micron of the 
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porous silica particles to which the C18 phase is bonded, using a gradient of 50 ppm 
trifluoroacetic acid (TFA) in milliQ water (solvent A) and 50 ppm TFA in acetonitrile 
(solvent B) at a flow rate of 1 mL/min. The gradient of the solvents was 20% to 60% B in 
10 minutes, then 20% B for the next 2 minutes. 
 
5.3     Results 
 
5.3.1     Growth rate, production of 6-MSA and primary metabolites in the 
first exponential phase 
 
S. cerevisiae IBT100083 was cultivated in batch cultivations with the glucose 
concentration of 100, 150 and 200 g/L. The results were compared with the batch 
cultivations with 20 and 50 g/L of glucose that were described in Chapter 3. The growth 
characteristics and the production of biomass, primary metabolites and 6-MSA as a 
function of time are shown in Figure 5.1.  
 
During the first exponential phase, the cells consumed glucose at their maximum rate. 
Even though the same strain was applied throughout this study, it grew at different 
specific growth rates due to the different initial glucose concentration in the medium. The 
maximum specific growth rate decreased in the fermentations with high concentrations of 
glucose, from 0.27 hr-1 at 20 g/L to 0.22 hr-1 at 200 g/L of glucose. In contrast the specific 
glucose uptake rate increased from 2.29 g glucose/g dw/hr at 20 g/L to 2.63 g glucose/g 
dw/hr at 150 g/L of glucose, but it was lower at the highest glucose concentration due to 
the lower specific growth rate at this glucose concentration (Figure 5.2). 
 
The total biomass and CO2 formation produced during the first exponential growth phase 
increased according to the increase in the initial glucose concentration, but the yields on 
glucose decreased at for increasing glucose concentrations. A similar observation was 
made for 6-MSA and all the primary metabolites except for pyruvate. In another words, 
although the total 6-MSA production increased from 6.34 mg/L at 20 g/L of glucose to 
approximately 100 mg of 6-MSA/L at 200 g/L of glucose, the yields of 6-MSA decreased 
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from 2.1 to 0.6 mg 6-MSA/g glucose when the glucose concentration increased from 20 to 
200 g/L. Unlike for the other primary metabolites, the yield of pyruvate on glucose 
increased when the concentration of glucose in the media increased until 100 g/L, but it 
then decreased for higher initial glucose concentrations (Figure 5.2). The increase in the 
pyruvate yield when the glucose concentration increased to a certain level seems to 
correlate with the specific glucose uptake rate. This indicates that these two parameters 
were related to each others. However, all the product yields were calculated in C-mol/C-
mol glucose (see Table 5.1) in order to evaluate the carbon balance, and this shows that 
for high initial glucose concentrations it was difficult to close the carbon balance. This is 
probably due to the formation of other byproducts such as organic acids and aldehydes 
during the fermentations with the high initial glucose concentration, and these compounds 
were not measured by the HPLC. 
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Figure 5.1. The concentration of 6-MSA, biomass, CO2, glucose and ethanol during the 
batch cultivations of S. cerevisiae IBT100083 in minimal media with different initial 
glucose concentrations. 
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Figure 5.2. The changes in the specific growth rate, specific glucose uptake rate and 
product yields in the glucose growth phase when growing S. cerevisiae IBT100083 in 
minimal media with different initial glucose concentrations. 
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Table 5.1. Product yields in glucose phase during the batch cultivations of S. cerevisiae 
IBT100083 in minimal media containing different glucose concentration. 
 
Initial glucose concentration (g/L) Yields 
(C-mmol/C-mol glucose) 20 50 100 150 200 
Y glucose,6-MSA 3.35 2.41 1.47 1.13 0.98 
Y glucose,biomass 145.68 142.64 123.15 109.74 108.52 
Y glucose,ethanol 504.96 506.71 483.61 461.45 456.24 
Y glucose,succinate 1.86 1.28 1.09 0.92 0.82 
Y glucose,acetate 11.21 11.19 9.36 8.20 7.62 
Y glucose,glycerol 63.37 35.38 33.55 31.74 29.86 
Y glucose,pyruvate 6.08 6.11 6.18 6.10 5.91 
Y glucose,CO2 259.78 272.70 255.27 229.01 212.41 
C-balance (%) 99.63 97.84 91.37 84.83 82.24 
 
 
5.3.2  Growth rate, production of 6-MSA and primary metabolites in the 
second exponential phase 
 
After glucose was consumed, the cells were growing on ethanol formed from the overflow 
metabolism in the glucose growth phase. The amount of ethanol in each batch cultivation 
was different owing to the different initial glucose concentrations. The total amount of 
ethanol produced from the cultivations after the complete exhaustion of glucose with 
initial glucose concentration of 20, 50, 100, 150, and 200 g/L were about 6.4, 17, 34, 52, 
and 63 g ethanol/L, respectively.  
 
As reported before, the use of ethanol as carbon source allowed at least ten-fold higher 6-
MSA yield than the use of glucose. However, this seemed to be dependent on the 
concentration of ethanol in the media. For low concentrations of ethanol, such as 6.4 and 
17 g/L, which resulted in the fermentations with initial glucose concentrations of 20 and 
50 g/L, the cells grew well and effectively used the ethanol as carbon source, resulting in 
high 6-MSA final titers of 250 and 570 mg of 6-MSA/L, respectively. The final titer of 6-
MSA after the second exponential growth phase started to decrease when the 
concentration of ethanol in the media was 34 g/L (450 mg 6-MSA/L), and even lower 
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titers of 230 and 100 mg 6-MSA/L when the ethanol concentration was 52 and 63 g/L, 
respectively (Figure 5.1).  
 
In the batch cultivation containing 52 g/L of ethanol (150 g/L of initial glucose), the cells 
grew with a poor specific growth rate as the biomass only increased slowly and also the 
CO2 production rate was very low. However, 6-MSA was still produced resulting in a 
final titer of 230 mg/L, which was substantially more than the about 100 mg/L produced 
during the glucose growth phase. Interestingly, when the concentration of ethanol was 63 
g/L, which resulted from the fermentation with the initial glucose concentration of 200 g/L, 
the cells were totally inhibited, as a diauxic shift in biomass production and CO2 
production were not observed. This resulted in no change of the 6-MSA concentration, 
which stayed at 100 mg of 6-MSA/L throughout the rest of the fermentation. 
 
The effects of the increasing ethanol concentration in the media on the specific growth rate, 
ethanol consumption rate and the 6-MSA yield are illustrated in Figure 5.3 where these 
parameters are plotted as function of the initial glucose concentration. Figure 5.3 reveals 
that even though the production of 6-MSA at the final stage increased from 250 up to 570 
mg/L when the initial glucose concentration was 20 and 50 g/L, the 6-MSA yield on 
ethanol was actually decreased. Furthermore, the higher concentration of ethanol reduced 
the growth of the cells and the ethanol consumption rates, resulting in lower 6-MSA yield.  
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Figure 5.3. The changes of growth rate, ethanol uptake rate and product yields during the 
ethanol phase when cultivated S. cerevisiae IBT100083 in minimal media with different 
initial glucose concentrations. 
 
5.4     Discussion 
The idea of this study was originated from the previous observation that the yield of 6-
MSA was substantially increased when S. cerevisiae carrying the 6-MSAS gene grew 
during the ethanol growth phase in aerobic cultivations. This made us believe that we 
could cultivate the cells in a medium with higher concentration of glucose (and hence also 
ethanol) in order to obtain higher amount of 6-MSA. We therefore cultivated the yeast 
cells in a glucose minimal medium at aerobic growth conditions with high initial 
concentrations of glucose as this will result in high concentrations of ethanol due to 
overflow metabolism towards ethanol in the cells. Furthermore, the cells will slowly adapt 
to the increasing ethanol concentration, and hence continue to consume the formed ethanol, 
which could be difficult if they were directly inoculated in media containing high ethanol 
concentrations. 
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During the batch cultivations in the first exponential phase where glucose was consumed, 
we found that the maximum specific growth rate of the cells, the yields of primary 
metabolites and 6-MSA on glucose decreased with high initial concentrations of glucose, 
especially when the initial glucose concentration was more than 100 g/L. The effect of 
high concentration of glucose on the growth and biomass formation was also studied by 
Ryu et al. (2000), who observed that when the glucose concentration in fed-batch 
cultivations increased above 400 g/L, the formation of biomass and the concentration of 
the product, erythritol, in the media were decreased. The inhibition on the growth of yeast 
cells by the high concentration of glucose made Overkamp et al. (2002) to search for a 
glucose tolerant strain in order to use this for high-level production of glycerol.  
 
Moreover, the decrease in the specific growth rate at high glucose concentrations observed 
here was also according to the observations from other studies. Most of them revealed that 
the increase in the sugar concentration from 120 to 180 g/L decreased the growth and 
viability of the yeast cells (Casey and Ingledew, 1986; Xu et al., 1996; Bafrnacová et al., 
1999; Ivorra et al., 1999), likely because of osmotic stress and a complex response that 
included rapid reduction in internal cell volume by water efflux (Meikle et al., 1988; 
Marechal and Gervais, 1994; Ivorra et al., 1999). Thomas et al. (1996) studied anabolic 
and catabolic pathway regulation at high glucose concentrations to understand its effect on 
cell metabolism and they established evidence that the synthesis of glycolytic enzymes as 
well as enzymes of the hexose monophosphate pathway, are regulated by glucose 
concentration. Furthermore, there are other possible explanations for the growth inhibition 
at high glucose concentrations, including the toxicity of some yeast sub-products, such as 
hexanoic, octanoic, and decanoic acids (Muñoz and Ingledew, 1990). However, Salmon 
(1989), Mauricio and Salmon (1992), and Salmon et al., (1993) proved that the principal 
factor limiting yeast metabolism at high glucose concentrations is an inhibition of sugar 
transport. Sugar transport in yeast has been widely studied. It is characterized by the 
presence of several transporters that have a distinct affinity to glucose (Ciriacy and 
Reifenberger, 1997). Those presenting high affinity to the substrate are subject to 
catabolic repression and are not detected during fermentations at high glucose 
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concentrations, indicating that these transporters are repressed or inhibited (Bisson et al., 
1987).  
 
Nevertheless, in the yeast fermentations, after glucose was exhausted, the ethanol that was 
formed during the use of glucose was used as another carbon source. As expected, the 
higher initial glucose concentration, the higher ethanol concentration was obtained. Even 
though ethanol has been found to be beneficial for the production of the polyketide 6-
MSA in yeast, there seems to be a limited level of ethanol concentration that yeast can 
tolerate. This, however, depends on the yeast strains. In this study where the yeast 
IBT100083 was applied, we found that the specific growth rate, the yield of 6-MSA on 
ethanol and the specific ethanol uptake rate in the cells decreased when the concentration 
of ethanol in the medium increased. This was likely due to the fact that the ethanol at high 
concentrations inhibit essential cellular functions, giving rise to toxic effects especially on 
plasma membrane and cytosolic enzymes (Lopes and Sola-Penna, 2001). Furthermore, 
non-volatile compounds produced during the growth on ethanol can also hinder the 
growth of the cells. All of these effects could be the reasons why the high initial 
concentration of glucose, e.g. 100, 150 and 200 g/L, the growth of the yeast cells 
decreased and the yields of 6-MSA were less than when there was used lower initial 
glucose concentratin, e.g. 20 and 50 g/L.  
 
In summary, S. cerevisiae IBT100083 was cultivated in glucose minimal media with 
different initial glucose concentrations ranging from 20 to 200 g/L and this resulted in 
different amount of ethanol formed. At low initial glucose concentrations (20 and 50 g/L), 
the yeast exhibited a high specific growth rate with high production and a high 6-MSA 
yield on glucose. The growth of yeast cells started to be inhibited when the initial glucose 
concentrations was higher than 50 g/L, resulting in lower production of 6-MSA and other 
primary metabolites, as well as the yields on both glucose and ethanol dropped. This was 
due to high osmotic stress caused by glucose and the toxic effects from ethanol and other 
organic compounds generated during the cultivations. Thus, when the initial glucose 
concentration was 200 g/L resulting in 63 g/L of ethanol there was slow growth on 
glucose and no growth on ethanol.  
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Chapter 6  
Transcriptional and Metabolic Responses to 
Heterologous Expression of a                  
Polyketide Synthase in S. cerevisiae  
 
 
Abstract 
Natural producers of many interesting polyketides are difficult to cultivate and 
characterize, and it is therefore desirable to use more well characterized host cells for 
production of these natural products. S. cerevisiae is a suitable host for heterologous 
polyketide production of fungal polyketides as the knowledge of genomic and 
physiological properties of this organism is well established and S. cerevisiae is easy to 
handle in a fermentation process. Moreover, it has been reported that a high polyketide 
yields can be obtained with this organism. In order to make S. cerevisiae a general 
platform for production of polyketides, it is valuable to understand how the metabolism is 
regulated and affected by heterologous expression of a polyketide synthase. We therefore 
performed genome-wide transcription analysis and metabolic network analysis of S. 
cerevisiae carrying plasmids with the 6-methylsalicylic acid synthase (6-MSAS) gene 
from Penicillium patulum which is a model polyketide synthase, and a phosphopant-
etheinyl transferase (PPTase) gene, npgA from Aspergillus nidulans. The recombinant and 
the reference strain, carrying empty plasmids, were grown in batch cultivations and cells 
for analysis were harvested from both the glucose and the ethanol growth phase. 
Furthermore, a strain with improved 6-MSA production, having over-expression of the 
gene ACC1 encoding acetyl-CoA carboxylase was included in the study. 
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Evaluation of the transcriptome data using reporter metabolite and subnetwork structure 
analysis, to identify coordinated regulation of genes, revealed that the expression of 6-
MSAS had a large effect on several parts of the metabolism. In particular amino acid 
metabolism was found to be significantly affected when comparing the strain carrying the 
6-MSAS gene to the reference strain. However, also glycolysis and other parts of the 
carbohydrate metabolism, e.g. pathways leading to storage carbohydrates were 
significantly influenced as a result of the heterologous polyketide synthase expression. 
The most noteworthy change of expression for the improved strain with over-expression 
of the ACC1 gene was observed for genes connected to fatty acid metabolism.  
 
Furthermore, by using [1-13C]-labeled glucose as carbon source and measuring metabolite 
labeling patterns, effects on the fluxes in the metabolic network due to 6-MSAS 
expression were investigated. It was shown that the flux towards acetyl-CoA was 
increased in the strains carrying the 6-MSAS gene, which corresponds to the amount of 6-
MSA produced by the cell.  
 
6.1     Introduction 
Polyketides are secondary metabolites from bacteria, fungi, plants and animals which are 
derived from the polymerization of short fatty acids (most common are acetate, malonate 
or propionate) in a process similar to fatty acid synthesis.  Polyketides are structurally a 
very diverse family of natural products with an extremely broad range of biological 
activities and pharmacological properties often use as antibiotics, antifungals, cytostatics, 
anticholesterolemics, antiparasitics, animal growth enhancers and natural insecticides. 
They represent the most medical important group of microbial metabolites with 20% of 
the top 10 selling drugs are polyketides or derived from polyketides. 
 
6-Methylsalicylic acid (6-MSA) has been used as a model polyketide for studies on 
heterologous expression. It has earlier been demonstrated that S. cerevisiae carrying the 6-
MSAS gene from Penicillium patulum, with the coexpression of a gene encoding 
phophopantetheinyl transferase (PPTase) is capable of producing significant amounts of 6-
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MSA (Kealey et al., 1998; Wattanachaisaereekul et al., 2007). Furthermore, improved 6-
MSA production has been demonstrated as a result of overexpression of ACC1 encoding 
acetyl-CoA carboxylase, which is the enzyme catalyzing the conversion of acetyl-CoA 
into malonyl-CoA (Chapter 3). This was done by replacing the native promoter of ACC1 
with the strong, constitutive TEF1 promoter. Physiological characterization of the 
improved strain has shown that S. cerevisiae is capable of producing 6-MSA with good 
yields, particularly when ethanol is the carbon source, resulting in a considerable drain of 
acetyl-CoA into 6-MSA. Thus, in this strain the flux of acetyl-CoA into 6-MSA 
production was as high as about 40% of the total drain of acetyl-CoA, with the remaining 
acetyl-CoA consumption mainly going into lipid biosynthesis (Chapter 3).  
 
The purpose of the present study was to gain a more detailed understanding of the effects 
on metabolism when yeast is producing 6-MSA, and also evaluate the effect of draining a 
large part of the acetyl-CoA pool into 6-MSA production. Hence, genome-wide 
transcription analysis and metabolic network analysis were applied on three different 
strains during aerobic growth in batch cultivations and samples were harvested both from 
the glucose and the ethanol phase. The S. cerevisiae strains investigated were a reference 
strain, carrying empty plasmids (IBT100081) and two different strains expressing the gene 
encoding 6-MSA synthase (6-MSAS) from P. patulum with co-expression of a PPTase 
from A. nidulans (IBT100082, IBT100083) (Chapter 3). One of the 6-MSAS expressing 
strains also has the ACC1 under the control of the strong, constitutive TEF1 promoter 
(IBT100083).  
 
6.2     Materials and methods 
 
6.2.1     Strains 
The three strains of S. cerevisiae used in this study have been described in Chapter 3 and 
they are listed in Table 6.1. 
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Table 6.1. List of strains used in this work. 
Strains Characteristics 
IBT100081 
(reference strain) 
CEN.PK 113-9D carrying empty plasmids pRS424 and pRS426 
IBT100082 CEN.PK 113-9D carrying plasmid with 6-MSAS gene from P. 
patulum (pRS426CTMSA-PP) and plasmid with the npgA 
encoding enzyme PPTase from A. nidulans (pRS424CTnpgA) 
IBT100083 CEN.PK 113-9D which the promoter of ACC1 is changed to TEF1 
promoter and carrying plasmid with 6-MSAS gene from P. 
patulum (pRS426CTMSA-PP) and plasmid with the npgA 
encoding enzyme PPTase from A. nidulans (pRS424CTnpgA) 
 
 
6.2.2     Bioreactors and cultivation conditions 
The strains were cultivated in 100 mL medium in 500 mL baffled shake flasks for 
propagation. The medium contained: glucose 10 g/L, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 
g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L Antifoam 298 (Sigma-Aldrich, St. Louse, MO, 
USA) and 2 mL/L trace metal solution (FeSO4.7H2O 3 g/L, ZnSO4.7H2O 4.5 g/L, 
CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, CoCl2.6H2O 0.3 g/L, CuSO4.5H2O 0.3 g/L, 
Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 g/L, and Na2EDTA.2H2O 15 g/L), and 2 
mL/L vitamin solution (d-biotin 50 mg/L, Ca-pantothenate 1 g/L, thiamin-HCl 1 g/L, 
pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-aminobenzoic acid 0.2 g/L, and m-inositol 
12.5 g/L). pH of the medium was adjusted to 6.5 by 2M NaOH prior to autoclaving. The 
cultures were incubated at 30 oC, with shaking at 150 rpm (model 3033, GFL, Burgwedel, 
Germany). When the absorbance (A600) reached 13 (2.3 g biomass/L), 0.1 mL of the 
culture was used as inoculum for the batch cultivations. 
 
Batch cultivations for transcription analysis with two duplicates were carried out in 
bioreactors (Biostat Braun Biotech International GmbH, Mulsungen, Germany) with a 
working volume of 2 L. The medium consisted of glucose 20 g/L, (NH4)2SO4 10 g/L, 
KH2PO4 3 g/L, MgSO4.7H2O 1 g/L with 0.05 mL/L Antifoam 298, 2 mL/L of trace metal 
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solution and 2 mL/L of vitamin solution. The temperature of the cultivations was kept at 
30oC, and the pH was automatically controlled at 5.0 by addition of 2M KOH. The 
agitation was 500 rpm and the bioreactors were aerated with 2 L air/min. 
 
Batch cultivations for flux analysis were carried out in the same kind of bioreactor with a 
working volume of 0.6 L. The medium composition was the same as used in the 
transcription analysis experiment except that half of the glucose used was labeled ([1-13C]-
labeled glucose; ISOTECTM, Miamisburg, OH, USA). The cultivations were controlled at 
30oC, pH 5.0, with an agitation of 500 rpm and aerated with 0.6 L air/min. 
 
6.2.3     Sampling 
For gene expression analysis, 20 mL samples were withdrawn in mid-exponential phase, 
one sample in the glucose phase and another one in the ethanol phase. The sample was 
rapidly poured into a 50 mL Falcon tube containing 30 mL crushed ice, mixed and 
pelleted at 0oC, 4000 rpm for 5 minutes. The supernatant was discarded and the tube 
containing the cells was immediately put in liquid nitrogen, and stored at -80°C until 
further analysis. 
 
For flux analysis, the samples were taken throughout the cultivation period, 6 samples 
during the first exponential glucose phase, and another 4 samples in the ethanol phase. 
The sample volume withdrawn was adjusted at each time point to give around 50 mg wet 
weight of biomass that is required for the analysis. The samples were immediately 
centrifuged at 0oC, 4000 rpm for 5 minutes. After the centrifugation, the supernatant was 
removed and kept at -20oC for analysis of glucose, primary metabolites and 6-MSA. The 
cell pellet was frozen instantaneously in liquid nitrogen and stored at -80°C before 
performing the biomass hydrolysis. Each time a sample for flux analysis was withdrawn 5 
mL of the culture was also taken for analysis of biomass dry weight. 
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6.2.4     Biomass measurement 
Biomass dry weight was determined by filtering 5 mL fermentation broth, through a dried, 
pre-weighed nitrocellulose filter (Gelman Science, Ann Arbor, MI) with a pore size 0.45 
μm. The residue was washed twice with distilled water. The filter was dried to constant 
weight in a microwave oven at 150 W for 10 minutes, cooled down in a desiccator, and 
the weight gain was measured. 
 
6.2.5     Analysis of glucose, primary metabolites and 6-MSA 
Fermentation samples were centrifuged and the supernatant was taken for later analysis of 
substrate and products. Glucose and primary metabolites was analyzed by high-
performance liquid chromatography (Dionex-HPLC; Sunnyvale, CA), equipped with an 
Aminex HPX-87H ion exclusion column, 300 mm × 7.8 mm (Bio-Rad Laboratories, 
Hercules, CA), which was operated at 60oC, and a flow rate of 0.6 mL/min of 5 mM 
H2SO4 using a refractive index detector (Shodex RI-71, Tokyo, Japan) and a UV detector 
(UVD340S, Dionex). 6-MSA was quantified from the filtrate by HPLC (Agilent 1100 
series) equipped with Luna C18(2) column, 150 × 4.60 mm with 5 micron of the porous 
silica particles to which the C18 phase is bonded, using a gradient of 50 ppm 
trifluoroacetic acid (TFA) in milliQ water (solvent A) and 50 ppm TFA in acetonitrile 
(solvent B) at a flow rate of 0.5 mL/min. The gradient of the solvents was 20% to 60% B 
in 10 minutes, then 20% B for the next 2 minutes. 
 
6.2.6     Extraction of total RNA 
Total RNA extraction was performed using a FastRNA®, Red Kit (Qbiogene, Illkirch 
Cedex, France). After thawing the samples on ice, the phenol reagent was added directly 
on the cells and added up to 1.2 mL into the tube containing glass bead. The mixture was 
shaken for 40 seconds at level 6 (Fast Prep, FP120, Savant Instrument Inc., Holbrook, NY, 
USA). The cell debris was pelleted and discarded. The supernatant was extracted three 
times by chloroform, 350, 300 and 200 μL, respectively. The top phase (phenol reagent 
phase) was transferred to a new tube and 500 μL of 80% cold ethanol at -20oC was added. 
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The samples were kept at -20 oC for 2 hours to pellet the RNA. The RNA pellet was 
washed by 80% cold ethanol and air dried. The dry pellet was dissolved in RNAse free 
water (ultraPURE, GIBCOTM, Grand Island, NY, USA). The quantity and quality of the 
extracted RNA was determined by DNAquant II (Pharmacia Biotech, Cambridge, 
England) and 2100 bioanalyzer using the RNA 6000 Nano Assay (Agilent Technologies, 
Inc., Santa Clara, CA, USA). The RNA was stored at -80oC until further processing. 
 
6.2.7     Probe preparation and hybridization 
cDNA synthesis, cRNA synthesis and biotin labeling of antisense cRNA were carried out 
according to Affymetrix GeneChip® manual. 15 μg of fragmented, labeled cRNA was 
hybridized to Yeast Genome 2.0 oligonucleotide probe arrays (Affymetrix, Santa Clara, 
CA, USA) as described in the Affymetrix GeneChip® manual for array processing. 
Washing and staining of arrays were performed using the GeneChip Fluidics Station 450 
and scanning with the Agilent Gene Array Scanner (Affymetrix). 
 
6.2.8     Whole genome transcription data analysis 
The acquisition and quantification of array images as primary data analysis were 
performed using the GeneChip® Operation Software (Affymetrix) v.1.1, resulting in the 
raw data CEL files. The individual chips were scaled to the global level of hybridization 
and normalized to the same median intensity using the qspline method, thereby making 
them comparable to each other (Workman et al., 2002). For each gene an expression index 
was calculated based on the probes by using the Li-Wong Model-Based Expression index 
(PM-only model) (Li and Wong, 2001). All array data were subsequently analyzed for the 
principal component analysis to discover any grouping in the chips.  
 
Statistical analysis was applied to determine the difference of the gene expression between 
the categories of replicated experiments. A Student t-test was employed for different pair-
wise comparisons in the glucose phase (IBT100082 versus IBT100081) and in the ethanol 
phase (IBT100082 versus IBT100081, and IBT100083 versus IBT100082). Furthermore 
the comparison of the strain IBT100082 in glucose phase versus ethanol phase was also 
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performed. Gene description and annotations were found in the Saccharomyces Genome 
Database (SGD; http://www.yeastgenome.org) by using SGD Gene Ontology Term Finder.  
 
The reporter metabolites (metabolites around which the most significant changes in the 
transcription occur) and highly correlated subnetwork (sets of connected genes with 
significant and coordinated transcriptional response to a perturbation) as described by Patil 
and Nielsen (2005), were also identified for each pair-wise comparison in order to be able 
to extract more information about the effects on metabolism and regulation due to the 
heterologous expression of 6-MSA compared to the reference strain in both the glucose 
and the ethanol phase.  
 
6.2.9     GC-MS analysis and fractional labeling of intracellular metabolites 
In order to quantify the intracellular fluxes, a combination of metabolite balancing and 
isotope labeling experiments were applied. The labeling experiments were performed by 
feeding the cultures with labeled glucose, allowing the labeled carbon atoms to distribute 
over the metabolic network, and subsequently analyse the [1-13C]-labeled distributions of 
intracellular compounds. The [1-13C]-labeling of the intracellular metabolites were 
determined by an indirect method based on measurements of the labeling pattern of the 
proteinogenic amino acids using GC-MS (Christensen and Nielsen, 1999). For GC-MS 
analysis, derivatization of amino acids is necessary. The amino acid derivatization applied 
in this study, originally developed by Christensen and Nielsen (1999) and later refined by 
Bapat et al. (unpublished data), starts with the hydrolysis of biomass for preparing the 
derivatives of amino acids, solid phase extraction (SPE) of amino acids from biomass 
hydrolyzate using Dowex cation exchange resin, subsequently by performing three 
methods 1) Ethylcholoformate derivatization (ECF) for Ala116, Asp188, Gly175, Ile158, 
Leu158, Lys156, Phe192, Pro142, Ser132, Ser175, Val144; 2) N,N-Dimethylformamide 
dimethyl acetal derivatization (DMFDMA) for Ala99, Ala158, Asp115, Asp216, Glu143, 
Glu230, Gly85, Gly144, Phe143, Val127, Val143, Val186; 3) Pyridine-Acetic acid 
anhydride derivatization (PAA) for Glc331. After the derivatization, each amino acid 
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isotopomer was detected by GC-MS according to the protocol described by Christensen 
and Nielsen (1999) which was subsequently developed by Bapat et al. (unpublished data). 
 
The raw data from GC-MS analysis were normalized using the summed fractional labeling 
(SFL) concept described elsewhere by Christensen and Nielsen (2000). This calculated 
SFL includes the natural labeling present in the carbon derived from the derivatization. In 
order to obtain the true SFL, the SFL value was corrected for the natural labeling of the 
carbon atoms derived from the derivatization agent and for the natural labeling of oxygen, 
hydrogen and nitrogen content of the amino acids (Wittmann and Heinzle, 1999). The 
consistency of the labeling measurements was evaluated by comparing the SFLs of a 
specific fragment, which were obtained by different methods, or by comparing different 
fragments of the same molecule resulting from a particular derivatization method.  
 
6.2.10     Flux quantifications 
The in vivo metabolic fluxes were estimated by combining metabolite balancing and 
isotope balancing. Metabolite balancing relies on the stoichiometry of the reactions that 
comprise the metabolic network and on a set of measured fluxes, giving rise to a linear 
system of equations with respect to the metabolic fluxes, and the isotope balancing is 
carried out on a carbon atom basis or the fraction of labeled carbon atoms in a given 
position of a metabolite. The combination of metabolite balancing and isotope balancing 
enabled the metabolic flux calculation without the need for the assumptions of co-factor 
requirement. The flux calculation in this study was accomplished by using C13 software 
which was previously developed by Christiansen and Nielsen (2000), and further extended 
by Grotkjær and David (2005). The mathematical framework adopted in this software was 
the one developed by Wiechert and de Graaf (1997).  
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6.3     Results and discussion 
 
6.3.1     Physiological characterization 
The strains S. cerevisiae IBT100081, 100082 and 100083 were cultivated in duplicates in 
glucose minimal media (20 g/L of glucose) in batch cultivations and the observed product 
yields from this study (Table 6.2) were in agreement with those previously described in 
Chapter 3. A summary of the batch cultivation data is given in the following to provide a 
background for interpretation of the transcription data and flux analysis. In the first 
exponential phase where glucose was used as a carbon source, the maximum specific 
growth rate (μmax) of the reference strain (IBT100081) was 0.33 hr-1, whereas those of 
IBT100082 and IBT100083 were 0.26 and 0.27 hr-1, respectively. The 6-MSA yield of 
IBT100082 was 1.4 mg/g glucose whereas the yield of IBT100083, having the native 
ACC1 promoter exchanged with the strong constitutive promoter TEF1, was 2.0 mg/g 
glucose. These results indicate an improved supply of the 6-MSA precursor malonyl-CoA 
due to the stronger expression of ACC1 and hence a higher production with IBT100083. 
No 6-MSA was produced by the reference strain IB100081 as expected as it carried the 
empty plasmids without the heterologous PKS gene.  
 
In the second exponential phase where the ethanol generated during growth on glucose 
was used as carbon source, the μmax of IBT100081, 100082 and 100083 were 0.06, 0.05 
and 0.06 hr-1, respectively (Table 6.2). Ethanol has earlier been observed to be a better 
carbon source for polyketide production than glucose (Wattanachaisaereekul et al., 2007) 
and in line with this the 6-MSA yield was higher for both IBT100082 and 100083 in the 
ethanol phase, 19 and 34 mg/g ethanol, respectively.  
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Table 6.2. The maximum specific growth rate and product yields of the three different 
strains in batch cultivations. Data were calculated both for the glucose and the ethanol 
growth phase. 
 
Strains Growth rate and product yields 
IBT100081 IBT100082 IBT100083 
Glucose phase 
   μmax (hr-1) 
   Yse (mg ethanol/g glucose) 
   Ysg (mg glycerol/g glucose) 
   Ysa (mg acetate/g glucose) 
   Ysm (mg 6-MSA/g glucose) 
   Ysx (mg biomass/g glucose) 
 
0.33 ± 0.01 
359.2 ± 3.7 
47.5 ± 0.3 
9.9 ± 0.2 
0.0 ± 0.0 
125.9 ± 2.2 
 
0.26 ± 0.01 
358.4 ± 7.8 
46.2 ± 4.9 
10.7 ± 0.9 
1.4 ± 0.1 
112.5 ± 1.0 
 
0.27 ± 0.00 
370.8 ± 3.7 
44.6 ± 0.9 
12.4 ± 0.7 
2.0 ± 0.0 
114.3 ± 0.4 
Ethanol phase 
   μmax (hr-1) 
   Ysm (mg 6-MSA/g ethanol) 
   Ysx (mg biomass/g ethanol) 
 
0.063 ± 0.001 
0.0 ± 0.0 
572.4 ± 4.9 
 
0.052 ± 0.004 
19.3 ± 2.7 
494.9 ± 9.2 
 
0.059 ± 0.001 
33.8 ± 0.1 
520.7 ± 5.3 
 
 
6.3.2     Transcription data and analysis 
Cells were harvested for transcription analysis both in the mid-exponential growth phase 
on glucose (IBT100081 and IBT100082) and in the mid-exponential part of the ethanol 
phase (IBT100081, IBT100082 and IBT100083). At each time point two cell samples 
were harvested, and consequently 10 arrays were being processed in order to assess the 
variance in expression in each gene between biological duplicates. The expression data 
were normalized using dChip which is based on the algorithm described by Li-Wong. 
From the yeast 2.0 genome Affymetrix array, the expression values for 5,814 annotated 
ORFs were identified. From this, all genes with an absent call in all arrays were removed. 
This pre-processing part with a file of normalized expression value resulted in data for 
5,636 genes. 
 
A principal component analysis (PCA) was performed for all the arrays based on 5,636 
genes to evaluate the consistency of data (Figure 6.1). There is a clear separation in strains 
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in two dimensions, and in particular the PC2 separates the strains whereas samples from 
the glucose and the ethanol phase were separated by the PC1. A good repeatability of the 
experiments was obtained as replicates were grouping close together when visualized by 
PCA. 
 
 
IBT100083 - ethanol 
IBT100082 - ethanol 
IBT100081 - ethanol 
IBT100081 - glucose 
IBT100082 - glucose 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. Principal component analysis of the three different strains, illustrating that the 
replicates of the experiments were grouping close together.  
 
For the 5,636 ORFs, which were measured to be expressed under at least one of the time-
points in at least one of the strains, pair-wise statistical comparisons were performed to 
identify significant changes in gene expression using the two-tails, null hypothesis with 
unequal variance t-test (Table 6.3). To assess the significant genes, a p-value cut-off of 
0.05 was established for the comparison of IBT100082 vs IBT100081 in the glucose and 
the ethanol phase, respectively, and for IBT100083 vs IBT100082 in the ethanol phase. 
Using a smaller cut-off result in too few genes and further analysis is therefore hampered. 
However, in the comparison of IBT100082 in glucose versus ethanol phase, a p-value cut-
off of 0.01 gave sufficient number of genes for further analysis.   
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Table 6.3. Total number of significant genes in the different pair-wise comparisons 
between the categories.  
 
Number of significant genes (up-/down-regulated) 
Glucose phase Ethanol phase IBT100082 
Cut-off 
(confidence level) 
IBT100082 vs  
IBT100081 
IBT100082 vs  
IBT100081 
IBT100083 vs  
IBT100082 
Ethanol phase vs 
Glucose phase 
0.05 (95%) 777 (600/177) 717 (322/395) 795 (346/449) 2126 (1388/1224) 
0.01 (99%) 173 (141/32) 136 (72/64) 129 (53/76) 935 (499/436) 
0.001 (99.9%) 10 (9/1) 9 (4/5) 7 (3/4) 155 (88/67) 
 
When comparing IBT100082 to IBT100081 in the glucose phase, 777 genes (600 up-
regulated, 177 down-regulated) were identified as having significant changed mRNA 
levels. From these 777 genes, only 52 genes displayed a fold change of more than 2 fold. 
All 52 genes were up-regulated due to expression of the gene encoding 6-MSAS (strain 
IBT100082).  
 
When the t-test was applied to the transcriptome data from cells harvested in the ethanol 
phase, a pair-wise comparison between IBT100082 and IBT100081 resulted in 717 genes 
that were significantly changed (322 up-regulated and 395 down-regulated) at a p-value 
cut-off of 0.05. Among the 717 genes, there were 54 genes (40 up-regulated and 14 down-
regulated) with a more than 2 fold change. In the comparison of IBT100083 versus 
IBT100082, 795 significantly changed genes (346 up-regulated and 449 down-regulated) 
were obtained of which 26 genes (17 up-regulated and 9 down-regulated) were having an 
absolute fold change of more than 2. In the comparison of only IBT100082 in glucose and 
ethanol phase, which p-value cut-off of 0.01 was chosen, 935 significant genes (499 up-
regulated and 436 down-regulated) was obtained which 103 genes (96 up-regulated and 7 
down-regulated) were changed more than 2 fold. The distribution of the genes with 
significantly changed expression in the genome and the gene ontology (GO) for each 
comparison in both the glucose and the ethanol phase can be found in Appendix A. 
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6.3.3     Identification of reporter metabolites and metabolic subnetworks 
For further understanding of the effect on gene transcription of expression of a polyketides 
synthase in S. cerevisiae, the algorithm developed by Patil and Nielsen (2005) was applied. 
This algorithm identifies subsets of genes with significant and coordinated transcriptional 
response connected via common metabolites, the so-called reporter metabolites. The 
identification of reporter metabolites is based on connecting the gene expression data with 
the metabolic network information from the genome-scale model of S. cerevisiae (Förster 
et al., 2003), which includes the genes encoding enzymes. Reporter metabolite analysis 
locates the parts of the metabolism that are most affected by a certain perturbation, hence 
enabling identification of commonly regulated genes.  
 
The identification of highly correlated subnetworks was carried out using the p-values 
from the pair-wise comparisons as input data in combination with information from the 
whole reaction set in the genome-scale model of S. cerevisiae. Within the identified 
subnetworks, additional subnetwork structures were searched by the repetition of the 
algorithm over the subnetwork previously obtained, resulting in more robust and smaller 
subnetworks (Patil and Nielsen, 2005). The reporter metabolites and the enzymes 
comprising in the subnetwork for each of pair-wise comparisons between each strain both 
in glucose and ethanol phase are illustrated in Figure 6.2-6.5. 
 
6.3.4     Global effect due to 6-MSA production 
For production of 6-MSA, it has been proved that a higher productivity could be achieved 
in the ethanol phase than in the glucose phase, therefore gene expression for both phases 
in the 6-MSA production strain (IBT100082) was investigated. It is interesting to note that 
genes involved in the formation of acetyl-CoA, i.e. ACS1 and ACS2, were up-regulated 
when ethanol was the carbon source. This is in agreement with the observations of others 
that a larger cytosolic acetyl-CoA pool is available during C2 carbon source utilization 
compared to glucose (Seker et al., 2005; van den Berg et al., 1996, 1998) and the 
improved 6-MSA production on ethanol may well be due to an increased acetyl-CoA 
availability. Also the reporter metabolite analysis points towards changes in the same area 
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of metabolism as acetate came out as a reporter metabolite in addition to the TCA 
metabolites oxaloacetate, malate and succinyl-CoA (Figure 6.2).  
 
When comparing the expression patterns during growth on ethanol for the reference strain 
and the 6-MSA producing strain, IBT100081 and IBT100082, respectively, reporter 
metabolites related to the carbohydrate metabolism could be identified, with glycogen as 
the most significant one. There are four genes encoding neighboring enzymes around 
glycogen namely GLC3, GPH1, GSY1 and GSY2. From the expression data, we found that 
GLC3 was down-regulated, but GPH1, GSY1 and GSY2 all were up-regulated in the strain 
IBT100082 in the ethanol phase. The up-regulation of the two glycogen synthase genes 
(GSY1 and GSY2) is in agreement with their description as being induced by glucose 
limitation, environmental stress by carrying a foreign gene, nitrogen starvation and entry 
into the stationary phase. All these reasons make glycogen as a top-scored reporter 
metabolite. We also found that the enzymes encoded by URA3, URA10, TKL2, ABZ1, 
TRP1, TRP4, MET2, AAT1, ARG1, ARG8 and GAD1 were included in the subnetwork 
(Figure 6.3), indicating that not only the glycogen synthases but also other enzymes 
relevant to carbohydrate and amino acid metabolism were influenced by 6-MSA 
biosynthesis.  
 
6.3.5     Global effect on amino acid metabolism 
From the statistical comparison of expression data using t-test, it was seen that several of 
the genes related to amino acid metabolism were significantly up-regulated in connection 
with 6-MSA biosynthesis. There were totally 38 significantly changed genes with 30 up-
regulated genes and 8 down regulated genes related to amino acid metabolism, and the 
neighboring enzymes around L-alanine were also presented in these 38 genes. In 
agreement, the analysis of reporter metabolites also revealed that there were considerable 
effects on the amino acid metabolism when comparing the 6-MSA producing strain 
(IBT100082) to the reference strain (IBT100081) cultivated in glucose. L-alanine was 
found to be a top-scored reporter metabolite. This means that the expression of the genes 
around L-alanine was the most significantly changed. Moreover, several enzymes 
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involved in the amino acid metabolism were included in the subnetwork for this 
comparison (Figure 6.4), confirming that amino acid metabolism has been significantly 
affected by the presence of 6-MSAS when cultivating the strains on glucose.  
 
6.3.6     Global effect on fatty acid metabolism 
Changes in gene expression between the strain IBT100083 and IBT100082 in the ethanol 
phase were investigated in order to study the effect on the yeast metabolism after the 
promoter of ACC1 has been replaced by the strong, constitutive TEF1 promoter. Reporter 
metabolite analysis revealed that there were major effects on the lipid metabolism after the 
change of the ACC1 promoter, episterol, a precursor in ergosterol biosynthesis, being the 
most significant reporter metabolite. Furthermore, other reporter metabolites were 
pyridoxine (vitamin B6) and derivatives thereof, which are connected to lipid metabolism 
as well (Figure 6.5). 
 
The comparison of gene expression for the strain IBT100083 with IBT100082 in the 
ethanol phase by t-test also demonstrated drastic influence on lipid metabolism. There 
were totally 37 genes with significant changes in expression, 23 genes were up-regulated 
and the rest down-regulated. The neighboring enzymes of the identified reporter 
metabolites were found among these 37 genes, indicating the consistency of the result 
from expression data analysis with different methods. Additionally, the analysis of 
metabolic subnetworks for these two strains in the ethanol phase (Figure 6.5) displayed 
the connection of the enzymes in this subnetwork with episterol, and other metabolites in 
fatty acid biosynthesis as well as the pyridoxine biosynthesis, since the enzymes encoded 
by ERG2, ERG3, PDX3, ACS1, and ACC1 were found to be co-regulated and significantly 
changed. This makes sense since the expression of ACC1, which encodes a key enzyme in 
fatty acid biosynthesis, had been changed. The observed changes in the lipid metabolism 
and especially in the expression of ACC1 were expected. Interestingly, glutamate 
dehydrogenase (Gdh1) was found as a significant enzyme in the subnetwork structure 
when comparing IBT100083 to IBT100082 in the ethanol phase. Since the gene that 
encodes for Gdh1 was down-regulated in the strain IBT100083, this indicates that less 
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NADPH was consumed, and consequently, that there might be more NADPH available in 
the cytosol to be used as precursor in the biosynthesis of 6-MSA.  
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Figure 6.2. The reporter metabolites (highlight in yellow) and correlated subnetwork (red 
for up-regulated genes and green for down-regulated genes) when compared the strain 
IBT100082 in ethanol phase versus the same strain in glucose phase. 
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Figure 6.3. The reporter metabolites (highlight in yellow) and correlated subnetwork (red 
for up-regulated genes and green for down-regulated genes) when compared the strain 
IBT100082 versus IBT100081 in ethanol phase. 
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Figure 6.4. The reporter metabolites (highlight in yellow) and correlated subnetwork (red 
for up-regulated genes and green for down-regulated genes) when compared the strain 
IBT100082 versus IBT100081 in glucose phase, indicating the global effect on amino acid 
metabolism. 
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Figure 6.5. The reporter metabolites (highlight in yellow) and correlated subnetwork (red 
for up-regulated genes and green for down-regulated genes) when compared the strain 
IBT100083 versus IBT100082 in ethanol phase, indicating the global effect on fatty acid 
metabolism. 
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6.3.7     Summed fractional labeling  
In order to characterize the metabolism and analyze the effect when there is 6-MSAS 
production, labeling experiment were performed as this allows for a quantitative as well as 
a qualitative study of the metabolism. Here [1-13C]-labeled glucose was used as a carbon 
source for the growth of the strains IBT100081, 100082 and 100083 in batch cultivations. 
 
Summed fractional labeling (SFL) of intracellular metabolite fragments of the reference 
strain and the strain carrying 6-MSAS from P. patulum were calculated. The experiments 
were carried out in the aerobic batch cultivations in which six samples were periodically 
taken from the fermenters during the first and second exponential phase where glucose 
and ethanol were consumed as carbon sources. The incorporation of label into some of the 
analyzed metabolite fragments from the S. cerevisiae carrying 6-MSAS from P. patulum 
and with over-expression of ACC1 (IBT100083) is shown in Figure 6.6 with the 
concentration of CO2 throughout the cultivation period, illustrating the first and second 
exponential and time to take samples (figure not shown for other strains). 
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Figure 6.6. Summed fractional labeling of some selected intracellular metabolites of the 
strain IBT100083 during the batch cultivation. The CO2 concentration was also shown to 
illustrate the glucose and ethanol phase. 
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From Figure 6.6 it can be seen that the SFLs calculated from the first six samples in the 
first exponential phase are constant which means that the isotopic pseudo steady state is 
achieved at this point. In contrast, SFL of the fragments are increased in the ethanol phase. 
The SFL of each fragments in the glucose phase for the three different strains were 
averaged and the data are listed in Table 6.4. 
 
Table 6.4. Measured summed fractional labelings (SFLs) of the different strains from the 
first six samples in the first exponential phase where the glucose was consumed in the 
batch cultivations 
 
Reported precursor         Strains 
         IBT100081          IBT100082          IBT100083 
Meta-
bolite 
m/z 
precursor 
c-atom 
correspondance 
Method 
SFL Dev SFL Dev SFL Dev 
Glc 331 Glc 1,2,3,4,5,6 PAA 55.76 1.84 54.79 2.61 54.77 1.73 
Gly 85 3PG 2 DMFDMA 1.12 0.14 1.13 0.05 1.16 0.06 
Gly 144  1,2 DMFDMA 4.45 0.58 4.43 0.27 3.30 0.55 
Gly 175  1,2 ECF 4.11 0.58 4.97 0.89 6.73 1.45 
Ser 132  2,3 ECF 24.57 0.72 24.69 0.15 24.90 0.20 
Ser 175  1,2 ECF 2.63 0.37 2.35 0.43 2.34 0.11 
Ala 99 PYR 2,3 DMFDMA 25.17 0.33 25.31 0.30 25.39 0.42 
Ala 116  2,3 ECF 25.61 0.18 25.98 0.30 26.06 0.31 
Ala 158  1,2,3 DMFDMA 27.33 0.11 27.86 0.41 28.83 0.57 
Val 127  2,2,3,3 DMFDMA 50.22 0.35 50.67 0.34 50.96 0.48 
Val 143  1,2 DMFDMA 5.41 0.10 5.41 0.14 5.66 0.21 
Val 144  2,2,3,3 ECF 50.53 0.31 51.39 0.44 51.69 0.37 
Val 186  1,2,2,3,3 DMFDMA 53.54 0.49 54.86 0.65 55.36 0.91 
Leu 158 PYR+AcCoA 2,2,3,3+2 ECF 72.61 0.31 73.39 0.69 73.96 0.28 
Asp 115 OAA 2 DMFDMA 1.55 0.19 1.16 0.09 1.27 0.12 
Asp 188  2,3,4 ECF 27.45 0.22 28.24 0.19 28.18 0.43 
Asp 216  1,2,3,4 DMFDMA 29.40 0.66 29.81 0.39 27.50 2.25 
Thr 146  2,3,4 ECF 25.70 1.06 26.22 0.27 26.49 0.21 
Thr 175  1,2 ECF 2.26 0.15 2.58 0.11 2.54 0.08 
Ile 158 OAA+PYR 2,3,4+2,3 ECF 53.51 0.34 54.11 0.33 54.36 0.48 
Glu 143 2KG 1,2 DMFDMA 27.56 3.15 24.84 1.90 25.30 0.69 
Glu 202  2,3,4,5 ECF 49.31 0.19 50.38 0.49 50.87 0.51 
Glu 230  1,2,3,4,5 DMFDMA 52.17 0.63 52.11 0.47 52.64 0.56 
Pro 142  2,3,4,5 ECF 49.87 0.26 50.83 0.36 51.20 0.50 
Lys 156 2KG+AcCoA 2,3,4,5+2 ECF 72.70 0.28 74.04 0.51 74.36 0.29 
Phe 143 PEP 1,2 DMFDMA 2.23 0.08 2.22 0.04 2.29 0.09 
Phe 192 PEP+E4P 2,2,3,3+1,2,3,4 ECF 63.65 0.66 64.74 0.67 64.85 0.43 
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The consistency of the SFL data was checked for all cultivations. For example, fragments 
Ala99, Ala 116, Val127 and Val144 are derived from the second and third atom of 
pyruvate. If the measurements were consistent, the labeling of the fragment Val127 and 
Val144 should be as twice as the labeling of the fragment Ala99 and Ala116. The same 
calculation was applied to the fragment of Asp188 and Thr146 which are derived from the 
second to the fourth atoms of oxaloacetate. Both fragments show the same SFL value, 
indicating that the data obtained from the experiment were highly consistent. 
 
6.3.8     Identification of pathways leading to pyruvate 
From Table 6.4, it can be seen that the key metabolites such as 3-phosphoglycerate (3PG), 
pyruvate, oxaloacetate (OAA), acetyl-CoA and α-ketoglutarate (AKG) are the precursors 
for the different kind of anino acids. Therefore, considering these amino acid fragments 
labeled in the different positions, it is possible not only to assess the SFLs of some key 
metabolites in the central carbon metabolism of S. cerevisiae, such as the Embden-
Meyerhof-Parnas (EMP), and tricarboxylic acid (TCA) cycle, but also to identify the 
activity of different pathways which is the first step in the metabolic network analysis.  
 
When [1-13C] glucose is metabolized into pyruvate via EMP pathway, 50% of the formed 
pyruvate is labeled in position 3. If pyruvate comes from Entner-Doudoroff (ED) pathway, 
50% of pyruvate is labeled in position 1. When the pentose phosphate (PP) pathway is 
active, the labeled carbon atom in the first position of glucose will be lost in the first step 
as carbondioxide, resulting in no labeled carbon atom in pyruvate. The carbon atom 
labeled in the first position of pyruvate can be calculated by the subtraction of the average 
between Ala116 and Ala99 from Ala158. The subtraction of the percentage of carbon 
atoms labeled in the first position from Val142 yields the SFL of the second carbon atom 
of pyruvate which can be subtracted from the average SFL of Ala116 and Ala99, giving 
the percent of carbon atom of pyruvate labeled in the third position. The changes of 
pyruvate labeled in each position throughout the cultivation period for three different 
strains are visualized in Figure 6.7. 
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Figure 6.7. Change of pyruvate atom labeling at position 1, 2 and 3 during the aerobic 
cultivations of three different strains when 50% of [1-13C]-labeled glucose was employed.   
(A) IBT100081, (B) IBT100082, and (C) IBT100083. 
 
From Figure 6.7, it can be seen that the EMP pathway is the major pathway that is active 
for all strains as the SFL of the pyruvate labeled in the 3rd position are the highest. In the 
glucose phase where the first six peaks are, the SFL of pyruvate labeled in the 1st and 2nd 
positions are approximately between 2-3 % for every strain, which are a little bit more 
than natural labeling (1.1 %), indicating that ED pathway and the back flux from the TCA 
cycle are less active compared to the EMP pathway. In the ethanol phase, illustrated by the 
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last four peaks, it is seen that the SFL of pyruvate labeled in the 1st and 2nd position are 
increased, especially the 2nd position increased about four times. Interestingly, the increase 
of the pyruvate labeled in the 2nd position occurs only in the strains carrying the 6-MSAS 
gene, but not with the reference strain. This can possibly be explained by the back flux 
from the TCA cycle, for example malic enzyme converts the TCA cycle intermediate 
malic acid into pyruvate, which led to the introduction of the pyruvate labeled in the 2nd 
position, and it seems like this back flux is activated by the presence of the polyketide 
synthase gene. However, during the ethanol growth phase in the reference strain, the 
pyruvate labeled in the 3rd position increased to almost 35%, while those for the strain 
carrying 6-MSAS gene remained at 25% in the ethanol phase. An increased activity of 
malic enzyme during growth on ethanol is consistent with findings of dos Santos et al. 
(2003), who found that this flux increased during the consumption of acetate.  
 
6.3.9     Metabolic flux calculation 
The qualitative analysis of the SFL data above can provide useful information about the 
labeled position for each metabolite, leading to the indication of the active pathway in the 
organism. However, to quantify the metabolic fluxes in the central carbon metabolism of 
both the reference strain and the strains producing 6-MSA, computer simulation combined 
with mathematical modeling were used to estimate the fluxes. Only the data in the first 
exponential phase, where the glucose was used as a carbon source, were used in the 
calculation. The inputs for the model are the average of the SFLs in the first six samples, 
the flux of precursors to biomass for the respiro-fermentative batch cultivation (Gombert 
et al., 2001) and the yields of ethanol, acetate, and glycerol on glucose. The model 
assumes some independent fluxes and computes the remaining fluxes and also a set of 
SFL values for intracellular metabolites. The deviation between the measured SFL and the 
calculated SFL, as well as the difference between the measured fluxes and the calculated 
fluxes were generated during the simulation. The optimization routine minimizes the sum 
of these two deviations. The results of the best fit in the first exponential growth phase for 
three different strains which were normalized with respect to 100 mole of glucose 
consumption, are shown in Figure 6.8. 
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Figure 6.8. Flux distributions in the central metabolism of S. cerevisiae for three batch 
cultivations. Values in the first line correspond to the fluxes of the reference strain 
(IBT100081), whereas the values in the second and third line correspond to those of the 
strain IBT100082 and IBT100083, respectively. All the fluxes shown are the net fluxes, 
relative to the glucose uptake of 100 moles. 
 142
Chapter 6               Transcriptional and metabolic responses to heterologous expression of a PKS… 
From Figure 6.8, the fluxes through each pathway for the three strains can be observed. 
The pathway that was mainly active for all the strains is the EMP pathway as 
approximately 90% of glucose came through this pathway. Among the three different 
strains, IBT100083 had the highest flux through the EMP pathway, followed by the strain 
IBT100082 and IBT100081, respectively. In the comparison between IBT100082 and 
IBT100081 (reference strain), the flux through the EMP pathway of IBT100082 was more 
than that of IBT100081. This is in accordance with the transcription data (Figure 6.4), 
which shows that the gene responsible for enzymes hexokinase (Hxk1), glucokinase 
(Glk1), phosphofructokinase (Pfk1), glyceroldehyde-3-phosphate dehydrogenase (Tdh1), 
phosphoglyceromutase (Gpm2), and enolase (Eno1) were included in subnetwork and all 
up-regulated in the strain IBT100082 compared to the reference strain. Furthermore, the 
gene encoding enzyme phophoglucoisomerase (Pgi1) responsible for the conversion of 
glucose-6-phosphate (G6P) to fructose-6-phosphate (F6P) which was not included in the 
subnetwork, was also up-regulated in IBT100082. The up-regulation of the genes and the 
increase in the flux through the EMP pathway in the strains producing 6-MSA, especially 
for the strain IBT100083, indicated that they needed to generate a high amount of acetyl-
CoA which is used as precursor for 6-MSA production. 
 
The PP pathway only carried a flux of about 2-6% of the incoming glucose flux, and the 
results show that the strain IBT100082 had a higher flux compared to IBT100081 
(reference strain) and IBT100083. In the oxidative phase, IBT100082 gave 6.36 mol of 
pentose-5-phosphate (P5P)/100 mol of glucose, whereas the reference strain and 
IBT100083 gave 5.77 and 2.67 mol of P5P/100 mol of glucose, respectively (Figure 6.8). 
The increase of the flux through the PP pathway in the strain IBT100082 compared to the 
reference strain (IBT100081) is related to the up-regulation of the genes encoding 
enzymes G6P dehydrogenase (Zwf1), 6-phosphogluconolactonase (Sol4) which were 
included in the subnetwork, and enzyme 6-phosphogluconate dehydrogenase (Gnd1) 
which was not included in the subnetwork (Figure 6.4). The decrease of the flux through 
the PP pathway in the strain IBT100083 was probably because the flux from G6P was 
pushed towards the EMP pathway and therefore there was a lower flux through the PP 
pathway in this strain.  
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After pyruvate was generated by the EMP pathway, it was converted to acetyl-CoA 
(ACCOA) which subsequently entered the TCA cycle through reaction with oxaloacetate 
(OAA) to form citrate and further isocitrate (ICIT), and α-ketoglutarate (AKG), 
respectively (Figure 6.8). For the three strains the flux from acetyl-CoA and oxaloacetate 
to α-ketoglutarate was about the same. After the branching from α-ketoglutarate to 
biomass, the net flux leading to oxaloacetate is almost zero in all three strains.  
 
When considering the flux from pyruvate through acetate (ACE), later converted to acetyl-
CoA which is used as the precursor for 6-MSA production, it was found that the flux in 
this branch was increased in the strains carrying the 6-MSAS gene, especially the strain 
IBT100083 where ACC1 is over-expressed. The flux from pyruvate to acetaldehyde 
(ACA) in the strains IBT100081, IBT100082 and IBT100083 were 169.07, 169.33 and 
170.85 mol of acetaldehyde/100 mol glucose, and flux from acetaldehyde to acetate in 
those strains were 10.16, 10.67 and 11.17 mol of acetate/100 mol glucose, respectively.  
 
Acetate produced by the cells can both be excreted out of the cells and converted by 
acetyl-CoA synthase (Acs1, 2) into acetyl-CoA. The total fluxes from acetate to acetyl-
CoA and from pyruvate to acetyl-CoA in the strains IBT100081, IBT100082, and 
IBT100083 were 7.47, 7.64 and 7.71 mol of acetyl-CoA/100 mol glucose, respectively, 
indicating that there were more precursor supply available for the production of 6-MSA in 
the strain IBT100083 than other strains. In the comparison of IBT100082 and IBT100081, 
the flux calculation of this pathway corresponds to the expression data which shows that 
THI3, PDB1, ALD3, ALD5, ACH1, ACS1, and ACS2 were up-regulated in the strain 
IBT100082 compared to IBT100081. However, for the strains IBT100082 and IBT100083 
only 0.17 and 0.24 mol of 6-MSA/100 mol of glucose are required for 6-MSA 
biosynthesis and the changes of fluxes are therefore expected to be small, where it is 
interesting that there actually a transcriptional response. 
 
In summary, the main changes in transcription profiles between the reference strain 
(IBT100081), the strain carrying 6-MSAS with its native promoter of ACC1 gene 
(IBT100082) and the strain carrying 6-MSAS gene with over-expression of ACC1 
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(IBT100083) were observed in the batch cultivations. Amino acid and carbohydrate 
metabolism were substantially changed when comparing the strain IBT100081 and 
IBT100082 in the glucose and ethanol phase, respectively, as many amino acids and 
carbohydrate compounds were identified as reporter metabolites and some of the 
neighbouring enzymes around reporter metabolites were included in the subnetwork 
structure. Lipid metabolism was also found to be significantly influenced after the change 
of the ACC1 promoter, which results in higher production of 6-MSA produced out of the 
cells. The metabolic network analysis was performed for quantitative inspection of 
metabolism. The result indicated that the fluxes in glycolysis, TCA cycle as well as fluxes 
from pyruvate through acetyl-CoA in the cytosol were increased in the strains carrying 6-
MSAS gene. However, redirecting the fluxes leading to the secreted metabolites ethanol 
and acetate towards increased production of acetyl-CoA may result in an increased 
production of 6-MSA.  
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Chapter 7  
In Silico Metabolic Engineering for Improved 
Production of 6-MSA in S. cerevisiae 
 
 
Abstract 
In silico evaluation of gene deletion in S. cerevisiae carrying 6-MSAS gene from P. 
patulum was performed using genome-scale reconstructed metabolic model in order to 
identify the deletion target to increase the flux through 6-MSA. By using the minimization 
of metabolic adjustments (MOMA) approach and the OptKnock algorithm, GDH1 was 
found as a gene deletion target with maximum yield of 0.04 mmol 6-MSA/g dw/hr at the 
μmax of 0.23 hr-1. Through the double deletion, the deletion of GDH1 and SER3 yields 
even higher 6-MSA at 0.07 mmol/g dw/hr with the μmax of 0.22 hr-1. 
 
7.1     Introduction 
Through metabolic engineering it is possible to introduce targeted genetic changes and 
engineer the metabolism of S. cerevisiae carrying a fungal PKS gene with the objective to 
obtain higher level production of 6-MSA at a high specific growth rate. However it is 
difficult to predict the effects of introducing genetic changes in yeast since its metabolism 
is often subjected to complex gene and enzyme regulations, and is constrained by mass 
and energy conservation laws on a numerous number of intracellular metabolites (Patil et 
al., 2005). A genome-scale model of S. cerevisiae (Förster et al., 2003) comprising the 
different levels of information, primarily on the stoichiometry of different reactions offer a 
suitable platform for developing the tools for analyzing and engineering metabolism (Patil 
et al., 2004). Regardless of the kinetics and regulation of the metabolism, it is possible to 
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at least partly predict the behaviour of the yeast metabolism by using analysis based on 
genome-scale stoichiometric models.  
 
7.2     Materials and methods 
 
7.2.1     Metabolic model 
Genome scale reconstruction of S. cerevisiae suggested by Förster et al. (2003) was used 
as stoichiometric model of yeast metabolism. The simulations were performed under the 
aerobic glucose-limited conditions. The glucose uptake rate was fixed to 3 mmol/g dw/hr 
and the oxygen uptake rate was kept constantly of 9 mmol/g dw/hr. 
 
7.2.2 Flux balance analysis (FBA), minimization of metabolic adjustments 
(MOMA) and genetic algorithm 
 
FBA, MOMA and genetic algorithm were obtained from Patil et al. (2005) 
 
7.3     Results and discussion 
Genome-scale stoichiometric models represent the integrated metabolic potential of a 
micro-organism. Through flux-balance analysis where constraints on fluxes are imposed 
through balances on all intracellular metabolites it is possible to identify all feasible 
metabolic phenotypes such as the fluxes through all metabolic reactions under steady state 
conditions (Förster et al., 2003). The approaches to determine the metabolic phenotypes 
are to use flux balance analysis (FBA) and minimization of metabolic adjustments 
(MOMA). These approaches were extensively reviewed in Kauffman et al. (2003) and 
Segre et al. (2002). Using the genome-scale metabolic model, FBA was applied to 
evaluate the potential for production of 6-MSA in yeast. The reactions towards the 
polyketide were added into the model and both the flux towards 6-MSA production and 
the specific growth rate were optimized using linear programming. Hereby the theoretical 
yields of 6-MSA (mmol/g dw/hr) at different specific growth rates were calculated and the 
results are shown in Figure 7.1. 
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Figure 7.1. The theoretical yield of 6-MSA from S. cerevisiae at different growth rates 
suggested by the genome scale model using an FBA approach. 
 
In order to identify possible targets for metabolic engineering to improve the production of 
6-MSA a gene deletion analysis was performed. Each gene encoding enzymes 
participating in the metabolism was deleted and the 6-MSA yield was calculated. The 
gene deletions obtained using the MOMA approach and the OptKnock algorithm for 
improving the yield of 6-MSA are summarized in Table 7.1. 
 
Table 7.1. Different gene deletions suggested by MOMA approach for improving the 
yield of 6-MSA in S. cerevisiae. 
 
Number of 
deletions 
Suggested gene deletions* 6-MSA yield 
(mmol/g dw/hr) 
μ max
(hr-1) 
1 GDH1 0.040 0.23 
2 GDH1, SER3, 0.070 0.22 
 GDH1, DAL7 0.061 0.24 
 GDH1, ICL1 0.059 0.24 
 GDH1, MTD1 0.051 0.23 
 GDH1, THR1 0.045  0.24 
 GDH1, YHL012W 0.042  0.24 
 GDH1, FDH2 0.042 0.24 
 GDH1, PRO2 0.041  0.24 
 GDH1, PRO1 0.041  0.24 
 GDH3, PCK1 0.041 0.24 
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* GDH1 :  NADPH(+)-dependent glutamate dehydrogenase 
SER3   : 3-Phosphoglycerate dehydrogenase 
DAL7 : Malate synthase 
ICL1 : Isocitrate lyase 
MTD1 : NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase 
THR1 : Homoserine kinase 
YHL012W : Putative protein of unknow function, has some homolgy to Ugp1p which encodes UDP-glucose 
pyrophosphorylase 
FDH2 : NAD(+)-dependent formate dehydrogenase 
PRO2 : Gamma-glutamyl phosphate reductase 
PRO1 : Gamma-glutamyl kinase 
PCK1 : Phosphoenolpyruvate carboxykinase 
  
Reported productivities of 6-MSA are about 0.022 mmol 6-MSA/g dw/hr at a μ max of 0.26 
hr-1, and in a strain with overexpression of ACC1 it is about 0.031 mmol 6-MSA/g dw/hr 
(μ max of 0.27 hr-1). The comparison of these 6-MSA productivities to those in Table 7.1 
indicates that through deletion of the target genes, the productivities of 6-MSA can be 
substantially increased due to the increase of NADPH and acetyl-CoA which are used as 
precursors for 6-MSA biosynthesis, especially by deletion of GDH1 and SER3 resulting in 
6-MSA specific productivity of about 0.07 mmol/g dw/hr. Thus the in silico gene deletion 
analysis could eventually be a tool and platform for designing an efficient yeast platform 
for the production of polyketides. 
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Chapter 8  
Cloning, Characterization and Heterologous Expression  
of atX from A. terreus IBT12713 and the Hybrid 
6-MSA Synthase Gene from P. patulum and  
A. terreus in S. cerevisiae  
 
 
Abstract 
Since the 6-MSAS gene from Penicillium patulum has been successfully expressed in S. 
cerevisiae and high production of 6-MSA was obtained, it is interesting to clone the 6-
MSAS gene from another organism and expressed this in yeast to investigate whether the 
production of 6-MSA is affected by the source of the gene. Aspergillus terreus has been 
reported to hold the gene atX which encodes a 6-MSAS. Here, atX from A. terreus 
IBT12713 was amplified by RT-PCR. The amino acid sequence of AtX protein in this 
study was characterized and found to have 99% identity to the AtX from other studies, and 
it showed 63% identity to the 6-MSAS from P. patulum. The atX from A. terreus 
IBT12713 was transformed into S. cerevisiae with co-expression of npgA from A. 
nidulans, but no 6-MSA was produced. The atX was modified by changing the 5´ terminal 
to that of 6-MSAS gene from P. patulum, resulting in a hybrid 6-MSAS gene which 
contained the gene from P. patulum at 5´ terminal and the gene from A. terreus at 3´ 
terminal. The hybrid 6-MSAS gene was co-transformed with the npgA from A. nidulans in 
S. cerevisiae, but again no 6-MSA could be detected. An explanation for the unsuccessful 
heterologous production of 6-MSA from A. terreus in S. cerevisiae might be due to codon 
bias and the formation of secondary structures of mRNA which could inhibit the 
translation process of mRNA into protein. An engineered atX was proposed by changing 
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the rare codons into the codons that are abundant in yeast and this should also prevent 
formation of secondary mRNA structures. However, the adapted atX sequence was not 
experimentally evaluated. 
 
8.1     Introduction 
Fungi are eukaryotic organisms that are more related to animals than plants. As they are 
heterotrophic, fungi share with animals the ability to export the hydrolytic enzymes to 
break down organic materials which can be absorbed for nutrition and continue the cycle 
of nutrients through the ecosystems (White and Arora, 2004). Many fungal species are 
free-living saprobes in woody substrates, soils, leaf litter, dead animal and animal 
exudates. However, a large diversity of other fungi are biotrophs or living symbiotic in 
associations with plants, algae, animals and prokaryotes such as lichens (Ahmadjian, 
1993), mycorrhizae, and leaf or stem endophytes (Smith and Read, 1997).  
 
Although fungi can cause immense economic losses due to their harmful activities as 
saprotrophs, including the damage to food and manufactured products as well as the 
parasitic activities that cause heavy crop losses (Stokstad, 2007) and diseases of humans 
and domestic animals (Rippon, 1988), they still provide a rich source of enzymes and 
metabolites that are of great economic importance. They have been long exploited as food 
and in food processing (Niederhaus and Stahl, 2003). Since the fermentation industry 
developed, fungi been used to produce an increasing range of valuable products including 
the polyketide metabolites which can be used as antibiotics and other drugs, e.g. antitumor 
and anticholesterolemic properties.  
 
So far only a few fungal polyketides have been studied in detail in order to understand 
their biosynthesis pathways and regulations. Those studies include fermentation 
optimization and heterologous expression of polyketide synthases in surrogate hosts. 
Heterologous expression of polyketide synthase genes is emerging as a viable alternative 
to both classical strain and fermentation process development, and molecular biological 
manipulation of the native producer strain (Pfeifer and Khosla, 2001). Heterologous 
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expression of fungal polyketide can provide strains with better fermentation characteristic 
that are more amenable to further optimization, or present the fermentation alternative for 
the symbiont-derived metabolites. 
 
Amongst the polyketides produced by fungi, 6-MSA is considered as a model fungal 
polyketide from P. patulum as it is the most well-characterized fungal polyketide. The 
gene encoding the enzyme responsible for the production of 6-MSA from P. patulum was 
heterologous expressed and intensively studied in S. cerevisiae. However, 6-MSA is 
naturally produced not only by P. patulum, but it is produced by P. expansum (White et al., 
2006), A. terreus (Fujii et al., 1996), and Byssochlamys nivea (Puel et al., unpublished) as 
well.  
 
The objective of this study is to investigate whether the production of 6-MSA in S. 
cerevisiae is affected by the source of the gene. Therefore, the 6-MSAS gene from A. 
terreus was cloned and heterologously expressed in S. cerevisiae in order to compare the 
production of 6-MSA to that from P. patulum. 
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8.2     Materials and methods 
 
8.2.1      Plasmids and strains 
The plasmids and strains used in this study are listed in Table 8.1. 
 
Table 8.1. List of plasmids and strains 
 Characteristics Reference 
Plasmids   
pRS426CT Expression vector containing TEF1 promoter, CYC1 terminator, 
and URA3 marker 
Wattanachaisaereekul  
et al. (submitted) 
pRS424CTnpgA Expression vector containing TEF1 promoter, CYC1 terminator, 
TRP1marker, and npgA from A. nidulans 
Wattanachaisaereekul     
et al. (submitted) 
pRS426CTMSA-AT Expression vector containing TEF1 promoter, CYC1 terminator, 
URA3 marker, and 6-MSAS gene from A. nidulans 
This study 
pRS426CTMSA-PP-AT Expression vector containing TEF1 promoter, CYC1 terminator, 
URA3 marker, and hybrid 6-MSAS gene from P. patulum and A. 
nidulans 
This study 
Strains   
A. terreus IBT12713 Wild type of A. terrues producing 6-MSA Our laboratory 
S. cerevisiae CEN.PK 113-9D MATa;ura3-52;HIS3;LEU2;trp1-289;MAL2-8;SUC2 Peter Kötter a
S. cerevisiae IBT100085 CEN.PK 113-9D with the change of ACC1 promoter to TEF1 
promoter, and carrying plasmids pRS426CTMSA-AT and 
pRS424CTnpgA 
This study 
S. cerevisiae IBT100086 CEN.PK 113-9D with the change of ACC1 promoter to TEF1 
promoter, and carrying plasmids pRS426CTMSA-PP-AT and 
pRS424CTnpgA 
This study 
 
a Institut für Mikrobiologie, der Johann Wolfgang Goethe-Universität Frankfurt, Germany 
 
 
8.2.2     Fungal cultivation and total RNA extraction 
The spore suspension of A. terrues IBT12713 was cultivated in 100 mL minimal media in 
500 mL shake flasks. The medium consisted of 20% w/v glucose 50 mL/L, 1M NaNO3 2 
mL/L, and mineral mix 4 mL/L. Mineral mix was prepared by adding KCl 26 g, 
MgSO4.7H2O 26 g, KH2PO4 76 g and trace element solution 50 mL in distilled water with 
the final volume of 1L. The trace element solution for 1 L consisted of CuSO4.5H2O 0.4 g, 
Na2BB4O7.10H2O 0.04 g, FeSO4.7H2O 0.8 g, MnSO4.2H2O 0.8 g, Na2MoO4.2H2O 0.8 g, 
and ZnSO4.7H2O 8.0 g. About 36 hr cultivation, the fungal mycelia were harvested and 
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filtrated through the mira-cloth. The medium absorbed by the mycelia was removed by 
pressing the mycelia inside the mira-cloth until they were dried. The mycelia were 
instantaneously ground into a fine powder in a mortar under the liquid nitrogen. The 
powder was then processed for the RNA isolation using NucleoSpin  RNA Plant Kit 
(Macherey-Nagel GmBH & Co. KG, Düren, Germany). To concentrate the extracted RNA, 
it was precipitated from the aqueous phase, followed by the addition of 0.25 volume of 
isopropanol and 0.25 volume of RNA precipitation solution (1.2 M NaCl, 0.8 M 
C
®
6H5Na3O7.2H2O). After thorough mixing, store the final solution for 10 minutes at room 
temperature. The precipitated RNA was collected by centrifugation at maximum speed for 
10 minutes at 4 °C in a microfuge. The pellet was washed twice with 75% ethanol and 
centrifuged again. Any remaining ethanol was removed with a disposable pipette tip. The 
open tube was stored on the bench for a few minutes to allow the ethanol to evaporate and 
then 50 μL of DEPC-treated water was added and the RNA solution was stored at -80 °C 
until further processing. 
 
8.2.3    Reverse transcription and polymerase chain reaction (RT-PCR) and 
yeast transformation 
 
The expand reverse transcriptase from E. coli AP401 (Basel, Switzerland) was used for 
reverse transcription reaction. Oligonucleotides were synthesized by MWG-Biotech, AG, 
Germany, are listed in Table 8.2. PCR reactions were performed using Phusion 
polymerase according to the manufacturer’s guideline. GFX spin columns from 
Amersham Pharmacia were used for purification of DNA from both gel band and solution. 
After the purification, the whole 6-MSAS gene was sent to MWG-Biotech, AG, Germany, 
for sequencing. Transformation of yeast cells was carried out according to Gietz and 
Woods (2002). E. coli DH5α was used for propagation of recombinant plasmids. The 
preparation of competent E. coli and transformation protocol were performed according to 
Sambrook and Russell (2001). 
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Table 8.2. The primers used for the amplification of 6-MSAS gene from A. terreus. The 
bold represents 6xHis Tag, and the underline sections indicate the restriction sites 
introduced to facilitate cloning. 
 
Primers Sequence (5´- 3´) 
 
SWA23 
 
 
   HindIII    SpeI BamHI  PstI   PacI       KpnI 
CCCAAGCTTTAGAACTAGTGGATCCCTGCAGGTTAATTAAGGAGGTACCTTTAAAATGGAGGTACATGGAGATGAAGTG 
 
SWA24 
 
   EcoRI         XhoI   AscI   SwaI        6xHis Tag 
CCGGAATTCTACATGACTCGAGGGCGCGCCATTTAAATTAATGATGATGATGATGATGATTTCCCATCTTTTCCAAAAA 
 
SWA25 
 
       BclI 
AAGTATTGATCATACAAGGCCGGACGGACCTC 
 
SWA26 
 
 
GGGACCTAGACTTCAGGTTGTC 
 
 
8.2.4     Yeast cultivation and analysis of 6-MSA 
In order to check the production of 6-MSA, the yeast carrying the plasmids with the 6-
MSAS gene from A. terreus and the npgA from A. nidulans was cultivated in the 100 mL 
minimal media medium in 500 mL baffled shake flasks. The medium consisted of glucose 
10 g/L, (NH4)2SO4 7.5 g/L, KH2PO4 14.4 g/L, MgSO4.7H2O 0.5 g/L, 0.05 mL/L Antifoam 
298 (Sigma-Aldrich, St. Louis, MO, USA) and 2 mL/L trace metal solution (FeSO4.7H2O 
3 g/L, ZnSO4.7H2O 4.5 g/L, CaCl2.6H2O 4.5 g/L, MnCl2.2H2O 0.84 g/L, CoCl2.6H2O 0.3 
g/L, CuSO4.5H2O 0.3 g/L, Na2MoO4.2H2O 0.4 g/L, H3BO3 1 g/L, KI 0.1 g/L, and 
Na2EDTA.2H2O 15 g/L), and 2 mL/L vitamin solution (d-biotin 50 mg/L, Ca-
pantothenate 1 g/L, thiamin-HCl 1 g/L, pyridoxin-HCl 1 g/L, nicotinic acid 1 g/L, p-
aminobenzoic acid 0.2 g/L, and m-inositol 12.5 g/L). pH of the medium was adjusted to 
6.5 by 2M NaOH prior to autoclaving. The cultures were incubated at 30 oC, with shaking 
at 150 rpm (model 3033, GFL, Burgwedel, Germany).  
 
After 48 hours fermentation, the fermentation broth was filtered through a 0.45 μm pore-
sized cellulose acetate filter (GE Osmonics Labstore, Minnetonka, MN). The filtrate was 
quantified for 6-MSA by HPLC (Agilent 1100 series) with Luna C18(2) column, 150 × 
4.60 mm with 5 micron of the porous silica particles to which the C18 phase is bonded, 
using a gradient of 50 ppm trifluoroacetic acid (TFA) in milliQ water (solvent A) and 50 
 160
Chapter 8               Cloning, characterization and heterologous expression of atX from A. terreus… 
ppm TFA in acetonitrile (solvent B) at a flow rate of 1 mL/min. The gradient of the 
solvents was 20% to 60% B in 10 minutes, then 20% B for the next 2 minutes. 
 
8.3     Results  
 
8.3.1     Construction of the plasmid and strain 
The purified RNA from A. terrues was used in the process of making cDNA of the 6-
MSAS gene by the reverse transcription reaction by using primer SWA24 which contain 
the 6xHis tag as a sequence specific reverse primer. In the PCR reaction primers SWA23 
and SWA24 (Table 8.2) were used for amplification of the 6-MSAS gene. To obtain the 
plasmid pRS426CTMSA-AT, the PCR product which was carrying the atX encoding the 
6-MSAS from A. terreus and amplified by RT-PCR was double digested by SpeI and 
EcoRI, and ligated into the SpeI/EcoRI site of plasmid pRS426CT. The plasmid 
pRS426CTMSA-AT was co-transformed with plasmid pRS424CTnpgA in S. cerevisiae 
CEN.PK113-9D to yield the S. cerevisiae IBT100085.  
 
8.3.2     Characterization of atX and heterologous production in S. cerevisiae 
The nucleotide sequence of atX was determined over the open reading frame as 5,430 bp 
(including the 6xHis Tag and stop codon) which was transcribed as 1,809 amino acids. 
(Appendix B.1). The open reading frame did not contain the intron as it was amplified 
from RNA. The sequence of atX from this study was compared with other 6-MSASs gene 
in order to investigate the similarity among the genes, and the results are summarized in 
Table 8.3. This indicates that atX from this study had a high similarity to the atX from 
other studies with 99% identity at both the nucleotide and the amino acid level, but it 
showed around 60% identity in the amino acid sequence to the 6-MSAS gene from P. 
patulum, A. clavatus and Byssochlamys nivea. S. cerevisiae IBT100085 carrying the 
plasmid with atX gene from A. terreus IBT12713 which was co-transformed with a 
plasmid bearing the npgA from A. nidulans (pRS424CTnpgA) was cultivated in glucose 
minimal media in shake flasks. Unfortunately no production of 6-MSA could be detected.  
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Table 8.3. Percent identity of the 6-MSAS gene from different organisms to the atX from 
A. terreus IBT12713 cloned by RT-PCR in this study  
 
Similarity to atX from A. tereues IBT12713 Accession number 
Amino acid level  Nucleotide level 
6-MSAS gene  
from different organisms 
% identity % coverage  % identity % coverage 
 
A. terreus NIH2624 99.6 100  99.8 100 XM_00121543 
A. terreus 99.4 100  99.2 100 U31329 
A. terreus 98.4 100  98.1 100 D85860 
A. clavatus 63.8 96.2  84.0 4.3 XM_001273092 
B. nivea 63.3 99.3  82.4 3.4 AF360398 
P. patulum 62.5 99.8  89.9 3.1 X55776 
 
 
8.3.3   Construction of the hybrid 6-MSAS gene from P. patulum-A. terreus 
and heterologous production in S. cerevisiae 
 
Since no 6-MSA was produced from S. cerevisiae carrying the A. terreus atX. The change 
of the 5´ region of some genes has shown to be absolutely necessary and apparently 
sufficient to obtain a good level of protein expression in different heterologous hosts 
(Batard et al., 2000). The front part of atX from A. terreus was therefore replaced with the 
front part of the 6-MSAS gene from P. patulum. The construction of the hybrid gene was 
firstly performed by searching for unique restriction sites that can easily be cut for 
swapping the DNA fragment. BglII which was located in the un-conserved region inside 
the acyltransferase (AT) domain of P. patulum 6-MSAS gene was used as the restriction 
site. BglII was not found in atX but it can be ligated with BclI. Therefore, a BclI restriction 
site was introduced in the primer SWA25. Two nucleotides ‘‘TA’’ were also included in 
the primer SWA25 at position 13 and 14 from 5´ end in order not to change the open 
reading frame after the ligation. However, the last part of atX was amplified by primer 
SWA25 and primer SWA26 by using plasmid pRS426CTMSA-AT as a template. The 
PCR product was cut by BclI/HindIII and ligated into the plasmid pRS426CTMSA-PP 
which had been cut by BglII and HindIII to yield the plasmid with hybrid 6-MSAS gene 
from P. patulum and A. terreus, pRS426CTMSA-PP-AT (Figure 8.1). To construct S. 
cerevisiae IBT100086, the plasmid pRS426CTMSA-PP-AT was co-transformed with 
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plasmid pRS424CTnpgA in yeast with the over-expression of ACC1 to ensure the high 
level of malonyl-CoA. Twenty-five transformants were selected and cultivated in glucose 
minimal media in the shake flasks for 48 hours. 6-MSA could not be detected from any of 
them. 
 
KS  AT  DH  KR   ACP 
 BglII  HindIII 
pRS426CTMSA-PP 5´ 3´ 
 AT KS  DH  KR   ACP 
 HindIII 
 SWA26 
BclI  SWA25 
pRS426CTMSA-AT 5´ 3´ 
 AT KS  DH  KR   ACP 
pRS426CTMSA-PP-AT 5´ 3´ 
ligation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1. Construction of thy hybrid plasmid pRS426CTMSA-PP-AT which the 6-
MSAS gene contains both parts from P. patulum (red) and A. terreus (green). 
 
8.4     Discussion 
There are several factors that play an important role in the expression of a gene in a 
heterologous host, such as the expression vector and the transcriptional promoter, the 
sequence around the N-terminal region, and the codon bias (Guftasson et al., 2004). Since 
the expression vector with the promoter used in this study was exactly the same as it was 
used for the expression of 6-MSAS gene from P. patulum, and since the change of the atX 
at the N-terminal to that from P. patulum did not lead to 6-MSA production, the main 
reason for lack of production of 6-MSA is believe to be codon bias. As the atX was 
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originally from A. terreus, there are some codons that are rarely used in S. cerevisiae, 
meaning that the tRNAs for these rare codons in yeast are scarce, thus the codon bias 
affects directly the translation process and the expression of the 6-MSAS protein. The 
frequency of codon usage for the whole genome of S. cerevisiae is shown in Appendix C. 
 
Comparing the nucleotide sequence of atX from A. terreus with the codon usage of S. 
cerevisiae, we found that there are 70 sites in atX that are rarely used in S. cerevisiae (47 
sites for rare codon with relative adaptiveness between 10-20, and 23 places for extremely 
rare codon with relative adaptiveness lower than 10). The 70 sites of codons in A. terreus 
atX which are rarely used in yeast are illustrated in Figure 8.2. Morover, by using 
GeneBee-Molecular Biology Server (Russia), we found that the mRNA transcribed from 
the A. terrues atX has a secondary structure which is not found in the mRNA of 6-MSAS 
gene from P. patulum. The secondary structure of the mRNA from atX was located at 
nucleotide position 4,628 to 4,882 (Figure 8.2) with a Gibbs free energy of -26.9 kcal/mol. 
The secondary structure with strong Gibbs free energy found here could inhibit the 
translation of mRNA into protein. By using Java Codon Adpatation Tool, Germany, the 
atX was in silico engineered such that the bias codons in atX were removed and replaced 
by the codons more frequently used in S. cerevisiae. The adapted atX sequence for the 
heterologous expression in yeast was shown in Appendix B.2. After the atX was adapted, 
the secondary structure of mRNA with strong energy between nucleotides was no longer 
found, indicating that the mRNA has a higher chance to be translated into protein. The 
structures of mRNA at position 4,628 to 4,882 before and after engineering are shown in 
Figure 8.3. However, the codon usage in atX from A. terrues and 6-MSAS gene from P. 
patulum which was successfully expressed in S. cerevisiae were compared in Table 8.4. 
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1  ATGGAGGTACATGGAGATGAAGTGTTGTCAGTCGACTCTGGCGTCTCAACTCCCCCGTCGACAGGAAGTGGATTTCGGAGGCCACTAGAGACCCCCGGAA 
101 CAGAAATCGGGAATCTCAATCTTAACCCTCAGAATGAGGTTGCCGTTGTTGGAATGGCCTGCCGGCTTGCCGGGGGCAATAATTCTCCGGAAGAACTGTG 
201 GCAGTCCATTCTAAACAGGAAGGATGCCTCTGGCGAGATCCCAAGCATGCGCTGGGAGCCGTATTACCGTCGGGATATTCGCAACCCCAAGATCCTAGAT 
301 CAAACGACAAAGCGCGGCTACTTCTTGGACCACGTCGAGAATTTTGATGCCGCGTTCTTTGGCGTTTCCCCCAAAGAGGCCGAGCAGATGGACCCCCAGC 
401 AGCGGTTGTCACTTGAGGTGACTTGGGAGGCCCTGGAAGACGCAGGAATCCCACCGCAGAGTTTGTCCGGCTCAGAAACAGCCGTGTTTATGGGAGTCAA 
501 TTCGGATGATTATTCCAAGCTCTTACTGGAAGATATTCCGAACGTGGAGGCCCGGATGGGCATCGGCACTGCGTACTGCGGAGTCCCGAACCGCATCTCC 
601 TACCACCTGAACCTCATGGGACCCAGCACTGCCGTTGATGCCGCCTGTGCCTCCTCTCTCGTTGCCATCCATCACGGACGACAAGCCATCCTGCAAGGGG 
701 AGAGCGAAGTCGCTATTGTCGGAGGAGTCAACGCCCTCTGCGGGCCAGGACTGACTCGCGTACTCGACAAGGCAGGAGCGACCTCCACGGAAGGTCGCTG 
801 TCTCTCTTTCGACGAAGATGCGAAGGGCTACGGCCGTGGTGAAGGAGCTGCGGTGGTGATCTTGAAACGGCTGTCCACCGCCATCCGGGACGGAGACCAC 
901 ATTCGCGCCATCATCAAGGGCAGTGCCGTAGCACAGGATGGCAAAACCAACGGCATCATGGCTCCCAACGCCAAGGCACAAGAGCTTGTGGCGTGGAATG 
1001 CGCTTCGGACAGCCGGAGTCGACCCTCTGACGGTTGGGTATGTGGAAGCTCACGCAACGTCAACCCCTCTTGGCGATCCTACCGAGGTCAGCGTCGTCTC 
1101 AGCAGTCTACGGCAAAGGCAGACCGGAAGGGAATCCTTGCTTCATTGGCTCTGTCAAACCCAACGTGGGCCATTTGGAAGCGGGCGCTGGCGCCGTCGGT 
1201 TTCATCAAAGCAGTCATGGCAGTTGAAAAGGCCATTTTCCCCCCACAAACCAACCTGAAGAGACTCAATTCTCGCATTGACTGGGGCCAAGCCGGAGTGA 
1301 AGGTCGTCCAGGAGACACTGGAATGGCCTGGCAATGAGGATGACGTCCGCCGAGCCGGTGTTTGCTCTTACGGATATGGTGGTACGGTCTCCCATGCAAT 
1401 CATCGAGGAGTTTGCGCAACAGCTCCAGCGGCCGACTACCAACACAACCGATGAAGACCCTCTGCCTCGGATTCTTCTCCTGTCGGCACCTCAAGAGAGA 
1501 CGCCTTGCTTTGCAGGCACGGACACAGGCCTCCTGGATTGCCGCGGAGGGCAGAAATAGAACCCTGGAGTCGATTGCAACCACCTTGAGCACTCGTCGTG 
1601 GGCACCATGACTACCGGGCTGCCATCATCGCAGAGAACCATGATGACGCTGTTCAGAAACTGTCTGACATTGTCAATGGTAAAGCAGCCGAATGGACGAC 
1701 GTCGAGTCGTGTTCTCGATGCCAGTTGCTCCAAGGACGTGGTGTGGGTTTTCTCCGGTCATGGCGCACAATGGACTGCAATGGCTACGGATCTCCTCAAA 
1801 GACATTGTGTTCTATCAAACAATCAGCCGTCTGGACCCGATTGTGGAGCGCGAAATGGGCTTCTCGGCATTGCATTCCCTTGCAAGTGGCGATTTCGAAT 
1901 CGTCCATCAAGGTGCAAGTGCTCACCTATCTCGTACAGGTGGGACTGGCTGCCATCTTGCGCTCGAAGGGATTGGAGCCCCAGGCTGTCATCGGTCATTC 
2001 AGTTGGCGAAATTGCCGCCTCAGTCGCGGCTGGCTGTCTGACTGCAGAAGAAGGCGCCCTGATTGTCACCCGCAGAGCAAACCTCTATCGGCGTGTGATG 
2101 GGCGCGGGCGCAATGGTTCTCGTCAACATTCCATTTGTCGACATGGAGAAAGAGCTTCAAGGCCGGACGGACCTCGTGGCCGCCATTGGCTCCTCGCCAT 
2201 CTTCATGTGTTGTTTCCGGTGCCACTGAGGCTGTCCTGGCACTCGTGGAAGACCTCAAGTCTCGTGGTGTCAACGCTTTCCGGGTCAAGACGGATATTCC 
2301 CTTCCACCACCCGATGCTGGATCAACTGTCCGAGCCCTTGCGAGAGGCCATGGCAGGGTCCCTGTCGCCACGCAAGCCCAGAGTCCGTCTTTACTCGACG 
2401 TCGGCAGAAGACCCACGCAGTATGGTTGCTCGGGATATATATTACTGGACCAGCAACATGGTCAACCCGGTCCGGTTGACGGCCGCAGTGCAGGCAGCAG 
2501 TGGACGATGGCCTGCGATTGTTCCTTGAAGTCTCTTCTCATCCCATTGTGTCCCACTCTGTCCGAGAGACCATGTTGGACCTGGGTGTGGAGGACTTCAC 
2601 CGTGACCAACACCATGGCTCGCAATAAGCCTGCCGACAAGACCATTCTGTCCAGCATTGCGCAGCTTCACTGTCGGGGCGCCGTCGTCAATTGGAAGAAG 
2701 CAGCTGCCGGGCCCTTGGGCGCTGGATGTGCCCTTGACGACCTGGGACCACAAGCCCTACTGGCGGCATATTCACACTGGCCCTATCAGTGCCTCGACTT 
2801 TGCACGATGTGGACAAACACACGCTGTTGGGTCAGCGCGTTCCCGTTGCGGGAGAAACAACTATGGTGTTCACCACCCAGATGGATGACCAGACCAAGCC 
2901 TTTCCCAGGAAGCCATCCACTGCACGGCTCTGAGATTGTTCCGGCTGCTGCCCTTGTCAACACTTTCCTGCATGCCACCGGGGCTACCACCCTTTCCAAC 
3001 ATTACCCTTCGCGTGCCAGTGGCCATCAGCCAGCCGCGCGACATCCAGGTGGTGGTGTCACAGAATCAAATCAAGATCTGCTCCCGTCTCACTCAGAAGG 
3101 CGGGTTCTGGGGCAGACGAAGGTTCCTGGCTGACACACACTACGGGTCAGTGGGAGGCTGGTGGAAGCAAGAACGCCCCGGCGCAACTCGATATTGCTGC 
3201 TATCAAGGCTCGTCTCGCTAATAACAAATTGGCGGACAACTTCTCCATCGACTATTTGGACAAGGTTGGCGTTTCAGCAATGGGCTTTCCTTGGGCAGTT 
3301 ACAGAGCACTACGGCACCCTGCAGGAGATGATCGCTCGCGTTGATGTCGCGCCAGACGTCCCCGCGACCAGTCCACTCCCCTGGGATGCTGCCTCTTGGG 
3401 CCCCGATCCTCGATGCGGCCACCTCAGTGGGATCCACTCTCTTTTTCGATCAGCCTCGCCTGCGCATGCCGGCTCACATTCACGGGGTTCAAGTCTACAC 
3501 CACGCAGCCGCCTCCCAAGGTGGGTTACCTGTACGTGGAAAAGGCTGGCGATCGGGATCTGGCGGTGCATGTCAGTGTCTGCGACGAGCTCGGAACCGTC 
3601 TTAGCTCGATTCGAATCCATGCGCTTTTCCGAGATCGAAGGCACGCCGGGCAGTAACGGCAGCGAGGAGAGTCTTGTCCATCAGCTCGCATGGCCTCCCG 
3701 CGATCTACAGCGAGAGGCCGCTGACAATCAACAATGTCGTCCTCGTTTCCCGGGATAAGAACGTCGCAGATCTCTACTGTGGGTCCTTGAAAGATCGTGT 
3801 GTCATCTATCACGGTGCTGGATGCTGCTGCCGACCTGCTTTCCCTTTCGCAGGATTCCAGCAGTGTCTTGCAAGCAAAAGATACAGCGGTGGTGTACGTG 
3901 CCCGGTCCCCTCCACAGCGCGGATTCTATCCCGACTGCGGCCCATTCTTTCCTCATGGAATTGCTCCTCCTGGTCAAAATCATTGTCAATGGCTCTTTGC 
4001 CCACCAAGGTCTTTGTCCTTACGGACCGCGTCTGCGAGAGTGAGTCTGCTACGGCTCTCGCTCAGTCTCCGATCCACGGTGTCTCCCGTATCATTGCTGC 
4101 GGAGCACCCAGATCAATGGGGCGGACTGATTGACGTCGAAACGCCGGGCCAGTTCTCACTCGAGACGATGAAGTATGTGCAGGAGGCGGATAACATCCGC 
4201 ATCTCGGATGGCATACCCAGAATTGCTCGTCTGCGCCCGCTTCCTCGCGACAAGCTCCTACCGCCTAGCAAGCAGACTTCCCTGCTCCCCCGACCCGAAG 
4301 GTACCTACTTGATTACGGGTGGACTGGGCGCTCTGGGGTTGGAGGTCGCACAGTTCCTGGTGGAAAAGGGTGCTCGTCGATTGATCCTCGTTTCTCGGCG 
4401 TGCCTTGCCTCCGCGCCGGGAGTGGGCAGACATCCTTGCTGATGCATCATCCTCGCTGGCGCCGGCGCTGGAGACAATCCAGGCCCTTGAAGCACAGGGA 
4501 GCCACTGTCCACACTCTTGCAGTGGACATTTCCTCTCCTGACGCAGCGCCTCAACTGGCTGTCGCCATTGATTCTCTGTCGCTACCCCCAGTCCGCGGCG 
4601 TGGTCCACGCAGCAGGCGTTCTGGACAGCCAGCTGGTCCTCTCCGCCACGTCAGACTCTGTCGAGCGCGTGCTGGCGCCCAAGATCACCGGAGCGCTGGT 
4701 CCTTGGCACCGTCTTCCCCCCCAAGGCCCTCGATTTCTTCATGCTATTCTCCTCGTGCGGACAGCTACTAGGCTTCCCGGGTCAAGCATCCTACGCGTCC 
4801 GGAAACGCGTTCCTTGATGCATTCGCAACCTCGCGCCGACACCAAGGAGACAACGCTGTCGCCGTGCAGTGGACCAGCTGGCGCTCCCTCGGCATGGCAG 
4901 CCAGTACCGACTTCATCAACGCTGAGCTGGCCAGCAAGGGCATCACTGACATCACGCGCGACGAGGGATTCCGCGCATGGATGCATATTTCCAAATATGA 
5001 TATCGACCAGGCCGCGGTCTTGCGCAGTCTGGCCTTCGAGGCCGATGAACCCCTCCCCACCCCTATCCTTACGGATATTGCCGTCCGCAAGGCTGGCTCC 
5101 GCCTCCTCCGCGGATGCTCCCTCTGCTGCACCGAAAGAGACGAACGAAATGCCGGAATCGATCCCGGAGCGTCGTACCTGGTTGGATGAGCGAATCCGTG 
5201 ATTGTGTGGCCCGCGTGCTTCAGCTGGGGAGCAGCGACGAGGTTGATTCCAAGGCCGCTCTGAGTGACCTGGGAGTCGACAGTGTCATGACCGTTAGCTT 
5301 GAGAGGTCAGCTGCAGAAGACGTTGGGGGTCAAGGTGCCACCCACACTGACCTGGAGTTGCCCGACGGTGTCACATCTGGTGGGATGGTTTTTGGAAAAG 
5401 ATGGGAAATCATCATCATCATCATCATTAA 
 
 
Figure 8.2. The distribution of codons in atX encoding 6-MSAS from A. terreus 
IBT12713 which are rarely used (relative adaptiveness 10-20; highlight in green), and are 
extremely rarely used in S. cerevisiae (relative adaptiveness lower than 10; hightlight in 
red). The highlight in yellow represents the area that the secondary structure with high 
energy has been found in mRNA. 
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  A (before) B (after) 
 
 
 
 
 
 
 
 
 
 
Figure 8.3. The structure of mRNA of atX at position 4,628 to 4,882 before and after in 
silico engineered the sequence. The large Gibbs free energy (-26.9 kcal/mol) between 
nucleotides indicated by the circle was found only in the structure of mRNA before 
reengineering.  
 
Table 8.4. The codon usage in 6-MSAS gene from P. patulum compared with atX from A. 
terreus IBT12713 before and after engineering the gene. 
 
atX from A. terreus IBT12713 Characteristics 6-MSAS gene from 
P. patulum Before engineering After engineering* 
Codons that rarely found in yeast 50 places 47 places 0 place 
Codons that extremely rarely found in yeast 18 places 23 places 0 place 
mRNA Secondary structure with high energy 0 place 1 place 0 place 
Successfully heterologous produced in yeast yes no N/A 
 
* The engineered atX has not been constructed yet. The sequence is shown in Appendix B.2. 
 
In conclusion, we constructed the plasmid with atX encoding 6-MSAS gene from A. 
terreus IBT12713. Another plasmid was constructed by a 6-MSAS gene fusion with the 
first part on the gene from P. patulum and the last part from A. terreus. These plasmids 
were transformed in S. cerevisiae with co-expression of the plasmid carrying npgA from A. 
nidulans. No production of 6-MSA could be detected from both strains. This might be due 
to the codons in atX that are rarely used in S. cerevisiae. The sequence of atX was adapted 
in order to remove the codon bias and unfavorable mRNA secondary structure. However, 
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the adapted sequence need to be tested experimentally to investigate whether it can lead to 
the production of 6-MSA.  
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Conclusions and future perspectives 
 
 
The overall objective of this dissertation was to study the heterologous expression of a 
fungal polyketide synthase in S. cerevisiae. 6-MSA, which is naturally produced by P. 
patulum was chosen as a model polyketide. Functional expression of the 6-MSAS gene in 
S. cerevisiae requires the co-expression of a heterologous phosphopantetheinyl transferase 
(PPTase) to convert the apo-PKS to its active holo form. PPTase genes from B. subtilis 
and A. nidulans, respectively, were used in this study. Using the GAL1 promoter to drive 
the expression, a plasmid carrying the 6-MSAS gene from P. patulum and a plasmid 
carrying either one of the two PPTase genes were co-transformed into S. cerevisiae. The 
strains were characterized in batch cultivations with a galactose minimal media, and better 
productivity of the heterologous produced 6-MSA was obtained by the co-expression of 
PPTase from A. nidulans. 
 
In order to improve the production of 6-MSA by enhancing the supply of precursors, the 
promoter of the gene (ACC1) encoding acetyl-CoA carboxylase, which catalyzes the 
conversion of acetyl-CoA to malonyl-CoA, was replaced with a strong, constitutive 
promoter (TEF1 promoter) in a S. cerevisiae strain harboring two plasmids carrying the 
genes encoding 6-MSAS from P. patulum and PPTase from A. nidulans, respectively. The 
strain was characterized in batch cultivations with a glucose minimal media, and a 60% 
increase in 6-MSA titer was observed compared to a strain having the native promoter in 
front of ACC1. However, 6-MSAS gene was also integrated in the chromosome at the site 
of YMLCΔ2 which resulted in a stable production strain, but yielded less 6-MSA than the 
plasmid strains. 
 
 169
                                                                                                    Conclusions and future perspectives. 
The strain carrying the 6-MSAS gene with the change of ACC1 to TEF1 promoter was 
cultivated in glucose minimal media with different initial glucose concentration from 20-
200 g/L in order to evaluate the optimum glucose concentration for the production of 
polyketide in yeast. A low production of 6-MSA in both glucose and ethanol phase was 
observed when an initial glucose concentration between 100-200 g/L was applied, 
possibly due to the hyperosmotic pressure and toxicity of ethanol as well as other by-
products that are formed during the cultivation. The optimum of initial glucose 
concentration was found between 20-50 g/L as a high specific growth rate and 6-MSA 
yield were obtained.  
 
Since 6-MSA was used as a model system to develop the platform for the polyketide 
production in yeast, it is interesting to understand the metabolic regulation of the whole 
cell during the biosynthesis of 6-MSA at the transcriptional level. Consequently, a DNA 
expression analysis using Affymetrix gene chips was performed. The evaluation of whole 
genome transcription response using reporter metabolite and subnetwork analysis revealed 
the global effect due to the expression of the 6-MSAS gene, not only on the central 
metabolism, EMP, TCA and PP pathways, but also on the amino acid metabolism when 
the strain carrying 6-MSA was cultivated on glucose minimal media, and on the fatty acid 
metabolism when the promoter of ACC1 was changed to TEF1 promoter. The result from 
metabolic flux analysis of [1-13C]-labeled glucose cultivations with the reference strain 
and strains carrying the 6-MSAS gene was in accordance with the result from transcription 
analysis and revealed that flux towards acetyl-CoA was increased in the strains carrying 
the 6-MSAS gene, especially in the strain with the change of the promoter of ACC1 to 
TEF1 promoter. 
 
The identification of further targets for metabolic engineering using a genome scale 
metabolic model and MOMA approach in order to improve 6-MSA production in yeast 
revealed that GDH1 and SER1 could be the targets for gene deletion, which may yield a 
2.3 times higher 6-MSA production than observed for the so far highest yielding strain, 
having the ACC1 promoter replaced.  
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All knowledge generated in this study can definitely be used as a basis for forming a 
platform for the production of polyketides in the future. For further investigations, the 
deletion of the target genes as mentioned above must be performed to validate the 
potential increase in 6-MSA production. The expression of the 6-MSAS gene from A. 
terreus in yeast must be investigated. The sequence of atX should be adapted in order to 
remove the codon bias and unfavorable mRNA secondary structure, and if it is expressed 
but the production of 6-MSA can not be detected, the experiment to extract 6-MSA out of 
the cells should be carried out. Furthermore, the test of this yeast system using another 
fungal polyketide or even more complex polyketides from different organisms is strongly 
suggested. 
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Appendix A 
Distribution of Transcripts in Gene Ontology (GO) 
Terms that are Significantly Changed in  
Different Pair-wise Comparisons 
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Appendix A.1. Distribution of transcripts in Gene Ontology (GO) terms that are 
significantly changed of the strain IBT100082 in ethanol phase compared to the same 
strain in glucose phase. 
 
A) Up-regulated genes (499 genes) 
Cluster frequency 
(total 499 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
generation of precursor metabolites and energy 53 10.6 181 2.5 8.22E-18 
energy derivation by oxidation of organic compounds 40 8.0 143 2.0 3.39E-12 
oxidative phosphorylation 22 4.4 46 0.6 2.31E-11 
coenzyme metabolic process 36 7.2 136 1.9 5.37E-10 
cofactor metabolic process 40 8.0 170 2.3 1.71E-09 
aerobic respiration 26 5.2 84 1.2 2.07E-08 
cellular respiration 26 5.2 90 1.2 1.16E-07 
cellular carbohydrate metabolic process 41 8.2 213 2.9 7.52E-07 
electron transport 15 3.0 33 0.5 8.19E-07 
carbohydrate metabolic process 43 8.6 233 3.2 1.13E-06 
ATP synthesis coupled electron transport 13 2.6 25 0.3 1.36E-06 
organelle ATP synthesis coupled electron transport 13 2.6 25 0.3 1.36E-06 
phosphorylation 33 6.6 155 2.1 2.55E-06 
acetyl-CoA metabolic process 11 2.2 20 0.3 1.19E-05 
monocarboxylic acid metabolic process 28 5.6 125 1.7 1.29E-05 
cofactor catabolic process 11 2.2 21 0.3 2.36E-05 
acetyl-CoA catabolic process 9 1.8 15 0.2 9.60E-05 
tricarboxylic acid cycle 9 1.8 15 0.2 9.60E-05 
cellular catabolic process 58 11.6 421 5.8 0.00013 
coenzyme catabolic process 10 2.0 20 0.3 0.00018 
phosphorus metabolic process 36 7.2 212 2.9 0.00024 
phosphate metabolic process 36 7.2 212 2.9 0.00024 
aldehyde metabolic process 10 2.0 21 0.3 0.00033 
catabolic process 58 11.6 434 6.0 0.00037 
glyoxylate metabolic process 5 1.0 5 0.1 0.00134 
TCA intermediate metabolic process 9 1.8 20 0.3 0.00236 
carboxylic acid metabolic process 43 8.6 313 4.3 0.00631 
organic acid metabolic process 43 8.6 313 4.3 0.00631 
mitochondrial electron transport 6 1.2 9 0.1 0.00636 
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B) Down-regulated genes (436 genes) 
Cluster frequency 
(total 436 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
ribosome biogenesis and assembly 125 28.7 410 5.6 3.29E-56 
ribonucleoprotein complex biogenesis and assembly 129 29.6 483 6.6 9.63E-51 
rRNA metabolic process 74 17.0 256 3.5 1.97E-29 
rRNA processing 71 16.3 249 3.4 1.10E-27 
cellular component organization and biogenesis 249 57.1 2281 31.3 1.12E-27 
organelle organization and biogenesis 182 41.7 1395 19.1 1.69E-26 
RNA processing 98 22.5 491 6.7 1.35E-25 
RNA metabolic process 152 34.9 1056 14.5 1.86E-25 
nucleobase and nucleic acid metabolic process 192 44.0 1675 23.0 6.81E-21 
cellular process 369 84.6 4670 64.0 6.80E-20 
metabolic process 296 67.9 3583 49.1 2.59E-13 
primary metabolic process 280 64.2 3317 45.5 3.83E-13 
cellular metabolic process 284 65.1 3473 47.6 2.37E-11 
ribosomal large subunit biogenesis and assembly 24 5.5 64 0.9 6.11E-11 
maturation of SSU-rRNA 20 4.6 45 0.6 1.69E-10 
maturation of SSU-rRNA from tricistronic rRNA transcript  20 4.6 45 0.6 1.69E-10 
biopolymer metabolic process 208 47.7 2344 32.1 2.15E-09 
macromolecule metabolic process 244 56.0 2923 40.1 3.65E-09 
maturation of 5.8S rRNA from tricistronic rRNA transcript  15 3.4 34 0.5 2.20E-07 
maturation of 5.8S rRNA 15 3.4 36 0.5 5.91E-07 
tRNA processing 22 5.0 84 1.2 2.05E-06 
tRNA modification 17 3.9 52 0.7 3.54E-06 
tRNA metabolic process 26 6.0 121 1.7 6.99E-06 
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript  10 2.3 18 0.2 1.44E-05 
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA 10 2.3 19 0.3 2.88E-05 
tRNA methylation 9 2.1 15 0.2 3.14E-05 
endonucleolytic cleavage in ITS1  10 2.3 20 0.3 5.46E-05 
endonucleolytic cleavages during rRNA processing 10 2.3 20 0.3 5.46E-05 
endonucleolytic cleavage of tricistronic rRNA transcript 10 2.3 20 0.3 5.46E-05 
cleavages during rRNA processing 10 2.3 21 0.3 9.88E-05 
ribosome export from nucleus 11 2.5 27 0.4 0.00016 
ribosome assembly 17 3.9 66 0.9 0.00019 
transcription from RNA polymerase I promoter 12 2.8 34 0.5 0.00028 
protein export from nucleus 15 3.4 55 0.8 0.00044 
macromolecular complex assembly 43 9.9 329 4.5 0.00072 
RNA modification 24 5.5 139 1.9 0.00193 
macromolecule localization 46 10.6 384 5.3 0.00345 
cellular component assembly 53 12.2 469 6.4 0.00354 
nuclear transport 22 5.0 128 1.8 0.00559 
nucleocytoplasmic transport 22 5.0 128 1.8 0.00559 
nuclear export 19 4.4 101 1.4 0.00629 
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Appendix A.2. Distribution of transcripts in Gene Ontology (GO) terms that are 
significantly changed in the strain IBT100082 compared to the reference strain 
(IBT100081), in the batch cultivation during the ethanol phase. 
 
A) Up-regulated genes (322 genes) 
Cluster frequency 
(total 322 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
nitrogen compound metabolic process 39 12.1 251 3.4 2.46E-09 
amino acid biosynthetic process 24 7.5 106 1.5 1.55E-08 
amine biosynthetic process 24 7.5 114 1.6 8.01E-08 
nitrogen compound biosynthetic process 24 7.5 115 1.6 9.72E-08 
carboxylic acid metabolic process 41 12.7 313 4.3 1.73E-07 
organic acid metabolic process 41 12.7 313 4.3 1.73E-07 
amine metabolic process 34 10.6 228 3.1 2.14E-07 
amino acid metabolic process 30 9.3 187 2.6 4.28E-07 
amino acid and derivative metabolic process 30 9.3 202 2.8 2.87E-06 
glutamine family amino acid metabolic process 13 4.0 43 0.6 0.0000175 
arginine biosynthetic process 7 2.2 10 0.1 0.0000274 
glutamine family amino acid biosynthetic process 10 3.1 27 0.4 0.0000884 
urea cycle intermediate metabolic process 7 2.2 15 0.2 0.00121 
arginine metabolic process 7 2.2 15 0.2 0.00121 
cellular carbohydrate metabolic process 26 8.1 213 2.9 0.00171 
carbohydrate transport 10 3.1 36 0.5 0.00187 
asparagine biosynthetic process 4 1.2 4 0.1 0.00312 
heterocycle metabolic process 14 4.3 76 1.0 0.00387 
monosaccharide transport 8 2.5 24 0.3 0.00438 
hexose transport 8 2.5 24 0.3 0.00438 
carbohydrate metabolic process 26 8.1 233 3.2 0.00904 
nonprotein amino acid metabolic process 5 1.6 9 0.1 0.01479 
nonprotein amino acid biosynthetic process 4 1.2 6 0.1 0.04357 
cytokinesis, completion of separation 5 1.6 11 0.2 0.05040 
 
B) Down-regulated genes (395 genes) 
Cluster frequency 
(total 395 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
DNA repair 27 6.8 192 2.6 0.00382 
response to DNA damage stimulus 30 7.6 236 3.2 0.00899 
response to endogenous stimulus 30 7.6 245 3.4 0.01889 
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Appendix A.3. Distribution of transcripts in Gene Ontology (GO) terms that are 
significantly changed in the strain IBT100082 compared to the reference strain 
(IBT100081), in the batch cultivation during the glucose phase. 
 
A) Up-regulated genes (600 genes) 
Cluster frequency 
(total 600 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
carbohydrate metabolic process 51 8.5 233 3.2 4.83E-08 
cellular carbohydrate metabolic process 45 7.5 213 2.9 2.39E-06 
catabolic process 68 11.3 434 6.0 0.00011 
cellular catabolic process 66 11.0 421 5.8 0.00017 
carboxylic acid metabolic process 53 8.8 313 4.3 0.00026 
organic acid metabolic process 53 8.8 313 4.3 0.00026 
cell communication 42 7.0 224 3.1 0.00030 
signal transduction 38 6.3 209 2.9 0.00251 
monocarboxylic acid metabolic process 27 4.5 125 1.7 0.00276 
monosaccharide metabolic process 22 3.7 92 1.3 0.00412 
nitrogen compound metabolic process 42 7.0 251 3.4 0.00679 
glucose metabolic process 17 2.8 65 0.9 0.01492 
alcohol metabolic process 30 5.0 163 2.2 0.02338 
carbohydrate biosynthetic process 18 3.0 75 1.0 0.03003 
coenzyme metabolic process 26 4.3 136 1.9 0.04227 
hexose metabolic process 19 3.2 85 1.2 0.05238 
response to stress 65 10.8 488 6.7 0.05939 
 
B) Down-regulated genes (177 genes) 
Cluster frequency 
(total 177 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
ribosome biogenesis and assembly 39 22.0 410 5.6 3.83E-11 
ribonucleoprotein complex biogenesis and assembly 42 23.7 483 6.6 7.70E-11 
cellular process 149 84.2 4670 64.0 1.00E-06 
RNA processing 34 19.2 491 6.7 1.06E-05 
nucleobase and nucleic acid metabolic process 73 41.2 1675 23.0 2.01E-05 
metabolic process 121 68.4 3583 49.1 7.99E-05 
cellular metabolic process 117 66.1 3473 47.6 0.00025 
primary metabolic process 113 63.8 3317 45.5 0.00032 
rRNA processing 21 11.9 249 3.4 0.00034 
organelle organization and biogenesis 61 34.5 1395 19.1 0.00049 
rRNA metabolic process 21 11.9 256 3.5 0.00053 
maturation of SSU-rRNA 9 5.1 45 0.6 0.00062 
maturation of SSU-rRNA from tricistronic rRNA transcript  9 5.1 45 0.6 0.00062 
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B) Down-regulated genes (177 genes) (continued) 
Cluster frequency 
(total 177 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
tRNA modification 9 5.1 52 0.7 0.00223 
cellular component organization and biogenesis 83 46.9 2281 31.3 0.00490 
RNA metabolic process 47 26.6 1056 14.5 0.00972 
macromolecule metabolic process 98 55.4 2923 40.1 0.01433 
protein-RNA complex assembly 13 7.3 144 2.0 0.02683 
ribosomal subunit assembly 8 4.5 55 0.8 0.02945 
 
 
Appendix A.4. Distribution of transcripts in Gene Ontology (GO) terms that are 
significantly changed in the strain IBT100083 compared to the strain IBT100082, in the 
batch cultivation during the ethanol phase. 
 
A) Up-regulated genes (346 genes) 
Cluster frequency 
(total 346 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
response to stress 42 12.1 488 6.7 0.09095 
 
B) Down-regulated genes (449 genes) 
Cluster frequency 
(total 449 genes) 
Background frequency 
(total 7292 genes) 
GO term 
genes % genes % 
P-value 
cellular process 351 78.2 4670 64.0 1.81E-08 
metabolic process 267 59.5 3583 49.1 0.00384 
nitrogen compound metabolic process 33 7.3.0 251 3.4 0.02558 
cellular metabolic process 255 56.8 3473 47.6 0.03781 
amine metabolic process 30 6.7 228 3.1 0.05915 
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Appendix B 
The Sequence of atX Encoding 6-MSAS from                  
A. terrues IBT12713 before and after Engineering 
 
Appendix B.1. The sequence atX encoding 6-MSAS from A. terreus IBT12173 amplified 
by RT-PCR 
 
1 ATGGAGGTACATGGAGATGAAGTGTTGTCAGTCGACTCTGGCGTCTCAACTCCCCCGTCG 
  M  E  V  H  G  D  E  V  L  S  V  D  S  G  V  S  T  P  P  S  
61 ACAGGAAGTGGATTTCGGAGGCCACTAGAGACCCCCGGAACAGAAATCGGGAATCTCAAT 
  T  G  S  G  F  R  R  P  L  E  T  P  G  T  E  I  G  N  L  N  
121 CTTAACCCTCAGAATGAGGTTGCCGTTGTTGGAATGGCCTGCCGGCTTGCCGGGGGCAAT 
  L  N  P  Q  N  E  V  A  V  V  G  M  A  C  R  L  A  G  G  N  
181 AATTCTCCGGAAGAACTGTGGCAGTCCATTCTAAACAGGAAGGATGCCTCTGGCGAGATC 
  N  S  P  E  E  L  W  Q  S  I  L  N  R  K  D  A  S  G  E  I  
241 CCAAGCATGCGCTGGGAGCCGTATTACCGTCGGGATATTCGCAACCCCAAGATCCTAGAT 
  P  S  M  R  W  E  P  Y  Y  R  R  D  I  R  N  P  K  I  L  D  
301 CAAACGACAAAGCGCGGCTACTTCTTGGACCACGTCGAGAATTTTGATGCCGCGTTCTTT 
  Q  T  T  K  R  G  Y  F  L  D  H  V  E  N  F  D  A  A  F  F  
361 GGCGTTTCCCCCAAAGAGGCCGAGCAGATGGACCCCCAGCAGCGGTTGTCACTTGAGGTG 
  G  V  S  P  K  E  A  E  Q  M  D  P  Q  Q  R  L  S  L  E  V  
421 ACTTGGGAGGCCCTGGAAGACGCAGGAATCCCACCGCAGAGTTTGTCCGGCTCAGAAACA 
  T  W  E  A  L  E  D  A  G  I  P  P  Q  S  L  S  G  S  E  T  
481 GCCGTGTTTATGGGAGTCAATTCGGATGATTATTCCAAGCTCTTACTGGAAGATATTCCG 
  A  V  F  M  G  V  N  S  D  D  Y  S  K  L  L  L  E  D  I  P  
541 AACGTGGAGGCCCGGATGGGCATCGGCACTGCGTACTGCGGAGTCCCGAACCGCATCTCC 
  N  V  E  A  R  M  G  I  G  T  A  Y  C  G  V  P  N  R  I  S  
601 TACCACCTGAACCTCATGGGACCCAGCACTGCCGTTGATGCCGCCTGTGCCTCCTCTCTC 
  Y  H  L  N  L  M  G  P  S  T  A  V  D  A  A  C  A  S  S  L  
661 GTTGCCATCCATCACGGACGACAAGCCATCCTGCAAGGGGAGAGCGAAGTCGCTATTGTC 
  V  A  I  H  H  G  R  Q  A  I  L  Q  G  E  S  E  V  A  I  V  
721 GGAGGAGTCAACGCCCTCTGCGGGCCAGGACTGACTCGCGTACTCGACAAGGCAGGAGCG 
  G  G  V  N  A  L  C  G  P  G  L  T  R  V  L  D  K  A  G  A  
781 ACCTCCACGGAAGGTCGCTGTCTCTCTTTCGACGAAGATGCGAAGGGCTACGGCCGTGGT 
  T  S  T  E  G  R  C  L  S  F  D  E  D  A  K  G  Y  G  R  G  
841 GAAGGAGCTGCGGTGGTGATCTTGAAACGGCTGTCCACCGCCATCCGGGACGGAGACCAC 
  E  G  A  A  V  V  I  L  K  R  L  S  T  A  I  R  D  G  D  H  
901 ATTCGCGCCATCATCAAGGGCAGTGCCGTAGCACAGGATGGCAAAACCAACGGCATCATG 
  I  R  A  I  I  K  G  S  A  V  A  Q  D  G  K  T  N  G  I  M  
961 GCTCCCAACGCCAAGGCACAAGAGCTTGTGGCGTGGAATGCGCTTCGGACAGCCGGAGTC 
  A  P  N  A  K  A  Q  E  L  V  A  W  N  A  L  R  T  A  G  V 
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1021 GACCCTCTGACGGTTGGGTATGTGGAAGCTCACGCAACGTCAACCCCTCTTGGCGATCCT 
  D  P  L  T  V  G  Y  V  E  A  H  A  T  S  T  P  L  G  D  P  
1081 ACCGAGGTCAGCGTCGTCTCAGCAGTCTACGGCAAAGGCAGACCGGAAGGGAATCCTTGC 
  T  E  V  S  V  V  S  A  V  Y  G  K  G  R  P  E  G  N  P  C  
1141 TTCATTGGCTCTGTCAAACCCAACGTGGGCCATTTGGAAGCGGGCGCTGGCGCCGTCGGT 
  F  I  G  S  V  K  P  N  V  G  H  L  E  A  G  A  G  A  V  G  
1201 TTCATCAAAGCAGTCATGGCAGTTGAAAAGGCCATTTTCCCCCCACAAACCAACCTGAAG 
  F  I  K  A  V  M  A  V  E  K  A  I  F  P  P  Q  T  N  L  K  
1261 AGACTCAATTCTCGCATTGACTGGGGCCAAGCCGGAGTGAAGGTCGTCCAGGAGACACTG 
  R  L  N  S  R  I  D  W  G  Q  A  G  V  K  V  V  Q  E  T  L  
1321 GAATGGCCTGGCAATGAGGATGACGTCCGCCGAGCCGGTGTTTGCTCTTACGGATATGGT 
  E  W  P  G  N  E  D  D  V  R  R  A  G  V  C  S  Y  G  Y  G  
1381 GGTACGGTCTCCCATGCAATCATCGAGGAGTTTGCGCAACAGCTCCAGCGGCCGACTACC 
  G  T  V  S  H  A  I  I  E  E  F  A  Q  Q  L  Q  R  P  T  T  
1441 AACACAACCGATGAAGACCCTCTGCCTCGGATTCTTCTCCTGTCGGCACCTCAAGAGAGA 
  N  T  T  D  E  D  P  L  P  R  I  L  L  L  S  A  P  Q  E  R  
1501 CGCCTTGCTTTGCAGGCACGGACACAGGCCTCCTGGATTGCCGCGGAGGGCAGAAATAGA 
  R  L  A  L  Q  A  R  T  Q  A  S  W  I  A  A  E  G  R  N  R  
1561 ACCCTGGAGTCGATTGCAACCACCTTGAGCACTCGTCGTGGGCACCATGACTACCGGGCT 
  T  L  E  S  I  A  T  T  L  S  T  R  R  G  H  H  D  Y  R  A  
1621 GCCATCATCGCAGAGAACCATGATGACGCTGTTCAGAAACTGTCTGACATTGTCAATGGT 
  A  I  I  A  E  N  H  D  D  A  V  Q  K  L  S  D  I  V  N  G  
1681 AAAGCAGCCGAATGGACGACGTCGAGTCGTGTTCTCGATGCCAGTTGCTCCAAGGACGTG 
  K  A  A  E  W  T  T  S  S  R  V  L  D  A  S  C  S  K  D  V  
1741 GTGTGGGTTTTCTCCGGTCATGGCGCACAATGGACTGCAATGGCTACGGATCTCCTCAAA 
  V  W  V  F  S  G  H  G  A  Q  W  T  A  M  A  T  D  L  L  K  
1801 GACATTGTGTTCTATCAAACAATCAGCCGTCTGGACCCGATTGTGGAGCGCGAAATGGGC 
  D  I  V  F  Y  Q  T  I  S  R  L  D  P  I  V  E  R  E  M  G  
1861 TTCTCGGCATTGCATTCCCTTGCAAGTGGCGATTTCGAATCGTCCATCAAGGTGCAAGTG 
  F  S  A  L  H  S  L  A  S  G  D  F  E  S  S  I  K  V  Q  V  
1921 CTCACCTATCTCGTACAGGTGGGACTGGCTGCCATCTTGCGCTCGAAGGGATTGGAGCCC 
  L  T  Y  L  V  Q  V  G  L  A  A  I  L  R  S  K  G  L  E  P  
1981 CAGGCTGTCATCGGTCATTCAGTTGGCGAAATTGCCGCCTCAGTCGCGGCTGGCTGTCTG 
  Q  A  V  I  G  H  S  V  G  E  I  A  A  S  V  A  A  G  C  L  
2041 ACTGCAGAAGAAGGCGCCCTGATTGTCACCCGCAGAGCAAACCTCTATCGGCGTGTGATG 
  T  A  E  E  G  A  L  I  V  T  R  R  A  N  L  Y  R  R  V  M  
2101 GGCGCGGGCGCAATGGTTCTCGTCAACATTCCATTTGTCGACATGGAGAAAGAGCTTCAA 
  G  A  G  A  M  V  L  V  N  I  P  F  V  D  M  E  K  E  L  Q  
2161 GGCCGGACGGACCTCGTGGCCGCCATTGGCTCCTCGCCATCTTCATGTGTTGTTTCCGGT 
  G  R  T  D  L  V  A  A  I  G  S  S  P  S  S  C  V  V  S  G  
2221 GCCACTGAGGCTGTCCTGGCACTCGTGGAAGACCTCAAGTCTCGTGGTGTCAACGCTTTC 
  A  T  E  A  V  L  A  L  V  E  D  L  K  S  R  G  V  N  A  F  
2281 CGGGTCAAGACGGATATTCCCTTCCACCACCCGATGCTGGATCAACTGTCCGAGCCCTTG 
  R  V  K  T  D  I  P  F  H  H  P  M  L  D  Q  L  S  E  P  L  
2341 CGAGAGGCCATGGCAGGGTCCCTGTCGCCACGCAAGCCCAGAGTCCGTCTTTACTCGACG 
  R  E  A  M  A  G  S  L  S  P  R  K  P  R  V  R  L  Y  S  T  
2401 TCGGCAGAAGACCCACGCAGTATGGTTGCTCGGGATATATATTACTGGACCAGCAACATG 
  S  A  E  D  P  R  S  M  V  A  R  D  I  Y  Y  W  T  S  N  M  
2461 GTCAACCCGGTCCGGTTGACGGCCGCAGTGCAGGCAGCAGTGGACGATGGCCTGCGATTG 
  V  N  P  V  R  L  T  A  A  V  Q  A  A  V  D  D  G  L  R  L  
2521 TTCCTTGAAGTCTCTTCTCATCCCATTGTGTCCCACTCTGTCCGAGAGACCATGTTGGAC 
  F  L  E  V  S  S  H  P  I  V  S  H  S  V  R  E  T  M  L  D  
2581 CTGGGTGTGGAGGACTTCACCGTGACCAACACCATGGCTCGCAATAAGCCTGCCGACAAG 
  L  G  V  E  D  F  T  V  T  N  T  M  A  R  N  K  P  A  D  K  
2641 ACCATTCTGTCCAGCATTGCGCAGCTTCACTGTCGGGGCGCCGTCGTCAATTGGAAGAAG 
  T  I  L  S  S  I  A  Q  L  H  C  R  G  A  V  V  N  W  K  K  
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2701 CAGCTGCCGGGCCCTTGGGCGCTGGATGTGCCCTTGACGACCTGGGACCACAAGCCCTAC 
  Q  L  P  G  P  W  A  L  D  V  P  L  T  T  W  D  H  K  P  Y  
2761 TGGCGGCATATTCACACTGGCCCTATCAGTGCCTCGACTTTGCACGATGTGGACAAACAC 
  W  R  H  I  H  T  G  P  I  S  A  S  T  L  H  D  V  D  K  H  
2821 ACGCTGTTGGGTCAGCGCGTTCCCGTTGCGGGAGAAACAACTATGGTGTTCACCACCCAG 
  T  L  L  G  Q  R  V  P  V  A  G  E  T  T  M  V  F  T  T  Q  
2881 ATGGATGACCAGACCAAGCCTTTCCCAGGAAGCCATCCACTGCACGGCTCTGAGATTGTT 
  M  D  D  Q  T  K  P  F  P  G  S  H  P  L  H  G  S  E  I  V  
2941 CCGGCTGCTGCCCTTGTCAACACTTTCCTGCATGCCACCGGGGCTACCACCCTTTCCAAC 
  P  A  A  A  L  V  N  T  F  L  H  A  T  G  A  T  T  L  S  N  
3001 ATTACCCTTCGCGTGCCAGTGGCCATCAGCCAGCCGCGCGACATCCAGGTGGTGGTGTCA 
  I  T  L  R  V  P  V  A  I  S  Q  P  R  D  I  Q  V  V  V  S  
3061 CAGAATCAAATCAAGATCTGCTCCCGTCTCACTCAGAAGGCGGGTTCTGGGGCAGACGAA 
  Q  N  Q  I  K  I  C  S  R  L  T  Q  K  A  G  S  G  A  D  E  
3121 GGTTCCTGGCTGACACACACTACGGGTCAGTGGGAGGCTGGTGGAAGCAAGAACGCCCCG 
  G  S  W  L  T  H  T  T  G  Q  W  E  A  G  G  S  K  N  A  P  
3181 GCGCAACTCGATATTGCTGCTATCAAGGCTCGTCTCGCTAATAACAAATTGGCGGACAAC 
  A  Q  L  D  I  A  A  I  K  A  R  L  A  N  N  K  L  A  D  N  
3241 TTCTCCATCGACTATTTGGACAAGGTTGGCGTTTCAGCAATGGGCTTTCCTTGGGCAGTT 
  F  S  I  D  Y  L  D  K  V  G  V  S  A  M  G  F  P  W  A  V  
3301 ACAGAGCACTACGGCACCCTGCAGGAGATGATCGCTCGCGTTGATGTCGCGCCAGACGTC 
  T  E  H  Y  G  T  L  Q  E  M  I  A  R  V  D  V  A  P  D  V  
3361 CCCGCGACCAGTCCACTCCCCTGGGATGCTGCCTCTTGGGCCCCGATCCTCGATGCGGCC 
  P  A  T  S  P  L  P  W  D  A  A  S  W  A  P  I  L  D  A  A  
3421 ACCTCAGTGGGATCCACTCTCTTTTTCGATCAGCCTCGCCTGCGCATGCCGGCTCACATT 
  T  S  V  G  S  T  L  F  F  D  Q  P  R  L  R  M  P  A  H  I  
3481 CACGGGGTTCAAGTCTACACCACGCAGCCGCCTCCCAAGGTGGGTTACCTGTACGTGGAA 
  H  G  V  Q  V  Y  T  T  Q  P  P  P  K  V  G  Y  L  Y  V  E  
3541 AAGGCTGGCGATCGGGATCTGGCGGTGCATGTCAGTGTCTGCGACGAGCTCGGAACCGTC 
  K  A  G  D  R  D  L  A  V  H  V  S  V  C  D  E  L  G  T  V  
3601 TTAGCTCGATTCGAATCCATGCGCTTTTCCGAGATCGAAGGCACGCCGGGCAGTAACGGC 
  L  A  R  F  E  S  M  R  F  S  E  I  E  G  T  P  G  S  N  G  
3661 AGCGAGGAGAGTCTTGTCCATCAGCTCGCATGGCCTCCCGCGATCTACAGCGAGAGGCCG 
  S  E  E  S  L  V  H  Q  L  A  W  P  P  A  I  Y  S  E  R  P  
3721 CTGACAATCAACAATGTCGTCCTCGTTTCCCGGGATAAGAACGTCGCAGATCTCTACTGT 
  L  T  I  N  N  V  V  L  V  S  R  D  K  N  V  A  D  L  Y  C  
3781 GGGTCCTTGAAAGATCGTGTGTCATCTATCACGGTGCTGGATGCTGCTGCCGACCTGCTT 
  G  S  L  K  D  R  V  S  S  I  T  V  L  D  A  A  A  D  L  L  
3841 TCCCTTTCGCAGGATTCCAGCAGTGTCTTGCAAGCAAAAGATACAGCGGTGGTGTACGTG 
  S  L  S  Q  D  S  S  S  V  L  Q  A  K  D  T  A  V  V  Y  V  
3901 CCCGGTCCCCTCCACAGCGCGGATTCTATCCCGACTGCGGCCCATTCTTTCCTCATGGAA 
  P  G  P  L  H  S  A  D  S  I  P  T  A  A  H  S  F  L  M  E  
3961 TTGCTCCTCCTGGTCAAAATCATTGTCAATGGCTCTTTGCCCACCAAGGTCTTTGTCCTT 
  L  L  L  L  V  K  I  I  V  N  G  S  L  P  T  K  V  F  V  L  
4021 ACGGACCGCGTCTGCGAGAGTGAGTCTGCTACGGCTCTCGCTCAGTCTCCGATCCACGGT 
  T  D  R  V  C  E  S  E  S  A  T  A  L  A  Q  S  P  I  H  G  
4081 GTCTCCCGTATCATTGCTGCGGAGCACCCAGATCAATGGGGCGGACTGATTGACGTCGAA 
  V  S  R  I  I  A  A  E  H  P  D  Q  W  G  G  L  I  D  V  E  
4141 ACGCCGGGCCAGTTCTCACTCGAGACGATGAAGTATGTGCAGGAGGCGGATAACATCCGC 
  T  P  G  Q  F  S  L  E  T  M  K  Y  V  Q  E  A  D  N  I  R  
4201 ATCTCGGATGGCATACCCAGAATTGCTCGTCTGCGCCCGCTTCCTCGCGACAAGCTCCTA 
  I  S  D  G  I  P  R  I  A  R  L  R  P  L  P  R  D  K  L  L  
4261 CCGCCTAGCAAGCAGACTTCCCTGCTCCCCCGACCCGAAGGTACCTACTTGATTACGGGT 
  P  P  S  K  Q  T  S  L  L  P  R  P  E  G  T  Y  L  I  T  G  
4321 GGACTGGGCGCTCTGGGGTTGGAGGTCGCACAGTTCCTGGTGGAAAAGGGTGCTCGTCGA 
  G  L  G  A  L  G  L  E  V  A  Q  F  L  V  E  K  G  A  R  R  
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4381 TTGATCCTCGTTTCTCGGCGTGCCTTGCCTCCGCGCCGGGAGTGGGCAGACATCCTTGCT 
  L  I  L  V  S  R  R  A  L  P  P  R  R  E  W  A  D  I  L  A  
4441 GATGCATCATCCTCGCTGGCGCCGGCGCTGGAGACAATCCAGGCCCTTGAAGCACAGGGA 
  D  A  S  S  S  L  A  P  A  L  E  T  I  Q  A  L  E  A  Q  G  
4501 GCCACTGTCCACACTCTTGCAGTGGACATTTCCTCTCCTGACGCAGCGCCTCAACTGGCT 
  A  T  V  H  T  L  A  V  D  I  S  S  P  D  A  A  P  Q  L  A  
4561 GTCGCCATTGATTCTCTGTCGCTACCCCCAGTCCGCGGCGTGGTCCACGCAGCAGGCGTT 
  V  A  I  D  S  L  S  L  P  P  V  R  G  V  V  H  A  A  G  V  
4621 CTGGACAGCCAGCTGGTCCTCTCCGCCACGTCAGACTCTGTCGAGCGCGTGCTGGCGCCC 
  L  D  S  Q  L  V  L  S  A  T  S  D  S  V  E  R  V  L  A  P  
4681 AAGATCACCGGAGCGCTGGTCCTTGGCACCGTCTTCCCCCCCAAGGCCCTCGATTTCTTC 
  K  I  T  G  A  L  V  L  G  T  V  F  P  P  K  A  L  D  F  F  
4741 ATGCTATTCTCCTCGTGCGGACAGCTACTAGGCTTCCCGGGTCAAGCATCCTACGCGTCC 
  M  L  F  S  S  C  G  Q  L  L  G  F  P  G  Q  A  S  Y  A  S  
4801 GGAAACGCGTTCCTTGATGCATTCGCAACCTCGCGCCGACACCAAGGAGACAACGCTGTC 
  G  N  A  F  L  D  A  F  A  T  S  R  R  H  Q  G  D  N  A  V  
4861 GCCGTGCAGTGGACCAGCTGGCGCTCCCTCGGCATGGCAGCCAGTACCGACTTCATCAAC 
  A  V  Q  W  T  S  W  R  S  L  G  M  A  A  S  T  D  F  I  N  
4921 GCTGAGCTGGCCAGCAAGGGCATCACTGACATCACGCGCGACGAGGGATTCCGCGCATGG 
  A  E  L  A  S  K  G  I  T  D  I  T  R  D  E  G  F  R  A  W  
4981 ATGCATATTTCCAAATATGATATCGACCAGGCCGCGGTCTTGCGCAGTCTGGCCTTCGAG 
  M  H  I  S  K  Y  D  I  D  Q  A  A  V  L  R  S  L  A  F  E  
5041 GCCGATGAACCCCTCCCCACCCCTATCCTTACGGATATTGCCGTCCGCAAGGCTGGCTCC 
  A  D  E  P  L  P  T  P  I  L  T  D  I  A  V  R  K  A  G  S  
5101 GCCTCCTCCGCGGATGCTCCCTCTGCTGCACCGAAAGAGACGAACGAAATGCCGGAATCG 
  A  S  S  A  D  A  P  S  A  A  P  K  E  T  N  E  M  P  E  S  
5161 ATCCCGGAGCGTCGTACCTGGTTGGATGAGCGAATCCGTGATTGTGTGGCCCGCGTGCTT 
  I  P  E  R  R  T  W  L  D  E  R  I  R  D  C  V  A  R  V  L  
5221 CAGCTGGGGAGCAGCGACGAGGTTGATTCCAAGGCCGCTCTGAGTGACCTGGGAGTCGAC 
  Q  L  G  S  S  D  E  V  D  S  K  A  A  L  S  D  L  G  V  D  
5281 AGTGTCATGACCGTTAGCTTGAGAGGTCAGCTGCAGAAGACGTTGGGGGTCAAGGTGCCA 
  S  V  M  T  V  S  L  R  G  Q  L  Q  K  T  L  G  V  K  V  P  
5341 CCCACACTGACCTGGAGTTGCCCGACGGTGTCACATCTGGTGGGATGGTTTTTGGAAAAG 
  P  T  L  T  W  S  C  P  T  V  S  H  L  V  G  W  F  L  E  K  
5401 ATGGGAAATCATCATCATCATCATCATTAA 
  M  G  N  H  H  H  H  H  H  -   
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1 ATGGAAGTTCACGGTGACGAAGTTTTGTCTGTTGACTCTGGTGTTTCTACTCCACCATCT 
  M  E  V  H  G  D  E  V  L  S  V  D  S  G  V  S  T  P  P  S  
61 ACTGGTTCTGGTTTCAGAAGACCATTGGAAACTCCAGGTACTGAAATCGGTAACTTGAAC 
  T  G  S  G  F  R  R  P  L  E  T  P  G  T  E  I  G  N  L  N  
121 TTGAACCCACAAAACGAAGTTGCTGTTGTTGGTATGGCTTGTAGATTGGCTGGTGGTAAC 
  L  N  P  Q  N  E  V  A  V  V  G  M  A  C  R  L  A  G  G  N  
181 AACTCTCCAGAAGAATTGTGGCAATCTATCTTGAACAGAAAGGACGCTTCTGGTGAAATC 
  N  S  P  E  E  L  W  Q  S  I  L  N  R  K  D  A  S  G  E  I  
241 CCATCTATGAGATGGGAACCATACTACAGAAGAGACATCAGAAACCCAAAGATCTTGGAC 
  P  S  M  R  W  E  P  Y  Y  R  R  D  I  R  N  P  K  I  L  D  
301 CAAACTACTAAGAGAGGTTACTTCTTGGACCACGTTGAAAACTTTGATGCTGCGTTCTTC 
  Q  T  T  K  R  G  Y  F  L  D  H  V  E  N  F  D  A  A  F  F  
361 GGTGTTTCGCCAAAGGAAGCTGAACAAATGGACCCACAACAAAGATTGTCTTTGGAAGTT 
  G  V  S  P  K  E  A  E  Q  M  D  P  Q  Q  R  L  S  L  E  V  
421 ACTTGGGAAGCTTTGGAAGACGCTGGTATCCCACCACAATCTTTGTCTGGTTCTGAAACT 
  T  W  E  A  L  E  D  A  G  I  P  P  Q  S  L  S  G  S  E  T  
481 GCTGTTTTCATGGGTGTTAACTCTGACGACTACTCTAAGTTGTTGTTGGAAGACATCCCA 
  A  V  F  M  G  V  N  S  D  D  Y  S  K  L  L  L  E  D  I  P  
541 AACGTTGAAGCTAGAATGGGTATCGGTACTGCTTACTGTGGTGTTCCAAACAGAATCTCT 
  N  V  E  A  R  M  G  I  G  T  A  Y  C  G  V  P  N  R  I  S  
601 TACCACTTGAACTTGATGGGTCCATCTACTGCTGTTGACGCTGCTTGTGCTTCTTCTTTG 
  Y  H  L  N  L  M  G  P  S  T  A  V  D  A  A  C  A  S  S  L  
661 GTTGCTATCCACCACGGTAGACAAGCTATCTTGCAAGGTGAATCTGAAGTTGCTATCGTT 
  V  A  I  H  H  G  R  Q  A  I  L  Q  G  E  S  E  V  A  I  V  
721 GGTGGTGTTAACGCTTTGTGTGGTCCAGGTTTGACTAGAGTTTTGGACAAGGCTGGTGCT 
  G  G  V  N  A  L  C  G  P  G  L  T  R  V  L  D  K  A  G  A  
781 ACTTCTACTGAAGGCCGTTGCCTATCTTTCGACGAAGACGCTAAGGGTTACGGTAGAGGT 
  T  S  T  E  G  R  C  L  S  F  D  E  D  A  K  G  Y  G  R  G  
841 GAAGGTGCTGCTGTTGTTATCTTGAAGAGATTGTCTACTGCTATCAGAGACGGTGACCAC 
  E  G  A  A  V  V  I  L  K  R  L  S  T  A  I  R  D  G  D  H  
901 ATCAGAGCTATCATCAAGGGTTCTGCTGTTGCTCAAGACGGTAAGACTAACGGTATCATG 
  I  R  A  I  I  K  G  S  A  V  A  Q  D  G  K  T  N  G  I  M  
961 GCTCCAAACGCTAAGGCTCAAGAATTGGTTGCTTGGAACGCTTTGAGAACTGCTGGTGTT 
  A  P  N  A  K  A  Q  E  L  V  A  W  N  A  L  R  T  A  G  V  
1021 GACCCATTGACTGTTGGTTACGTTGAAGCTCACGCTACTTCTACTCCATTGGGTGACCCA 
  D  P  L  T  V  G  Y  V  E  A  H  A  T  S  T  P  L  G  D  P  
1081 ACTGAAGTGAGCGTTGTTTCGGCTGTGTACGGAAAGGGTAGACCAGAAGGTAACCCATGT 
  T  E  V  S  V  V  S  A  V  Y  G  K  G  R  P  E  G  N  P  C  
1141 TTCATCGGTTCTGTTAAGCCAAACGTTGGTCACTTGGAAGCTGGTGCTGGTGCTGTTGGT 
  F  I  G  S  V  K  P  N  V  G  H  L  E  A  G  A  G  A  V  G  
1201 TTCATCAAGGCTGTTATGGCTGTTGAAAAGGCTATCTTCCCACCACAAACTAACTTGAAG 
  F  I  K  A  V  M  A  V  E  K  A  I  F  P  P  Q  T  N  L  K  
1261 AGATTGAACTCTAGAATCGACTGGGGTCAAGCTGGTGTTAAGGTTGTTCAAGAAACTTTG 
  R  L  N  S  R  I  D  W  G  Q  A  G  V  K  V  V  Q  E  T  L  
1321 GAATGGCCAGGTAACGAAGACGACGTTAGAAGAGCTGGTGTTTGTTCTTACGGTTACGGC 
  E  W  P  G  N  E  D  D  V  R  R  A  G  V  C  S  Y  G  Y  G  
1381 GGCACTGTAAGCCACGCTATCATCGAAGAATTCGCTCAACAATTGCAAAGACCAACTACT 
  G  T  V  S  H  A  I  I  E  E  F  A  Q  Q  L  Q  R  P  T  T  
1441 AACACTACTGACGAAGACCCATTGCCAAGAATCTTGTTGTTGTCTGCTCCACAAGAAAGA 
  N  T  T  D  E  D  P  L  P  R  I  L  L  L  S  A  P  Q  E  R  
1501 AGATTGGCTTTGCAAGCTAGAACTCAAGCTTCTTGGATCGCTGCTGAAGGTAGAAACAGA 
  R  L  A  L  Q  A  R  T  Q  A  S  W  I  A  A  E  G  R  N  R  
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1561 ACTTTGGAATCTATCGCTACTACTTTGTCTACTAGAAGAGGTCACCACGACTACAGAGCT 
  T  L  E  S  I  A  T  T  L  S  T  R  R  G  H  H  D  Y  R  A  
1621 GCTATCATCGCTGAAAACCACGACGACGCTGTTCAAAAGTTGTCTGACATCGTTAACGGT 
  A  I  I  A  E  N  H  D  D  A  V  Q  K  L  S  D  I  V  N  G  
1681 AAGGCTGCTGAATGGACTACTTCTTCTAGAGTTTTGGACGCTTCTTGTAGTAAGGACGTT 
  K  A  A  E  W  T  T  S  S  R  V  L  D  A  S  C  S  K  D  V  
1741 GTGTGGGTGTTCTCTGGTCACGGTGCTCAATGGACTGCTATGGCTACTGACTTGTTGAAG 
  V  W  V  F  S  G  H  G  A  Q  W  T  A  M  A  T  D  L  L  K  
1801 GACATCGTTTTCTACCAAACTATCTCTAGATTGGACCCAATCGTTGAAAGAGAAATGGGT 
  D  I  V  F  Y  Q  T  I  S  R  L  D  P  I  V  E  R  E  M  G  
1861 TTTAGTGCTCTCCACTCTTTGGCGTCTGGTGACTTCGAATCTTCTATCAAAGTTCAAGTA 
  F  S  A  L  H  S  L  A  S  G  D  F  E  S  S  I  K  V  Q  V  
1921 CTCACTTACCTCGTTCAGGTTGGTCTCGCTGCTATCCTCAGATCTAAGGGTTTGGAACCA 
  L  T  Y  L  V  Q  V  G  L  A  A  I  L  R  S  K  G  L  E  P  
1981 CAAGCTGTTATCGGTCACTCTGTTGGTGAAATCGCTGCTTCTGTTGCTGCTGGTTGTTTG 
  Q  A  V  I  G  H  S  V  G  E  I  A  A  S  V  A  A  G  C  L  
2041 ACTGCTGAAGAAGGTGCTTTGATCGTTACTAGAAGAGCTAACTTGTACAGAAGAGTTATG 
  T  A  E  E  G  A  L  I  V  T  R  R  A  N  L  Y  R  R  V  M  
2101 GGTGCTGGTGCTATGGTTTTGGTTAACATCCCATTCGTTGACATGGAAAAGGAATTGCAA 
  G  A  G  A  M  V  L  V  N  I  P  F  V  D  M  E  K  E  L  Q  
2161 GGTAGAACTGACTTGGTTGCTGCTATCGGTTCTTCTCCATCTTCTTGTGTTGTTTCTGGT 
  G  R  T  D  L  V  A  A  I  G  S  S  P  S  S  C  V  V  S  G  
2221 GCTACTGAAGCTGTTTTGGCTTTGGTTGAAGACTTGAAGTCTAGAGGTGTTAACGCTTTC 
  A  T  E  A  V  L  A  L  V  E  D  L  K  S  R  G  V  N  A  F  
2281 AGAGTTAAGACTGACATCCCATTCCACCACCCAATGTTGGACCAATTGTCTGAACCATTG 
  R  V  K  T  D  I  P  F  H  H  P  M  L  D  Q  L  S  E  P  L  
2341 AGAGAAGCTATGGCTGGTTCTTTGTCTCCAAGAAAGCCAAGAGTTAGATTGTACTCTACT 
  R  E  A  M  A  G  S  L  S  P  R  K  P  R  V  R  L  Y  S  T  
2401 TCTGCTGAAGACCCAAGATCTATGGTTGCTAGAGACATCTACTACTGGACTTCTAACATG 
  S  A  E  D  P  R  S  M  V  A  R  D  I  Y  Y  W  T  S  N  M  
2461 GTTAACCCAGTTAGATTGACTGCTGCTGTTCAAGCTGCTGTTGACGACGGTTTGAGATTG 
  V  N  P  V  R  L  T  A  A  V  Q  A  A  V  D  D  G  L  R  L  
2521 TTCTTGGAAGTTTCTTCTCACCCAATCGTTTCTCACTCTGTTAGAGAAACTATGTTGGAC 
  F  L  E  V  S  S  H  P  I  V  S  H  S  V  R  E  T  M  L  D  
2581 TTGGGTGTTGAAGACTTCACTGTTACTAACACTATGGCTAGAAACAAGCCAGCTGACAAG 
  L  G  V  E  D  F  T  V  T  N  T  M  A  R  N  K  P  A  D  K  
2641 ACTATCTTGTCTTCTATCGCTCAATTGCACTGTAGAGGTGCTGTTGTTAACTGGAAGAAG 
  T  I  L  S  S  I  A  Q  L  H  C  R  G  A  V  V  N  W  K  K  
2701 CAATTGCCAGGTCCATGGGCTTTGGACGTTCCATTGACTACTTGGGACCACAAGCCATAC 
  Q  L  P  G  P  W  A  L  D  V  P  L  T  T  W  D  H  K  P  Y  
2761 TGGAGACACATCCACACTGGTCCAATCTCTGCTTCTACTTTGCACGACGTTGACAAGCAC 
  W  R  H  I  H  T  G  P  I  S  A  S  T  L  H  D  V  D  K  H  
2821 ACTTTGTTGGGTCAAAGAGTTCCAGTTGCTGGTGAAACTACTATGGTTTTCACTACTCAA 
  T  L  L  G  Q  R  V  P  V  A  G  E  T  T  M  V  F  T  T  Q  
2881 ATGGACGACCAAACTAAGCCATTCCCAGGTTCTCACCCATTGCACGGTTCTGAAATCGTT 
  M  D  D  Q  T  K  P  F  P  G  S  H  P  L  H  G  S  E  I  V  
2941 CCAGCTGCTGCTTTGGTTAACACTTTCTTGCACGCTACTGGTGCTACTACTTTGTCTAAC 
  P  A  A  A  L  V  N  T  F  L  H  A  T  G  A  T  T  L  S  N  
3001 ATCACTTTGAGAGTTCCAGTTGCTATCTCTCAACCAAGAGACATCCAAGTTGTTGTTTCT 
  I  T  L  R  V  P  V  A  I  S  Q  P  R  D  I  Q  V  V  V  S  
3061 CAAAACCAAATCAAGATCTGTTCTAGATTGACTCAAAAGGCTGGTTCTGGTGCTGACGAA 
  Q  N  Q  I  K  I  C  S  R  L  T  Q  K  A  G  S  G  A  D  E  
3121 GGTTCTTGGTTGACTCACACTACTGGTCAATGGGAAGCTGGTGGTTCTAAGAACGCTCCA 
  G  S  W  L  T  H  T  T  G  Q  W  E  A  G  G  S  K  N  A  P  
3181 GCTCAATTGGACATCGCTGCTATCAAGGCTAGATTGGCTAACAACAAGTTGGCTGACAAC 
  A  Q  L  D  I  A  A  I  K  A  R  L  A  N  N  K  L  A  D  N  
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3241 TTCTCTATCGACTACTTGGACAAGGTTGGTGTTTCTGCTATGGGTTTCCCATGGGCTGTT 
  F  S  I  D  Y  L  D  K  V  G  V  S  A  M  G  F  P  W  A  V  
3301 ACTGAACACTACGGTACTTTGCAAGAAATGATCGCTAGAGTTGACGTTGCTCCAGACGTT 
  T  E  H  Y  G  T  L  Q  E  M  I  A  R  V  D  V  A  P  D  V  
3361 CCAGCTACTTCTCCATTGCCATGGGACGCTGCTTCTTGGGCTCCAATCTTGGACGCTGCT 
  P  A  T  S  P  L  P  W  D  A  A  S  W  A  P  I  L  D  A  A  
3421 ACTTCTGTTGGTTCTACTTTGTTCTTCGACCAACCAAGATTGAGAATGCCAGCTCACATC 
  T  S  V  G  S  T  L  F  F  D  Q  P  R  L  R  M  P  A  H  I  
3481 CACGGTGTTCAAGTTTACACTACTCAACCACCACCAAAGGTTGGTTACTTGTACGTTGAA 
  H  G  V  Q  V  Y  T  T  Q  P  P  P  K  V  G  Y  L  Y  V  E  
3541 AAGGCTGGTGACAGAGACCTCGCGGTTCACGTAAGCGTGTGCGACGAATTGGGTACTGTT 
  K  A  G  D  R  D  L  A  V  H  V  S  V  C  D  E  L  G  T  V  
3601 TTGGCTAGATTCGAATCTATGAGATTCTCTGAAATCGAAGGTACTCCAGGTTCTAACGGT 
  L  A  R  F  E  S  M  R  F  S  E  I  E  G  T  P  G  S  N  G  
3661 TCTGAGGAGAGCTTGGTTCACCAACTCGCTTGGCCACCAGCTATCTACTCTGAAAGACCA 
  S  E  E  S  L  V  H  Q  L  A  W  P  P  A  I  Y  S  E  R  P  
3721 TTGACTATCAATAATGTTGTGCTGGTTTCTAGAGACAAGAACGTTGCTGACTTGTACTGT 
  L  T  I  N  N  V  V  L  V  S  R  D  K  N  V  A  D  L  Y  C  
3781 GGTTCGTTGAAGGACAGAGTGTCGTCGATCACTGTGCTAGACGCTGCTGCTGACTTGTTG 
  G  S  L  K  D  R  V  S  S  I  T  V  L  D  A  A  A  D  L  L  
3841 TCTTTGTCTCAAGACTCTTCTTCTGTTTTGCAAGCTAAGGACACTGCTGTTGTTTACGTT 
  S  L  S  Q  D  S  S  S  V  L  Q  A  K  D  T  A  V  V  Y  V  
3901 CCAGGTCCATTGCACTCTGCTGACTCTATCCCAACTGCTGCTCACTCTTTCTTGATGGAA 
  P  G  P  L  H  S  A  D  S  I  P  T  A  A  H  S  F  L  M  E  
3961 TTGTTGTTGTTGGTTAAGATCATCGTTAACGGTTCTTTGCCAACTAAGGTTTTCGTTTTG 
  L  L  L  L  V  K  I  I  V  N  G  S  L  P  T  K  V  F  V  L  
4021 ACTGACAGAGTTTGTGAATCTGAATCTGCTACTGCTTTGGCTCAATCTCCAATCCACGGT 
  T  D  R  V  C  E  S  E  S  A  T  A  L  A  Q  S  P  I  H  G  
4081 GTTTCTAGAATCATCGCTGCTGAACACCCCGACCAATGGGGTGGTCTCATCGACGTTGAG 
  V  S  R  I  I  A  A  E  H  P  D  Q  W  G  G  L  I  D  V  E  
4141 ACTCCAGGTCAATTCTCTTTGGAAACTATGAAGTACGTTCAAGAAGCTGACAACATCAGA 
  T  P  G  Q  F  S  L  E  T  M  K  Y  V  Q  E  A  D  N  I  R  
4201 ATCTCTGACGGTATCCCAAGAATCGCTAGATTGAGACCATTGCCAAGAGACAAGTTGTTG 
  I  S  D  G  I  P  R  I  A  R  L  R  P  L  P  R  D  K  L  L  
4261 CCACCATCTAAGCAAACTTCTTTGTTGCCAAGACCAGAAGGTACTTACTTGATCACTGGT 
  P  P  S  K  Q  T  S  L  L  P  R  P  E  G  T  Y  L  I  T  G  
4321 GGTTTGGGTGCTTTGGGTTTGGAAGTTGCTCAATTCTTGGTTGAAAAGGGTGCTAGAAGA 
  G  L  G  A  L  G  L  E  V  A  Q  F  L  V  E  K  G  A  R  R  
4381 TTGATCTTGGTTTCTAGAAGAGCTTTGCCACCAAGAAGAGAATGGGCTGACATCTTGGCT 
  L  I  L  V  S  R  R  A  L  P  P  R  R  E  W  A  D  I  L  A  
4441 GACGCTTCTTCTTCTTTGGCTCCAGCTTTGGAAACTATCCAAGCTTTGGAAGCTCAAGGT 
  D  A  S  S  S  L  A  P  A  L  E  T  I  Q  A  L  E  A  Q  G  
4501 GCTACTGTTCACACTTTGGCTGTTGACATCTCTTCTCCAGACGCTGCTCCACAATTGGCT 
  A  T  V  H  T  L  A  V  D  I  S  S  P  D  A  A  P  Q  L  A  
4561 GTTGCTATCGACTCTTTGTCTTTGCCACCAGTTAGAGGTGTTGTTCACGCTGCTGGTGTT 
  V  A  I  D  S  L  S  L  P  P  V  R  G  V  V  H  A  A  G  V  
4621 TTGGACTCTCAATTGGTTTTGTCTGCTACTTCTGACTCGGTTGAGAGAGTCCTGGCTCCA 
  L  D  S  Q  L  V  L  S  A  T  S  D  S  V  E  R  V  L  A  P  
4681 AAGATCACTGGCGCGTTGGTACTAGGCACTGTATTCCCACCGAAGGCTTTGGACTTCTTC 
  K  I  T  G  A  L  V  L  G  T  V  F  P  P  K  A  L  D  F  F  
4741 ATGTTGTTCTCTTCTTGTGGTCAATTGTTGGGTTTCCCAGGTCAAGCTTCTTACGCTTCT 
  M  L  F  S  S  C  G  Q  L  L  G  F  P  G  Q  A  S  Y  A  S  
4801 GGTAACGCTTTCTTGGACGCTTTCGCTACTTCTAGAAGACACCAAGGTGACAACGCTGTT 
  G  N  A  F  L  D  A  F  A  T  S  R  R  H  Q  G  D  N  A  V  
4861 GCTGTTCAATGGACTTCTTGGAGATCTTTGGGTATGGCTGCTTCTACTGACTTCATCAAC 
  A  V  Q  W  T  S  W  R  S  L  G  M  A  A  S  T  D  F  I  N  
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4921 GCTGAATTGGCTTCTAAGGGTATCACTGACATCACTAGAGACGAAGGTTTCAGAGCTTGG 
  A  E  L  A  S  K  G  I  T  D  I  T  R  D  E  G  F  R  A  W  
4981 ATGCACATCTCTAAGTACGACATCGACCAAGCTGCTGTTTTGAGATCTTTGGCTTTCGAA 
  M  H  I  S  K  Y  D  I  D  Q  A  A  V  L  R  S  L  A  F  E  
5041 GCTGACGAACCATTGCCAACTCCAATCTTGACTGACATCGCTGTTAGAAAGGCTGGTTCT 
  A  D  E  P  L  P  T  P  I  L  T  D  I  A  V  R  K  A  G  S  
5101 GCTTCTTCTGCTGACGCTCCATCTGCTGCTCCAAAGGAAACTAACGAAATGCCAGAATCT 
  A  S  S  A  D  A  P  S  A  A  P  K  E  T  N  E  M  P  E  S  
5161 ATCCCAGAAAGAAGAACTTGGTTGGACGAAAGAATCAGAGACTGTGTTGCTAGAGTTTTG 
  I  P  E  R  R  T  W  L  D  E  R  I  R  D  C  V  A  R  V  L  
5221 CAATTGGGTTCTTCTGACGAAGTTGACTCTAAGGCTGCTTTGTCTGACTTGGGTGTTGAC 
  Q  L  G  S  S  D  E  V  D  S  K  A  A  L  S  D  L  G  V  D  
5281 TCTGTTATGACTGTTTCTTTGAGAGGTCAATTGCAAAAGACTTTGGGTGTTAAGGTTCCA 
  S  V  M  T  V  S  L  R  G  Q  L  Q  K  T  L  G  V  K  V  P  
5341 CCAACTTTGACTTGGTCTTGTCCAACTGTTTCTCACTTGGTTGGTTGGTTCTTGGAAAAG 
  P  T  L  T  W  S  C  P  T  V  S  H  L  V  G  W  F  L  E  K  
5401 ATGGGTAACCATCATCATCATCATCATTAA 
  M  G  N  H  H  H  H  H  H  -   
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Appendix C 
Codon Usage in Saccharomyces cerevisiae 
 
Saccharomyces cerevisiae [gbpln]: 14374 CDS's (6511964 codons)  
 
fields: [triplet] [frequency: per thousand] ([number]) ([relative adaptiveness]) 
 
UUU 26.1(170060)(100)  UCU 23.4(152620)(100)  UAU 18.8(122354)(100)  UGU  8.1( 52733)(100) 
UUC 18.4(119910)( 70)  UCC 14.2( 92548)( 61)  UAC 14.8( 96248)( 79)  UGC  4.8( 30943)( 59) 
UUA 26.2(170327)( 96)  UCA 18.7(121596)( 80)  UAA  1.0(  6799)(100)  UGA  0.7(  4295)( 70) 
UUG 27.2(176823)(100)  UCG  8.6( 55800)( 37)  UAG  0.5(  3265)( 50)  UGG 10.4( 67560)(100) 
 
CUU 12.3( 79881)( 45)  CCU 13.5( 87990)( 74)  CAU 13.6( 88855)(100)  CGU  6.4( 41669)( 30) 
CUC  5.4( 35412)( 20)  CCC  6.8( 44190)( 37)  CAC  7.8( 50602)( 57)  CGC  2.6( 16894)( 12) 
CUA 13.4( 87337)( 49)  CCA 18.3(118921)(100)  CAA 27.3(177781)(100)  CGA  3.0( 19515)( 14) 
CUG 10.5( 68195)( 39)  CCG  5.3( 34483)( 29)  CAG 12.1( 78912)( 44)  CGG  1.7( 11328)(  8) 
 
AUU 30.1(196148)(100)  ACU 20.2(131748)(100)  AAU 35.7(232548)(100)  AGU 14.2( 92246)( 61) 
AUC 17.1(111678)( 57)  ACC 12.7( 82630)( 63)  AAC 24.8(161656)( 69)  AGC  9.7( 63472)( 41) 
AUA 17.8(116024)( 59)  ACA 17.8(115724)( 88)  AAA 41.9(272927)(100)  AGA 21.3(138740)(100) 
AUG 21.0(136644)(100)  ACG  8.0( 51972)( 40)  AAG 30.8(200886)( 74)  AGG  9.2( 60209)( 43) 
 
GUU 22.1(143671)(100)  GCU 21.2(137737)(100)  GAU 37.6(245031)(100)  GGU 23.9(155345)(100) 
GUC 11.7( 76454)( 53)  GCC 12.6( 81955)( 59)  GAC 20.2(131713)( 54)  GGC  9.8( 63684)( 41) 
GUA 11.8( 76661)( 53)  GCA 16.2(105545)( 76)  GAA 45.6(297191)(100)  GGA 10.9( 71034)( 46) 
GUG 10.8( 70084)( 49)  GCG  6.2( 40267)( 29)  GAG 19.2(125264)( 42)  GGG  6.0( 39230)( 25) 
 
Coding GC 39.76% 1st letter GC 44.58% 2nd letter GC 36.62% 3rd letter GC 38.10% 
 
Source: http://www.kazusa.or.jp/codon/ 
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